{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The goal of this neural network is to determine the usefulness of an article. \n",
    "\n",
    "A prompt is given to the Ollama LLM to classify an article as 0 (not useful) or 1 (useful)\n",
    "\n",
    "The neural network is then trained on a set of articles that the LLM has classified. \n",
    "\n",
    "After training, a new article can be inputed and given a score of 0 or 1 for it's usefulness with respect to the initial prompt."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "import numpy as np\n",
    "import os\n",
    "import pickle\n",
    "import copy\n",
    "import ollama\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "import ollama\n",
    "from sklearn.model_selection import train_test_split\n",
    "\n",
    "\n",
    "\n",
    "import time\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Here's a breakdown of the libraries we're importing:\n",
    "\n",
    "numpy handles numerical computations for the neural network, \n",
    "ollama interfaces with the language model for embeddings and summaries, \n",
    "and requests with xml.etree.ElementTree enables PubMed API interactions to fetch article data. \n",
    "pandas organizes article metadata, matplotlib visualizes training metrics, and sklearn ensures proper train-test splitting. \n",
    "\n",
    "These dependencies enable seamless data processing, model training, and result analysis, ensuring the project is robust and scalable.\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "#----------------\n",
    "# LAYER DENSE\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Layer_Dense:\n",
    "    def __init__(self, n_inputs, n_neurons, weight_regularizer_l1=0, weight_regularizer_l2=0, bias_regularizer_l1=0, bias_regularizer_l2=0):\n",
    "        self.weights = .01 * np.random.randn(n_inputs, n_neurons)\n",
    "        self.biases = np.zeros((1, n_neurons))\n",
    "        self.weight_regularizer_l1 = weight_regularizer_l1\n",
    "        self.weight_regularizer_l2 = weight_regularizer_l2\n",
    "        self.bias_regularizer_l1 = bias_regularizer_l1\n",
    "        self.bias_regularizer_l2 = bias_regularizer_l2\n",
    "\n",
    "    def forward(self, inputs, training):\n",
    "        self.inputs = inputs\n",
    "        self.output = np.dot(inputs, self.weights) + self.biases\n",
    "        return self.output\n",
    "\n",
    "    def backward(self, dvalues):\n",
    "        self.dweights = np.dot(self.inputs.T, dvalues)\n",
    "        self.dbiases = np.sum(dvalues, axis=0, keepdims=True)\n",
    "        if self.weight_regularizer_l1 > 0:\n",
    "            dl1 = np.ones_like(self.weights)\n",
    "            dl1[self.weights < 0] = -1\n",
    "            self.dweights += self.weight_regularizer_l1 * dl1\n",
    "        if self.weight_regularizer_l2 > 0:\n",
    "            self.dweights += 2 * self.weight_regularizer_l2 * self.weights\n",
    "        if self.bias_regularizer_l1 > 0:\n",
    "            dl1 = np.ones_like(self.biases)\n",
    "            dl1[self.biases < 0] = -1\n",
    "            self.dbiases += self.bias_regularizer_l1 * dl1\n",
    "        if self.bias_regularizer_l2 > 0:\n",
    "            self.dbiases += 2 * self.bias_regularizer_l2 * self.biases\n",
    "        self.dinputs = np.dot(dvalues, self.weights.T)\n",
    "        return self.dinputs\n",
    "\n",
    "    def get_parameters(self):\n",
    "        return self.weights, self.biases\n",
    "\n",
    "    def set_parameters(self, weights, biases):\n",
    "        self.weights = weights\n",
    "        self.biases = biases\n",
    "\n",
    "class Layer_Dropout:\n",
    "    def __init__(self, rate):\n",
    "        self.rate = 1 - rate\n",
    "\n",
    "    def forward(self, inputs, training):\n",
    "        self.inputs = inputs\n",
    "        if not training:\n",
    "            self.output = inputs.copy()\n",
    "        else:\n",
    "            self.binary_mask = np.random.binomial(1, self.rate, size=inputs.shape) / self.rate\n",
    "            self.output = inputs * self.binary_mask\n",
    "        return self.output\n",
    "\n",
    "    def backward(self, dvalues):\n",
    "        self.dinputs = dvalues * self.binary_mask\n",
    "        return self.dinputs  # Added return\n",
    "\n",
    "class Layer_Input:\n",
    "    def forward(self, inputs, training):\n",
    "        self.output = inputs\n",
    "        return self.output\n",
    "\n",
    "#----------------\n",
    "# ACTIVATION FUNCTIONS\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Activation_ReLU:\n",
    "    def forward(self, inputs, training):\n",
    "        self.inputs = inputs\n",
    "        self.output = np.maximum(0, inputs)\n",
    "        return self.output\n",
    "\n",
    "    def backward(self, dvalues):\n",
    "        self.dinputs = dvalues.copy()\n",
    "        self.dinputs[self.inputs <= 0] = 0\n",
    "        return self.dinputs\n",
    "\n",
    "    def predictions(self, outputs):\n",
    "        return outputs\n",
    "\n",
    "class Activation_Sigmoid:\n",
    "\n",
    "    def forward(self, inputs, training):\n",
    "        self.inputs = inputs\n",
    "        self.output = 1 / (1 + np.exp(-inputs))\n",
    "        return self.output\n",
    "\n",
    "    def backward(self, dvalues):\n",
    "        if self.output is None:\n",
    "            raise ValueError(\"Sigmoid backward: self.output is None; forward pass may not have been called correctly\")\n",
    "        self.dinputs = dvalues * (1 - self.output) * self.output\n",
    "        return self.dinputs\n",
    "\n",
    "    def predictions(self, outputs):\n",
    "        return (outputs > 0.5) * 1\n",
    "\n",
    "\n",
    "#----------------\n",
    "# OPTIMIZER\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Optimizer_SGD:\n",
    "    def __init__(self, learning_rate=1., decay=0., momentum=0.):\n",
    "        self.learning_rate = learning_rate\n",
    "        self.current_learning_rate = learning_rate\n",
    "        self.decay = decay\n",
    "        self.iterations = 0\n",
    "        self.momentum = momentum\n",
    "\n",
    "    def pre_update_params(self):\n",
    "        if self.decay:\n",
    "            self.current_learning_rate = self.learning_rate * (1. / (1. + self.decay * self.iterations))\n",
    "\n",
    "    def update_params(self, layer):\n",
    "        if self.momentum:\n",
    "            if not hasattr(layer, 'weight_momentums'):\n",
    "                layer.weight_momentums = np.zeros_like(layer.weights)\n",
    "                layer.bias_momentums = np.zeros_like(layer.biases)\n",
    "            weight_updates = self.momentum * layer.weight_momentums - self.current_learning_rate * layer.dweights\n",
    "            layer.weight_momentums = weight_updates\n",
    "            bias_updates = self.momentum * layer.bias_momentums - self.current_learning_rate * layer.dbiases\n",
    "            layer.bias_momentums = bias_updates\n",
    "        else:\n",
    "            weight_updates = -self.current_learning_rate * layer.dweights\n",
    "            bias_updates = -self.current_learning_rate * layer.dbiases\n",
    "        layer.weights += weight_updates\n",
    "        layer.biases += bias_updates\n",
    "\n",
    "    def post_update_params(self):\n",
    "        self.iterations += 1\n",
    "\n",
    "\n",
    "#----------------\n",
    "# LOSS FUNCTIONS\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Loss:\n",
    "    def regularization_loss(self):\n",
    "        regularization_loss = 0\n",
    "        for layer in self.trainable_layers:\n",
    "            if layer.weight_regularizer_l1 > 0:\n",
    "                regularization_loss += layer.weight_regularizer_l1 * np.sum(np.abs(layer.weights))\n",
    "            if layer.weight_regularizer_l2 > 0:\n",
    "                regularization_loss += layer.weight_regularizer_l2 * np.sum(layer.weights * layer.weights)\n",
    "            if layer.bias_regularizer_l1 > 0:\n",
    "                regularization_loss += layer.bias_regularizer_l1 * np.sum(np.abs(layer.biases))\n",
    "            if layer.bias_regularizer_l2 > 0:\n",
    "                regularization_loss += layer.bias_regularizer_l2 * np.sum(layer.biases * layer.biases)\n",
    "        return regularization_loss\n",
    "\n",
    "    def remember_trainable_layers(self, trainable_layers):\n",
    "        self.trainable_layers = trainable_layers\n",
    "\n",
    "    def calculate(self, output, y, *, include_regularization=False):\n",
    "        sample_losses = self.forward(output, y)\n",
    "        data_loss = np.mean(sample_losses)\n",
    "        self.accumulated_sum += np.sum(sample_losses)\n",
    "        self.accumulated_count += len(sample_losses)\n",
    "        if not include_regularization:\n",
    "            return data_loss\n",
    "        return data_loss, self.regularization_loss()\n",
    "\n",
    "    def calculate_accumulated(self, *, include_regularization=False):\n",
    "        data_loss = self.accumulated_sum / self.accumulated_count\n",
    "        if not include_regularization:\n",
    "            return data_loss\n",
    "        return data_loss, self.regularization_loss()\n",
    "\n",
    "    def new_pass(self):\n",
    "        self.accumulated_sum = 0\n",
    "        self.accumulated_count = 0\n",
    "\n",
    "\n",
    "\n",
    "class Loss_BinaryCrossEntropy(Loss):\n",
    "    def forward(self, y_pred, y_true):\n",
    "        y_pred_clipped = np.clip(y_pred, 1e-7, 1-1e-7)\n",
    "        if len(y_true.shape) == 1:\n",
    "            y_true = y_true[:, np.newaxis]\n",
    "        sample_losses = -(y_true * np.log(y_pred_clipped) + (1 - y_true) * np.log(1 - y_pred_clipped))\n",
    "        sample_losses = np.mean(sample_losses, axis=-1)\n",
    "        return sample_losses\n",
    "\n",
    "    def backward(self, dvalues, y_true):\n",
    "        samples = len(dvalues)\n",
    "        outputs = len(dvalues[0])\n",
    "        clipped_dvalues = np.clip(dvalues, 1e-7, 1-1e-7)\n",
    "        if len(y_true.shape) == 1:\n",
    "            y_true = y_true[:, np.newaxis]\n",
    "        self.dinputs = -(y_true / clipped_dvalues - (1 - y_true) / (1 - clipped_dvalues)) / outputs\n",
    "        self.dinputs = self.dinputs / samples\n",
    "        return self.dinputs\n",
    "\n",
    "\n",
    "#----------------\n",
    "# ACCURACY\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Accuracy:\n",
    "    def calculate(self, predictions, y):\n",
    "        comparisons = self.compare(predictions, y)\n",
    "        accuracy = np.mean(comparisons)  # Fraction of correct predictions\n",
    "        self.accumulated_sum += np.sum(comparisons)  # Total correct\n",
    "        self.accumulated_count += len(comparisons)   # Total samples\n",
    "        return accuracy  # No need to cap if computed correctly\n",
    "\n",
    "    def calculate_accumulated(self):\n",
    "        if self.accumulated_count == 0:\n",
    "            return 0\n",
    "        accuracy = self.accumulated_sum / self.accumulated_count\n",
    "        return min(accuracy, 1.0)  # Cap here to catch any overflow\n",
    "\n",
    "    def new_pass(self):\n",
    "        self.accumulated_sum = 0\n",
    "        self.accumulated_count = 0\n",
    "\n",
    "class Accuracy_Binary(Accuracy):\n",
    "    def __init__(self):\n",
    "        self.new_pass()\n",
    "\n",
    "    def compare(self, predictions, y):\n",
    "        # Ensure both predictions and y are 1D\n",
    "        binary_predictions = (predictions > 0.5).flatten()  # Convert to 1D boolean\n",
    "        if len(y.shape) == 2:\n",
    "            y = y.flatten()  # Ensure y is 1D\n",
    "        if len(binary_predictions) != len(y):\n",
    "            raise ValueError(f\"Shape mismatch: predictions {binary_predictions.shape}, y {y.shape}\")\n",
    "        return binary_predictions == y  # 1D boolean array"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "These classes define the core components of the neural network architecture. \n",
    "Layer_Dense implements fully connected layers with support for L1/L2 regularization to prevent overfitting, crucial for handling high-dimensional article embeddings. \n",
    "\n",
    "Layer_Dropout introduces randomization during training to enhance model generalization, critical for small datasets. \n",
    "\n",
    "Layer_Input serves as the entry point for data, ensuring compatibility with the network. Together, they form a flexible, custom-built neural network tailored for binary classification of article usefulness.\n",
    "\n",
    "Activation functions introduce non-linearity and map outputs to desired ranges. \n",
    "Activation_ReLU accelerates training by applying a non-linear transformation to hidden layers, promoting sparse activations. \n",
    "\n",
    "Activation_Sigmoid is used in the output layer to produce probabilities between 0 and 1, ideal for binary classification of articles as useful or not useful. These functions ensure the model can learn complex patterns and deliver interpretable predictions.\n",
    "\n",
    "\n",
    "\n",
    "The Optimizer_SGD class implements stochastic gradient descent with momentum and learning rate decay, optimizing the neural network’s weights to minimize prediction errors. Momentum accelerates convergence by incorporating past gradients, while decay adjusts the learning rate to stabilize training. This optimizer ensures efficient and effective training, enabling the model to learn from article embeddings and improve classification accuracy.\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "Loss_BinaryCrossEntropy computes the loss for binary classification, guiding the model to minimize errors in predicting article usefulness. It includes regularization to penalize overly complex models, enhancing generalization. Accuracy_Binary measures the proportion of correct predictions, providing a clear metric to evaluate model performance. These components are essential for training and assessing the model’s ability to classify articles accurately.\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "#----------------\n",
    "# MODEL OBJECT\n",
    "#----------------\n",
    "\n",
    "class funny_guy:\n",
    "    def __init__(self):\n",
    "        self.layers = []\n",
    "\n",
    "    def add(self, layer):\n",
    "        self.layers.append(layer)\n",
    "\n",
    "    def set(self, *, loss, optimizer, accuracy):\n",
    "        if loss is not None:\n",
    "            self.loss = loss\n",
    "        if optimizer is not None:\n",
    "            self.optimizer = optimizer\n",
    "        if accuracy is not None:\n",
    "            self.accuracy = accuracy\n",
    "\n",
    "    def finalize(self):\n",
    "        self.input_layer = Layer_Input()\n",
    "        layer_count = len(self.layers)\n",
    "        self.trainable_layers = []\n",
    "        for i in range(layer_count):\n",
    "            if i == 0:\n",
    "                self.layers[i].prev = self.input_layer\n",
    "                self.layers[i].next = self.layers[i + 1]\n",
    "            elif i < layer_count - 1:\n",
    "                self.layers[i].prev = self.layers[i - 1]\n",
    "                self.layers[i].next = self.layers[i + 1]\n",
    "            else:\n",
    "                self.layers[i].prev = self.layers[i - 1]\n",
    "                self.layers[i].next = self.loss\n",
    "                self.output_layer_activation = self.layers[i]\n",
    "            if hasattr(self.layers[i], 'weights'):\n",
    "                self.trainable_layers.append(self.layers[i])\n",
    "        if self.loss is not None:\n",
    "            self.loss.remember_trainable_layers(self.trainable_layers)\n",
    "\n",
    "    def forward(self, X, training):\n",
    "        self.input_layer.forward(X, training)\n",
    "        output = self.input_layer.output\n",
    "        for layer in self.layers:\n",
    "            output = layer.forward(output, training)\n",
    "        return output\n",
    "\n",
    "    def backward(self, output, y):\n",
    "        dvalues = self.loss.backward(output, y)\n",
    "        for layer in reversed(self.layers):\n",
    "            dvalues = layer.backward(dvalues)\n",
    "        return dvalues\n",
    "\n",
    "    def train(self, X, y, *, epochs=1, batch_size=None, print_every=1, validation_data=None):\n",
    "        # Initialize history dictionary\n",
    "        self.history = {'train_loss': [], 'train_acc': [], 'val_loss': [], 'val_acc': []}\n",
    "\n",
    "        train_steps = 1\n",
    "        if batch_size is not None:\n",
    "            train_steps = len(X) // batch_size\n",
    "            if train_steps * batch_size < len(X):\n",
    "                train_steps += 1\n",
    "\n",
    "        for epoch in range(1, epochs + 1):\n",
    "            print(f'epoch: {epoch}')\n",
    "            self.loss.new_pass()\n",
    "            self.accuracy.new_pass()\n",
    "\n",
    "            for step in range(train_steps):\n",
    "                batch_X = X if batch_size is None else X[step * batch_size:(step + 1) * batch_size]\n",
    "                batch_y = y if batch_size is None else y[step * batch_size:(step + 1) * batch_size]\n",
    "\n",
    "                output = self.forward(batch_X, training=True)\n",
    "                data_loss, regularization_loss = self.loss.calculate(output, batch_y, include_regularization=True)\n",
    "                loss = data_loss + regularization_loss\n",
    "                predictions = self.output_layer_activation.predictions(output)\n",
    "                accuracy = self.accuracy.calculate(predictions, batch_y)\n",
    "\n",
    "                self.backward(output, batch_y)\n",
    "                self.optimizer.pre_update_params()\n",
    "                for layer in self.trainable_layers:\n",
    "                    self.optimizer.update_params(layer)\n",
    "                self.optimizer.post_update_params()\n",
    "\n",
    "                if not step % print_every or step == train_steps - 1:\n",
    "                    print(f'step: {step}, acc: {accuracy:.3f}, loss: {loss:.3f}, '\n",
    "                          f'(data_loss: {data_loss}, reg_loss: {regularization_loss:.3f}), '\n",
    "                          f'lr: {self.optimizer.current_learning_rate}')\n",
    "\n",
    "            # Store training metrics\n",
    "            epoch_data_loss, epoch_regularization_loss = self.loss.calculate_accumulated(include_regularization=True)\n",
    "            epoch_loss = epoch_data_loss + epoch_regularization_loss\n",
    "            epoch_accuracy = self.accuracy.calculate_accumulated()\n",
    "            self.history['train_loss'].append(epoch_loss)\n",
    "            self.history['train_acc'].append(epoch_accuracy)\n",
    "            print(f'training, acc: {epoch_accuracy:.3f}, loss: {epoch_loss:.3f}, '\n",
    "                  f'(data_loss: {epoch_data_loss}, reg_loss: {epoch_regularization_loss:.3f}), '\n",
    "                  f'lr: {self.optimizer.current_learning_rate}')\n",
    "\n",
    "            # Store validation metrics if provided\n",
    "            if validation_data is not None:\n",
    "                X_val, y_val = validation_data\n",
    "                val_loss, val_acc = self.evaluate(X_val, y_val, batch_size=batch_size)\n",
    "                self.history['val_loss'].append(val_loss)\n",
    "                self.history['val_acc'].append(val_acc)\n",
    "            else:\n",
    "                self.history['val_loss'].append(None)\n",
    "                self.history['val_acc'].append(None)\n",
    "\n",
    "        return self.history  # Return history for plotting\n",
    "\n",
    "    def evaluate(self, X_val, y_val, *, batch_size=None):\n",
    "        validation_steps = 1\n",
    "        if batch_size is not None:\n",
    "            validation_steps = len(X_val) // batch_size\n",
    "            if validation_steps * batch_size < len(X_val):\n",
    "                validation_steps += 1\n",
    "        self.loss.new_pass()\n",
    "        self.accuracy.new_pass()\n",
    "\n",
    "        for step in range(validation_steps):\n",
    "            batch_X = X_val if batch_size is None else X_val[step * batch_size:(step + 1) * batch_size]\n",
    "            batch_y = y_val if batch_size is None else y_val[step * batch_size:(step + 1) * batch_size]\n",
    "            output = self.forward(batch_X, training=False)\n",
    "            self.loss.calculate(output, batch_y)\n",
    "            predictions = self.output_layer_activation.predictions(output)\n",
    "            self.accuracy.calculate(predictions, batch_y)\n",
    "\n",
    "        validation_loss = self.loss.calculate_accumulated()\n",
    "        validation_accuracy = self.accuracy.calculate_accumulated()\n",
    "        print(f'validation, acc: {validation_accuracy:.3f}, loss: {validation_loss:.3f}')\n",
    "        print(f\"Val predictions: {predictions.flatten()}\")\n",
    "        return validation_loss, validation_accuracy  # Return metrics for history\n",
    "\n",
    "    def predict(self, X, *, batch_size=None):\n",
    "        prediction_steps = 1\n",
    "        if batch_size is not None:\n",
    "            prediction_steps = len(X) // batch_size\n",
    "            if prediction_steps * batch_size < len(X):\n",
    "                prediction_steps += 1\n",
    "        output = []\n",
    "        for step in range(prediction_steps):\n",
    "            batch_X = X if batch_size is None else X[step * batch_size:(step + 1) * batch_size]\n",
    "            batch_output = self.forward(batch_X, training=False)\n",
    "            output.append(batch_output)\n",
    "        return np.vstack(output)\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The funny_guy class orchestrates the neural network by managing layers, loss, optimizer, and accuracy. It supports forward and backward passes, training, evaluation, and prediction. \n",
    "\n",
    "The train method logs performance metrics and supports validation, enabling iterative improvements. \n",
    "\n",
    "This modular design allows easy experimentation with architectures and hyperparameters, making the model adaptable for classifying article usefulness.\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "-----------------------------------------------------------------------------------------------------------------"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "#----------------\n",
    "# Pubmed Scraping\n",
    "#----------------\n",
    "\n",
    "\n",
    "def fetch_pubmed_ids(query, max_results=20):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    search_url = f\"{base_url}esearch.fcgi?db=pubmed&term={query}&retmax={max_results}&retmode=xml\"\n",
    "    response = requests.get(search_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch IDs: {response.status_code}\")\n",
    "    root = ET.fromstring(response.content)\n",
    "    return [id_elem.text for id_elem in root.findall(\".//Id\")]\n",
    "\n",
    "def fetch_pubmed_details(pmids):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    fetch_url = f\"{base_url}efetch.fcgi?db=pubmed&id={','.join(pmids)}&retmode=xml\"\n",
    "    response = requests.get(fetch_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch details: {response.status_code}\")\n",
    "    fetch_root = ET.fromstring(response.content)\n",
    "    articles = {}\n",
    "    fetched_pmids = set()\n",
    "    for article in fetch_root.findall(\".//PubmedArticle\"):\n",
    "        pmid = article.findtext(\".//PMID\")\n",
    "        title = article.findtext(\".//ArticleTitle\") or \"No title\"\n",
    "        abstract = article.findtext(\".//AbstractText\") or \"\"\n",
    "        articles[pmid] = {'title': title, 'abstract': abstract}\n",
    "        fetched_pmids.add(pmid)\n",
    "    missing = set(pmids) - fetched_pmids\n",
    "    if missing:\n",
    "        print(f\"Warning: Missing PMIDs in fetch: {missing}\")\n",
    "    return articles\n",
    "\n",
    "def get_ollama_embedding(text, model='nomic-embed-text'):\n",
    "    response = ollama.embeddings(model=model, prompt=text)\n",
    "    return np.array(response['embedding'])\n",
    "\n",
    "def get_ollama_summary(text, model='llama3'):\n",
    "    prompt = f\"Summarize the following article in 2-3 sentences:\\n\\n{text}\"\n",
    "    response = ollama.generate(model=model, prompt=prompt)\n",
    "    return response['response']\n",
    "\n",
    "\n",
    "def process_articles(pmids, articles_dict):\n",
    "    X, y, texts, summaries = [], [], [], []\n",
    "    valid_pmids = []\n",
    "    \n",
    "    # Step 1: Fetch and summarize articles\n",
    "    for pmid in pmids:\n",
    "        if pmid not in articles_dict:\n",
    "            print(f\"Warning: PMID {pmid} not found in articles_dict, skipping.\")\n",
    "            continue\n",
    "        article = articles_dict[pmid]\n",
    "        full_text = f\"{article['title']} {article['abstract']}\"\n",
    "        summary = get_ollama_summary(full_text)\n",
    "        embedding = get_ollama_embedding(summary)\n",
    "        X.append(embedding)\n",
    "        texts.append(full_text)\n",
    "        summaries.append(summary)\n",
    "        valid_pmids.append(pmid)\n",
    "    \n",
    "    X = np.array(X)\n",
    "    \n",
    "    # Step 2: Prompt user to label based on summaries\n",
    "    print(\"Label the following articles based on their summaries (1 = useful, 0 = not useful):\")\n",
    "    y = []\n",
    "    for i, pmid in enumerate(valid_pmids):\n",
    "        while True:\n",
    "            try:\n",
    "                label = int(input(f\"PMID {pmid}: {summaries[i][:250]}...\\nLabel (1/0): \"))\n",
    "                if label in [0, 1]:\n",
    "                    y.append(label)\n",
    "                    break\n",
    "                print(\"Please enter 0 or 1.\")\n",
    "            except ValueError:\n",
    "                print(\"Invalid input, please enter 0 or 1.\")\n",
    "    \n",
    "    # Step 3: Print full text and summary for reference\n",
    "    print(\"\\nProcessed articles:\")\n",
    "    for pmid, text, summary, label in zip(valid_pmids, texts, summaries, y):\n",
    "        print(f\"PMID {pmid}:\")\n",
    "        print(f\"Full Text: {text[:250]}...\")\n",
    "        print(f\"Summary: {summary}\")\n",
    "        print(f\"Label: {label}\\n\")\n",
    "    \n",
    "    return X, np.array(y)\n",
    "\n",
    "def normalize_embeddings(X):\n",
    "    X_mean = np.mean(X, axis=0)\n",
    "    X_std = np.std(X, axis=0)\n",
    "    return (X - X_mean) / (X_std + 1e-8)  # Avoid division by zero\n",
    "\n",
    "def create_article_data(query, max_results=20):\n",
    "    all_pmids = fetch_pubmed_ids(query, max_results)\n",
    "    train_pmids, test_pmids = train_test_split(all_pmids, test_size=0.2, random_state=42)\n",
    "    train_articles = fetch_pubmed_details(train_pmids)\n",
    "    test_articles = fetch_pubmed_details(test_pmids)\n",
    "    X_train, y_train = process_articles(train_pmids, train_articles)\n",
    "    X_test, y_test = process_articles(test_pmids, test_articles)\n",
    "    \n",
    "    # Normalize embeddings after creation\n",
    "    X_train = normalize_embeddings(X_train)\n",
    "    X_test = normalize_embeddings(X_test)\n",
    "    \n",
    "    assert not set(train_pmids) & set(test_pmids), \"Overlap detected!\"\n",
    "    return X_train, y_train, X_test, y_test\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# ------------------------------------------------\n",
    "# Randomizing assigned labels for code debugging \n",
    "# ------------------------------------------------\n",
    "\n",
    "# def process_articles(pmids, articles_dict):\n",
    "#     X, y, texts = [], [], []\n",
    "#     for pmid in pmids:\n",
    "#         article = articles_dict[pmid]\n",
    "#         text = f\"{article['title']} {article['abstract']}\"\n",
    "#         embedding = get_ollama_embedding(text)\n",
    "#         X.append(embedding)\n",
    "#         texts.append(text)\n",
    "#     X = np.array(X)\n",
    "#     np.random.seed(42)\n",
    "#     y = np.random.randint(0, 2, size=len(pmids))\n",
    "#     print(\"Assigned random labels for testing:\")\n",
    "#     for pmid, label, text in zip(pmids, y, texts):\n",
    "#         print(f\"PMID {pmid}: {text[:250]}... Label: {label}\")\n",
    "#     return X, np.array(y)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading saved data from article_data.pkl\n",
      "epoch: 1\n",
      "step: 0, acc: 0.500, loss: 0.699, (data_loss: 0.6987388006625573, reg_loss: 0.000), lr: 0.005\n",
      "step: 2, acc: 0.500, loss: 0.694, (data_loss: 0.6943909165786921, reg_loss: 0.000), lr: 0.00499001996007984\n",
      "step: 3, acc: 0.750, loss: 0.691, (data_loss: 0.6913583640660993, reg_loss: 0.000), lr: 0.0049850448654037895\n",
      "training, acc: 0.438, loss: 0.696, (data_loss: 0.6956638943860933, reg_loss: 0.000), lr: 0.0049850448654037895\n",
      "validation, acc: 0.250, loss: 0.698\n",
      "Val predictions: [0 0 0 1]\n",
      "epoch: 2\n",
      "step: 0, acc: 0.500, loss: 0.692, (data_loss: 0.6922669095794045, reg_loss: 0.000), lr: 0.0049800796812749\n",
      "step: 2, acc: 0.750, loss: 0.687, (data_loss: 0.6874622072334874, reg_loss: 0.000), lr: 0.004970178926441352\n",
      "step: 3, acc: 0.750, loss: 0.690, (data_loss: 0.690380427700798, reg_loss: 0.000), lr: 0.00496524329692155\n",
      "training, acc: 0.500, loss: 0.692, (data_loss: 0.6915346271511962, reg_loss: 0.000), lr: 0.00496524329692155\n",
      "validation, acc: 0.000, loss: 0.698\n",
      "Val predictions: [0 1 0 1]\n",
      "epoch: 3\n",
      "step: 0, acc: 0.750, loss: 0.688, (data_loss: 0.6883752321464054, reg_loss: 0.000), lr: 0.004960317460317461\n",
      "step: 2, acc: 0.750, loss: 0.687, (data_loss: 0.6870345282950772, reg_loss: 0.000), lr: 0.0049504950495049506\n",
      "step: 3, acc: 0.750, loss: 0.691, (data_loss: 0.6911201161710898, reg_loss: 0.000), lr: 0.004945598417408507\n",
      "training, acc: 0.688, loss: 0.690, (data_loss: 0.6902433805203206, reg_loss: 0.000), lr: 0.004945598417408507\n",
      "validation, acc: 0.000, loss: 0.699\n",
      "Val predictions: [0 1 0 1]\n",
      "epoch: 4\n",
      "step: 0, acc: 1.000, loss: 0.684, (data_loss: 0.6839119548367949, reg_loss: 0.000), lr: 0.004940711462450593\n",
      "step: 2, acc: 0.750, loss: 0.683, (data_loss: 0.6825519532708528, reg_loss: 0.000), lr: 0.004930966469428008\n",
      "step: 3, acc: 0.750, loss: 0.691, (data_loss: 0.6910768258033989, reg_loss: 0.000), lr: 0.004926108374384237\n",
      "training, acc: 0.688, loss: 0.687, (data_loss: 0.6874188213856675, reg_loss: 0.000), lr: 0.004926108374384237\n",
      "validation, acc: 0.000, loss: 0.699\n",
      "Val predictions: [0 1 0 1]\n",
      "epoch: 5\n",
      "step: 0, acc: 1.000, loss: 0.680, (data_loss: 0.6802691272906186, reg_loss: 0.000), lr: 0.004921259842519685\n",
      "step: 2, acc: 0.750, loss: 0.679, (data_loss: 0.6789411035349008, reg_loss: 0.000), lr: 0.004911591355599214\n",
      "step: 3, acc: 0.500, loss: 0.694, (data_loss: 0.6936037841336834, reg_loss: 0.000), lr: 0.0049067713444553495\n",
      "training, acc: 0.750, loss: 0.686, (data_loss: 0.6858821604749954, reg_loss: 0.000), lr: 0.0049067713444553495\n",
      "validation, acc: 0.250, loss: 0.699\n",
      "Val predictions: [0 1 1 1]\n",
      "epoch: 6\n",
      "step: 0, acc: 1.000, loss: 0.679, (data_loss: 0.6786357796274929, reg_loss: 0.000), lr: 0.004901960784313725\n",
      "step: 2, acc: 0.750, loss: 0.678, (data_loss: 0.677761738139376, reg_loss: 0.000), lr: 0.004892367906066536\n",
      "step: 3, acc: 0.500, loss: 0.695, (data_loss: 0.695387325590567, reg_loss: 0.000), lr: 0.004887585532746824\n",
      "training, acc: 0.750, loss: 0.685, (data_loss: 0.684951999508313, reg_loss: 0.000), lr: 0.004887585532746824\n",
      "validation, acc: 0.500, loss: 0.699\n",
      "Val predictions: [1 1 1 1]\n",
      "epoch: 7\n",
      "step: 0, acc: 1.000, loss: 0.678, (data_loss: 0.6776414640141039, reg_loss: 0.000), lr: 0.0048828125\n",
      "step: 2, acc: 1.000, loss: 0.678, (data_loss: 0.6775607590316961, reg_loss: 0.000), lr: 0.004873294346978557\n",
      "step: 3, acc: 0.250, loss: 0.695, (data_loss: 0.6946069586924073, reg_loss: 0.000), lr: 0.004868549172346641\n",
      "training, acc: 0.750, loss: 0.684, (data_loss: 0.6840317891489978, reg_loss: 0.000), lr: 0.004868549172346641\n",
      "validation, acc: 0.500, loss: 0.699\n",
      "Val predictions: [1 1 1 1]\n",
      "epoch: 8\n",
      "step: 0, acc: 1.000, loss: 0.676, (data_loss: 0.676200506168342, reg_loss: 0.000), lr: 0.0048638132295719845\n",
      "step: 2, acc: 0.750, loss: 0.678, (data_loss: 0.6780612417494261, reg_loss: 0.000), lr: 0.004854368932038835\n",
      "step: 3, acc: 0.250, loss: 0.697, (data_loss: 0.6965645881208377, reg_loss: 0.000), lr: 0.004849660523763337\n",
      "training, acc: 0.688, loss: 0.684, (data_loss: 0.6840797911471941, reg_loss: 0.000), lr: 0.004849660523763337\n",
      "validation, acc: 0.500, loss: 0.699\n",
      "Val predictions: [1 1 1 1]\n",
      "epoch: 9\n",
      "step: 0, acc: 1.000, loss: 0.671, (data_loss: 0.6706924094821318, reg_loss: 0.000), lr: 0.0048449612403100775\n",
      "step: 2, acc: 1.000, loss: 0.672, (data_loss: 0.6720099912411446, reg_loss: 0.000), lr: 0.00483558994197292\n",
      "step: 3, acc: 0.500, loss: 0.696, (data_loss: 0.6959858795759122, reg_loss: 0.000), lr: 0.004830917874396136\n",
      "training, acc: 0.812, loss: 0.680, (data_loss: 0.6796125468723941, reg_loss: 0.000), lr: 0.004830917874396136\n",
      "validation, acc: 0.500, loss: 0.699\n",
      "Val predictions: [1 1 1 1]\n",
      "epoch: 10\n",
      "step: 0, acc: 1.000, loss: 0.664, (data_loss: 0.6642392410277045, reg_loss: 0.000), lr: 0.004826254826254826\n",
      "step: 2, acc: 0.750, loss: 0.671, (data_loss: 0.6714507802406603, reg_loss: 0.000), lr: 0.004816955684007708\n",
      "step: 3, acc: 0.000, loss: 0.699, (data_loss: 0.6991449803075731, reg_loss: 0.000), lr: 0.004812319538017325\n",
      "training, acc: 0.625, loss: 0.679, (data_loss: 0.6787921195804067, reg_loss: 0.000), lr: 0.004812319538017325\n",
      "validation, acc: 0.500, loss: 0.700\n",
      "Val predictions: [1 1 1 1]\n",
      "Predictions: [0.50580079 0.50961034 0.50436323 0.51321216]\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x500 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Save labels\n",
    "\n",
    "# File to save/load data\n",
    "DATA_FILE = \"article_data.pkl\"\n",
    "\n",
    "def load_or_create_data(query, max_results):\n",
    "    \"\"\"Load saved data if it exists, otherwise create and save it.\"\"\"\n",
    "    if os.path.exists(DATA_FILE):\n",
    "        print(f\"Loading saved data from {DATA_FILE}\")\n",
    "        with open(DATA_FILE, 'rb') as f:\n",
    "            data = pickle.load(f)\n",
    "            return data['X_train'], data['y_train'], data['X_test'], data['y_test']\n",
    "    else:\n",
    "        print(f\"Creating new data for query: {query}\")\n",
    "        X_train, y_train, X_test, y_test = create_article_data(query, max_results)\n",
    "        data = {\n",
    "            'X_train': X_train,\n",
    "            'y_train': y_train,\n",
    "            'X_test': X_test,\n",
    "            'y_test': y_test\n",
    "        }\n",
    "        with open(DATA_FILE, 'wb') as f:\n",
    "            pickle.dump(data, f)\n",
    "        print(f\"Saved data to {DATA_FILE}\")\n",
    "        return X_train, y_train, X_test, y_test\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    query = \"machine learning cancer\"\n",
    "    max_results = 60\n",
    "\n",
    "    # Load or create data\n",
    "    X_train, y_train, X_test, y_test = load_or_create_data(query, max_results)\n",
    "\n",
    "    # Build and train model\n",
    "    model = funny_guy()\n",
    "    model.add(Layer_Dense(768, 64))\n",
    "    model.add(Activation_ReLU())\n",
    "    model.add(Layer_Dropout(.2))\n",
    "    model.add(Layer_Dense(64, 1))\n",
    "    model.add(Activation_Sigmoid())\n",
    "    model.set(\n",
    "        loss=Loss_BinaryCrossEntropy(),\n",
    "        optimizer=Optimizer_SGD(learning_rate=0.005, decay=1e-3),\n",
    "        accuracy=Accuracy_Binary()\n",
    "    )\n",
    "    model.finalize()\n",
    "\n",
    "    history = model.train(X_train, y_train, epochs=10, batch_size=4, print_every=2, validation_data=(X_test, y_test))\n",
    "\n",
    "    # Predict\n",
    "    predictions = model.predict(X_test[:5])\n",
    "    print(\"Predictions:\", predictions.flatten())\n",
    "\n",
    "    # Plotting\n",
    "    epochs_range = range(1, len(history['train_loss']) + 1)\n",
    "    plt.figure(figsize=(12, 5))\n",
    "    plt.subplot(1, 2, 1)\n",
    "    plt.plot(epochs_range, history['train_loss'], label='Training Loss')\n",
    "    plt.plot(epochs_range, history['val_loss'], label='Validation Loss')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Loss')\n",
    "    plt.title('Loss Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.subplot(1, 2, 2)\n",
    "    plt.plot(epochs_range, history['train_acc'], label='Training Accuracy')\n",
    "    plt.plot(epochs_range, history['val_acc'], label='Validation Accuracy')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Accuracy')\n",
    "    plt.title('Accuracy Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.tight_layout()\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "improve loss and accuracy\n",
    "\n",
    "100 max results, thats a lot -> use ollama to decide which are useful/not useful for me\n",
    "adjusted epoch, batch size, learning rate, decay\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Creating new data for query: machine learning cancer\n",
      "\n",
      "Processed articles with LM labels:\n",
      "PMID 40205350:\n",
      "Full Text: Comprehensive analysis of scRNA-seq and bulk RNA-seq data via machine learning and bioinformatics reveals the role of lysine metabolism-related genes in gastric carcinogenesis. Gastric cancer (GC) is a highly aggressive and heterogeneous cancer with ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers used machine learning and bioinformatics to analyze RNA sequencing data from gastric cancer samples and found that genes involved in lysine metabolism play a role in the development of gastric cancer. Gastric cancer is a complex and aggressive disease, but this study shed light on how lysine metabolism-related genes contribute to its progression.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40198270:\n",
      "Full Text: Multimarker assessment of B cell and plasma cell subsets and their prognostic role in the colorectal cancer microenvironment. While the association between cytotoxic T lymphocytes and favorable prognosis in colorectal cancer is well established, the ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers studied the different types of B cells (a type of immune cell) and plasma cells (which produce antibodies) in colorectal cancer tumors to understand their characteristics and role in determining prognosis. While the importance of T cells in predicting good outcomes for patients with colorectal cancer is well known, the significance of B cells remains unclear. This study aimed to shed light on the relationship between different types of B cells and plasma cells and patient survival.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40210337:\n",
      "Full Text: Radiomics in early detection of bilio-pancreatic lesions: A narrative review. Radiomics is transforming the field of early detection of bilio-pancreatic lesions, offering significant advancements in diagnostic accuracy and personalized treatment plan...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Radiomics, which analyzes medical images to extract high-dimensional data, is revolutionizing the detection of bilio-pancreatic lesions such as pancreatic cancer and biliary duct cancer. This approach offers improved diagnostic accuracy and personalized treatment planning by revealing complex patterns undetectable through traditional imaging evaluation. The integration of radiomics with genomic data and liquid biopsies holds future promise for individualized patient care.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40207548:\n",
      "Full Text: Past, present, and future of exosomes research in cancer: A bibliometric and visualization analysis. Cancer seriously threatens the lives and health of people worldwide, and exosomes seem to play an important role in managing cancer effectively, whic...\n",
      "Summary: Here is a 2-3 sentence summary of the article:\n",
      "\n",
      "The article analyzes the past, present, and future of exosomes research in cancer using bibliometric analysis, finding an increasing trend in annual publications and identifying top-performing countries, institutions, and journals. The study also highlights key keywords, authors, and journals in the field, as well as promising research topics for future exploration. Overall, the article aims to provide valuable insights for scholars and policymakers by visualizing the structure, hotspots, and evolutionary trends of exosomes research in cancer.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40201178:\n",
      "Full Text: AI discovery of TLR agonist-driven phenotypes reveals unique features of peripheral cells from healthy donors and ART-suppressed people living with HIV. Selective and potent Toll-like receptor (TLR) agonists are currently under evaluation in preclini...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers used artificial intelligence to discover unique features of peripheral cells from healthy donors and individuals living with HIV who are on antiretroviral therapy (ART). The study focused on Toll-like receptor (TLR) agonists, which have potential therapeutic applications for diseases like cancer and chronic viral infections. By analyzing the effects of TLR pathway stimulation on peripheral blood mononuclear cell cultures from people living with HIV and healthy donors, researchers aimed to better understand how different TLR agonists impact cellular populations and phenotypes.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40214699:\n",
      "Full Text: Biological characteristics prediction of endometrial cancer based on deep convolutional neural network and multiparametric MRI radiomics. The exploration of deep learning techniques for predicting various biological characteristics of endometrial can...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed a deep learning-based method using multiparametric MRI radiomics to predict various biological characteristics of endometrial cancer, including myometrial invasion, lymph-vascular space invasion, histologic grade, and estrogen receptor status. The method achieved high accuracy in predicting these features, with area under the curve values ranging from 0.924 to 0.960. The proposed scheme outperformed a comparative scheme and could provide clinical significance for accurate diagnosis and treatment decision-making.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40208029:\n",
      "Full Text: A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles. Gastric cancer (GC) is a highly heterogeneous disease, and the response of patients to clinical treatment varies substantially. Th...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Gastric cancer (GC) is a heterogeneous disease with varying responses to treatments, making it challenging to predict curative effects. Researchers developed a machine learning approach to identify patterns in tumour-infiltrating immune cell profiles that can predict the clinical efficacy of GC treatment. This new method uses flow cytometry to detect immune variables and could potentially help personalize treatment for patients with GC.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40196847:\n",
      "Full Text: Dendritic cell-derived MYD88 potentiates as a biomarker for immune regulation in hepatocellular carcinoma and may predict a better immunological result. MYD88 (myeloid differentiation primary response 88) is a key adaptor protein mediate immune respo...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "MYD88, an adaptor protein, plays a key role in immune responses through Toll-like receptors and interleukin-1 receptor signaling. In dendritic cells, MYD88 helps mediate maturation and function, contributing to innate immunity. High expression of MYD88 in dendritic cells may serve as a biomarker for better immunological outcomes in hepatocellular carcinoma patients.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40216368:\n",
      "Full Text: Artificial intelligence-driven integration of multi-omics and radiomics: A new hope for precision cancer diagnosis and prognosis. Despite advances in cancer diagnosis and treatment, the disease remains a major health challenge. Integrating multi-omic...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The integration of artificial intelligence, multi-omics (the study of multiple types of biological data), and radiomics (the extraction of imaging features) has shown promise in improving cancer diagnosis and prognosis. This approach combines molecular insights into tumor biology with imaging features to predict outcomes and guide personalized treatment. The goal is to enhance resolution, scalability, and non-invasive diagnostics to improve early detection and treatment of cancer.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40200572:\n",
      "Full Text: Identification of Diagnostic Biomarkers for Colorectal Polyps Based on Noninvasive Urinary Metabolite Screening and Construction of a Nomogram. Colorectal polyps (CRPs) are precursors to colorectal cancer (CRC), and early detection is crucial for pre...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers sought to identify non-invasive biomarkers in urine that could diagnose colorectal polyps, precursors to colon cancer. They analyzed urinary metabolites and developed a diagnostic nomogram based on these findings. The goal was to provide a non-invasive method for detecting colorectal polyps early, which is crucial for preventing the progression to colon cancer.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40215672:\n",
      "Full Text: A comprehensive review and evaluation of machine learning-based approaches for identifying tumor T cell antigens. The precise identification of tumor T-cell antigens (TTCAs) is crucial for advancements in cancer immunotherapy and other clinical uses....\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The study reviews machine learning-based approaches for identifying tumor T-cell antigens (TTCAs), which are crucial for cancer immunotherapy and other clinical uses. The review examines various aspects of TTCA predictor development, including algorithms, methodologies, datasets, feature encoding methods, and web server usability. The goal is to provide a comprehensive overview of existing predictors and offer insights for developing high-accuracy TTCA predictors in the future.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40206662:\n",
      "Full Text: Machine learning based radiomics approach for outcome prediction of meningioma - a systematic review. Meningioma is the most common brain tumor in adults. Magnetic resonance imaging (MRI) is the preferred imaging modality for assessing tumor outcomes...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Meningioma, the most common brain tumor in adults, can be assessed using magnetic resonance imaging (MRI). A machine learning-based radiomics approach, which analyzes tumor heterogeneity, offers a non-invasive alternative to biopsies and enhances diagnostic and prognostic accuracy. This review aims to summarize the performance measures of machine learning-based radiomics models for predicting meningioma recurrence and overall survival outcomes.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40198481:\n",
      "Full Text: Application of machine learning models to explore prognosis and cause of death in advanced intrahepatic cholangiocarcinoma patients undergoing chemotherapy. This study was aimed at examining the causes of death (CODs) in patients with advanced intrah...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The study investigated the causes of death among patients with advanced intrahepatic cholangiocarcinoma (ICC) undergoing chemotherapy, aiming to understand the prognosis and treatment outcomes. Machine learning models were used to identify factors related to patient survival and predict treatment results. The goal was to improve care for patients with advanced ICC by better understanding the disease and its progression under chemotherapy.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40210131:\n",
      "Full Text: Spatially-resolved Single-cell Morphometry of Benign Breast Disease Biopsy Images Uncovers Quantitative Cytomorphometric Features Predictive of Subsequent Invasive Breast Cancer Risk. Currently, benign breast disease (BBD) pathologic classification a...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers used machine learning-based single-cell morphometry to analyze breast biopsy images from women with benign breast disease (BBD) and found that specific cytomorphometric features were predictive of subsequent invasive breast cancer risk. The features included epithelial nuclear morphology changes, such as increasing size and chromasia, which were associated with low-grade breast cancer following proliferative disease without atypia. In contrast, stromal cellular density was linked to high-grade breast cancer following non-proliferative disease.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40197378:\n",
      "Full Text: Risk Prediction of Post-Transplant Lymphoproliferative Disease in Heart Transplant Patients. Post-transplant lymphoproliferative disease (PTLD) represents the second most frequent malignancy in cardiac allograft recipients and constitutes up to 10% o...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A study analyzed data from 55,150 adult heart transplant patients to develop a risk prediction model for post-transplant lymphoproliferative disease (PTLD). The model identified cyclosporine use, positive donor Epstein-Barr Virus IgG, induction with OKT3, and the donor's HLA B38 antigen as risk factors for developing PTLD at 3-5 years post-transplant. Additionally, African American recipients had a lower risk of developing PTLD compared to other ethnic groups.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40216832:\n",
      "Full Text: Leveraging machine learning in precision medicine to unveil organochlorine pesticides as predictive biomarkers for thyroid dysfunction. Exposure to organochlorine pesticides (OCPs) poses significant health risks, including cancer, endocrine dysregula...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers used machine learning models to analyze blood samples for organochlorine pesticides (OCPs) and their association with thyroid disturbances. The study found that high frequencies of certain OCPs, such as Heptachlor, Methoxychlor, and Endrin, were detected in over 70% of serum samples and were significantly correlated with thyroid dysfunction. Machine learning models, particularly Random Forest and Gradient Boosting Machine, achieved high accuracy rates in classifying thyroid status using the OCP data.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40201531:\n",
      "Full Text: Artificial intelligence-assisted machine learning models for predicting lung cancer survival. This study aimed to evaluate the feasibility of large language model-Advanced Data Analysis (ADA) in developing and implementing machine learning models to ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The study explores the use of artificial intelligence-assisted machine learning models to predict the survival rates of lung cancer patients. The researchers aimed to evaluate the feasibility and potential implications of using large language model-Advanced Data Analysis (ADA) for developing predictive models that can inform nursing practice.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40201726:\n",
      "Full Text: Radiologic imaging biomarkers in triple-negative breast cancer: a literature review about the role of artificial intelligence and the way forward. Breast cancer is one of the most common and deadly cancers in women. Triple-negative breast cancer (TNB...\n",
      "Summary: Here is a 2-3 sentence summary of the article:\n",
      "\n",
      "The article reviews the current state-of-the-art uses of artificial intelligence (AI) in radiologic imaging to diagnose and manage triple-negative breast cancer (TNBC), a particularly aggressive type of breast cancer. AI has the potential to analyze high-resolution images of tumors and identify anatomical and functional properties that may not be visible to the human eye, allowing for more effective diagnosis, treatment, and prognosis. The review aims to provide a comprehensive overview of radiomic and deep learning-based AI developments in TNBC management over the past decade (2013-2024).\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40208480:\n",
      "Full Text: Incorporating frequency domain features into radiomics for improved prognosis of esophageal cancer. Esophageal cancer is a highly aggressive gastrointestinal malignancy with a poor prognosis, making accurate prognostic assessment essential for patien...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed a new approach to predict the prognosis of esophageal cancer by incorporating frequency domain features into traditional radiomics analysis. The combined approach outperformed individual methods, achieving an accuracy of 74% and area under the curve (AUC) of 0.85 in predicting death risk. The results were validated through Kaplan-Meier survival analysis and suggest that this method can provide accurate prognosis for esophageal cancer patients.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40214613:\n",
      "Full Text: A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas. Isocitrate dehydrogenase-mutant gliomas are lethal brain cancers that impair quality of lif...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed a multimodal analytical pipeline integrating transcriptomics, proteomics, and radiomics data to predict recurrence risk in patients with IDH-mutant gliomas. They identified novel signatures of patient risk based on gene expression, protein level, and imaging features, including a gene signature (KRT19, RUNX3, and SCRT2) and protein signature (ATXN10, EIF4H, ITGAV, and NCAM1) associated with early recurrence. The pipeline improved patient stratification compared to histomolecular classification alone, providing a better understanding of IDH-mutant glioma subtypes and their risk of recurrence.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40206169:\n",
      "Full Text: Explainable AI-based feature importance analysis for ovarian cancer classification with ensemble methods. Ovarian Cancer (OC) is one of the leading causes of cancer deaths among women. Despite recent advances in the medical field, such as surgery, ch...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Ovarian cancer is a leading cause of cancer deaths among women, with limited improvements in diagnosis using clinical parameters due to non-specific symptoms at early stages. Ensemble machine learning algorithms can identify complex patterns in clinical data, but lack insight into their decision-making process. Explainable AI (XAI) models, such as LIME and SHAP Kernels, can provide deeper understanding of ensemble model predictions, increasing their applicability for ovarian cancer diagnosis.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40209153:\n",
      "Full Text: RRM-TransUNet: Deep-Learning Driven Interactive Model for Precise Pancreas Segmentation in CT Images. Pancreatic diseases such as cancer and pancreatitis pose significant health risks. Early detection requires precise segmentation results. Fully auto...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A new deep-learning driven model called RRM-TransUNet has been developed to improve pancreas segmentation in CT images. This interactive model allows for clinical expertise to be integrated, enabling more accurate and reliable results compared to fully automatic algorithms. The goal is to enable early detection of pancreatic diseases such as cancer and pancreatitis.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40216786:\n",
      "Full Text: LUND-PROBE - LUND Prostate Radiotherapy Open Benchmarking and Evaluation dataset. Radiotherapy treatment for prostate cancer relies on computed tomography (CT) and/or magnetic resonance imaging (MRI) for segmentation of target volumes and organs at r...\n",
      "Summary: Here is a 2-3 sentence summary of the article:\n",
      "\n",
      "The LUND-Probe dataset is a publicly available clinical dataset containing MRI and synthetic CT images, target and organ segmentations, and radiotherapy dose distributions for 432 patients with prostate cancer treated with MRI-guided radiotherapy. The dataset also includes an extended version with additional deep learning-generated segmentations, uncertainty maps, and manually adjusted segmentations by radiation oncologists. This resource aims to aid research in automated radiotherapy treatment planning, segmentation, and model uncertainty investigation.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40197140:\n",
      "Full Text: Identification of Overlapping Genetic Signatures Between Obstructive Sleep Apnea and Lung Cancer: Moving Beyond \"One Drug, One Disease\" Paradigm of Pharmaceutical Innovation. Traditional paradigms of pharmaceutical innovation have long relied on the ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The traditional approach to pharmaceutical innovation, where one drug targets one disease, may not be effective for all conditions. Instead, researchers are exploring a \"one drug, polydisease\" paradigm by identifying shared genetic mechanisms between different diseases. A study found overlapping genetic signatures between obstructive sleep apnea (OSA) and lung cancer, suggesting that a single therapeutic approach may be effective in treating both conditions.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40210329:\n",
      "Full Text: Integrating artificial intelligence with endoscopic ultrasound in the early detection of bilio-pancreatic lesions: Current advances and future prospects. The integration of Artificial Intelligence (AI) in endoscopic ultrasound (EUS) represents a tran...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The integration of artificial intelligence (AI) with endoscopic ultrasound (EUS) has improved the early detection and management of biliopancreatic lesions, such as pancreatic cancer and biliary diseases. AI-driven models have enhanced diagnostic accuracy, particularly in distinguishing between benign and malignant conditions, and enabled precise image analysis and real-time lesion classification. Emerging applications, including AI-guided FNA and biopsy, aim to further improve diagnostic yields while reducing errors, with future developments focusing on multimodal imaging and predictive analytics.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40213418:\n",
      "Full Text: Pharmacological potential of bioactive compounds in  The pharmacological potential of bioactive compounds found in the plant, ...\n",
      "Summary: I apologize, but you didn't provide an article for me to summarize. Please share the article text, and I'll be happy to help you with a summary!\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40199332:\n",
      "Full Text: The Utilization of the k-means clustering for Cancer Cell Detection and Classification with Serous Effusion. Cytological analysis of serous effusion specimens is essential for cancer diagnosis. In this work, we analyzed three-dimensional (3D) morphol...\n",
      "Summary: Here is a 2-3 sentence summary of the article:\n",
      "\n",
      "Researchers used k-means clustering to analyze 3D morphologic features of cells from serous effusion specimens to diagnose cancer. The method separated cell distributions objectively and effectively based on volume, surface, and other morphological features linked to cell, nucleus, and mitochondria. The results showed promise for quickly profiling cells for cancer diagnosis in clinical settings, potentially improving detection and treatment outcomes.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40210748:\n",
      "Full Text: Molecular typing of gliomas on the basis of integrin family genes and a functional study of ITGA7. Gliomas are highly malignant tumors of the central nervous system, and their complex molecular heterogeneity poses major therapeutic challenges. Integr...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers analyzed integrin family genes to understand their role in glioma pathogenesis and developed a new molecular classification system for these brain tumors based on integrin expression. The analysis revealed a strong correlation between integrin-based subtypes and glioma malignancy, as well as specific clinical features and tumor microenvironments associated with each subtype. The study also identified ITGA7 as a potential biomarker for gliomas and demonstrated its role in poor prognosis.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40202866:\n",
      "Full Text: A Deep-Learning-Enabled Workflow to Estimate Real-World Progression-Free Survival in Patients with Metastatic Breast Cancer: Study Using De-identified Electronic Health Records. Progression-free survival (PFS) is a crucial endpoint in cancer drug res...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A new study uses de-identified electronic health records to develop a deep-learning-enabled workflow for estimating real-world progress-free survival (PFS) in patients with metastatic breast cancer. This approach aims to improve upon traditional methods, such as manual abstraction of clinical progression from unstructured notes, which are resource-intensive and time-consuming. The use of natural language processing (NLP) and machine learning can accelerate the extraction of tumor progression information from real-world data.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40215447:\n",
      "Full Text: Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials. Cetuximab (CET), targeting the epidermal growth f...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers used machine learning models to analyze early longitudinal toxicity trajectories in patients with metastatic colorectal cancer receiving cetuximab, a treatment targeting epidermal growth factor receptor. The analysis predicted patient survival and cetuximab concentration levels based on early toxicity patterns. The study aimed to identify patient subpopulations that may benefit from long-term cetuximab treatment.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40211017:\n",
      "Full Text: Predicting viral host codon fitness and path shifting through tree-based learning on codon usage biases and genomic characteristics. Viral codon fitness (VCF) of the host and the VCF shifting has seldom been studied under quantitative measurements, a...\n",
      "Summary: Here is a summary of the article in 3 sentences:\n",
      "\n",
      "Researchers used machine learning to predict the codon fitness of viruses infecting different hosts, including humans, based on codon usage biases and genomic characteristics. The study found that the wobble position of viral codons is crucial for distinguishing host codon fitness and developed a bioinformatics tool to simulate codon-based virus fitness shifting. The results also suggested that some coronaviruses may have a closer relationship with SARS-CoV-2 in terms of human codon fitness, providing new insights for evolution research and virus monitoring.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40216970:\n",
      "Full Text: Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions. ...\n",
      "Summary: Here is a summary of the article:\n",
      "\n",
      "Researchers developed a mathematical model to study the progression of HER2-positive premalignant lesions into invasive breast cancer. The model revealed that growth factors, such as epidermal growth factor receptor (EGFR) and platelet-derived growth factor (PDGF), play a key role in promoting the transition from premalignant to malignant cells.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40214108:\n",
      "Full Text: The power of microRNA regulation-insights into immunity and metabolism. MicroRNAs (miRNAs) are a prominent class of small non-coding RNAs that control gene expression. This comprehensive review explores the intricate roles of miRNAs in metabolism and...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The article reviews the role of microRNAs (miRNAs) in regulating gene expression, focusing on their impact on metabolism and immunity, as well as the emerging field of immunometabolism. MiRNAs play complex roles in glucose and lipid metabolism, T-cell development and function, and orchestrating interactions between metabolic processes and immune responses. The article also explores how artificial intelligence (AI) is revolutionizing miRNA research by identifying and validating potential biomarkers.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40208442:\n",
      "Full Text: MLG2Net: Molecular Global Graph Network for Drug Response Prediction in Lung Cancer Cell Lines. Drug response prediction (DRP) is a central task in the era of precision medicine. Over the past decade, the emergence of deep learning (DL) has greatly c...\n",
      "Summary: Here is a summary of the article in 3 sentences:\n",
      "\n",
      "The authors introduce MLG2Net, a deep-learning model inspired by graph neural networks that predicts drug response in lung cancer cell lines based on pharmacogenomics data. The model consists of two key components: local and global graph networks describing drug SMILES and cell line genomics represented as a map. The results show that MLG2Net outperforms three reference graph networks, achieving high correlation with actual drug responses.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40216371:\n",
      "Full Text: A novel machine learning-based workflow to capture intra-patient heterogeneity through transcriptional multi-label characterization and clinically relevant classification. Patient classification into specific molecular subtypes is paramount in biomed...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A new machine learning-based approach aims to capture the diversity of molecular characteristics within individual patients with complex diseases. Traditional methods often oversimplify patient profiles, failing to account for the coexistence of traits from multiple subtypes. By recognizing intra-patient heterogeneity, this workflow hopes to improve patient characterization and personalized treatment outcomes.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40200294:\n",
      "Full Text: Association between the lactate dehydrogenase-to-albumin ratio and 28-day mortality in septic patients with malignancies: analysis of the MIMIC-IV database. Sepsis remains a leading cause of mortality in critically ill patients, particularly those wi...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The study analyzed data from critically ill patients with sepsis and underlying malignancies to determine the prognostic value of the lactate dehydrogenase-to-albumin ratio (LDAR) for predicting mortality. The LDAR was found to be associated with 28-day ICU mortality in this population, which is particularly vulnerable due to immunosuppression and metabolic dysregulation. The study aimed to evaluate the predictive power of LDAR as a potential tool for identifying high-risk patients.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40216830:\n",
      "Full Text: Predicting PD-L1 status in NSCLC patients using deep learning radiomics based on CT images. Radiomics refers to the utilization of automated or semi-automated techniques to extract and analyze numerous quantitative features from medical images, such ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed a deep learning radiomics (DLR) approach to predict programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) patients using computed tomography (CT) images. The DLR model showed an area under the curve of 0.85 for predicting PD-L1 status, with high sensitivity and specificity. When combined with clinical data, the integrated model performed even better, with an AUC of 0.91, making it a promising tool for clinical decision-making and personalized treatment strategies.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40202151:\n",
      "Full Text: Bioinformatics Combined With Biological Experiments to Identify the Pathogenetic Link of Type 2 Diabetes for Breast Cancer. Type 2 diabetes mellitus (T2DM) constitutes a significant risk factor for breast cancer (BC), with affected women exhibiting a...\n",
      "Summary: Here is a summary of the article in 3 sentences:\n",
      "\n",
      "Type 2 diabetes mellitus (T2DM) has been linked to an increased risk of breast cancer, with women affected by both conditions experiencing poorer prognoses and treatment resistance. The relationship between T2DM and breast cancer is significant, with women with both conditions having a two- to three-fold increased likelihood of developing breast cancer. Elucidating the comorbidities associated with T2DM and breast cancer can improve diagnostic and therapeutic strategies for breast cancer.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40208478:\n",
      "Full Text: Machine learning-based prognostic modeling integrating PANoptosis in head and neck squamous cell carcinoma. Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous and aggressive cancer, posing challenges for prognosis and treatment. ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Head and neck squamous cell carcinoma (HNSCC) is a complex and aggressive cancer type that is difficult to predict and treat. The article suggests that machine learning-based prognostic modeling can be used to better understand the role of PANoptosis, a process that regulates programmed necrosis, in HNSCC. By integrating PANoptosis into these models, researchers may be able to improve our understanding of how HNSCC responds to the immune system and develop more effective treatment strategies.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40197763:\n",
      "Full Text: Tissue classification from raw diffusion-weighted images using machine learning. In diffusion-weighted imaging (DWI), a large collection of diffusion models is available to provide insights into tissue characteristics. However, these models are limit...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The article discusses the limitations of using diffusion-weighted imaging (DWI) to classify tissues. Currently, many diffusion models are available, but they are limited by preconceived assumptions and computational challenges, which can prevent fully extracting information from the diffusion MR signal.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40205255:\n",
      "Full Text: Development and Validation of an Early Recurrence Prediction Model for High-Grade Glioma Integrating Temporalis Muscle and Tumor Features: Exploring the Prognostic Value of Temporalis Muscle. This study aimed to develop and validate a predictive mode...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed and validated a predictive model for early recurrence of high-grade glioma within 180 days, incorporating both tumor features and metrics from the temporalis muscle. The optimal model, called TM_Tumor_HistGradientBoosting, included 16 features, including preoperative and postoperative temporalis muscle metrics, and outperformed a tumor-only model in accuracy, recall, and F1 score. The study found that combining temporalis muscle metrics with preoperative tumor MRI substantially improved the accuracy of early recurrence prediction and highlighted the significant clinical value of temporalis muscle metrics as objective and sustainable prognostic indicators.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40196451:\n",
      "Full Text: Molecular Subtypes and Immune Microenvironment Characterization of the Annulus Fibrosus in Intervertebral Disc Degeneration: Insights From Translation Factor-Related Gene Analysis. This study aims to examine the role of translation factors (TF) in in...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The study investigates the relationship between translation factors (TFs) and intervertebral disc degeneration (IVDD), with a focus on the annulus fibrosus. The researchers used unsupervised clustering methods to analyze TF-related genes and identify molecular subtypes of the annulus fibrosus in IVDD. This analysis aims to provide insights into the clinical relevance of TFs in IVDD.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40205439:\n",
      "Full Text: Filtering cells with high mitochondrial content depletes viable metabolically altered malignant cell populations in cancer single-cell studies. Single-cell transcriptomics has transformed our understanding of cellular diversity, yet noise from techni...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Single-cell transcriptomics can reveal cellular diversity, but technical artifacts and low-quality cells can obscure biological signals. One common practice is to filter out cells with high mitochondrial RNA counts, thought to indicate cell death. However, this approach may be too stringent for malignant cells, which naturally have higher baseline mitochondrial gene expression.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40207200:\n",
      "Full Text: Transcriptome analysis reveals the potential role of neural factor EN1 for long-terms survival in estrogen receptor-independent breast cancer. Breast cancer patients with estrogen receptor-negative (ERneg) status, encompassing triple negative breast ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers analyzed RNA sequencing data from breast cancer patients with estrogen receptor-negative status to identify potential biomarkers for long-term survival. They found that nerve-related pathways were differentially enriched between patients who did or did not experience early recurrence, suggesting a role for neural factor EN1 in predicting survival. The study also developed an early recurrence index and nomogram that accurately predicted 10-year survival outcomes for these patients.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40206097:\n",
      "Full Text: Tongue coating microbiota-based machine learning for diagnosing digestive system tumours. Digestive system tumours (DSTs) often diagnosed late due to nonspecific symptoms. Non-invasive biomarkers are crucial for early detection and improved outcomes....\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers have developed a machine learning approach that uses microbiota from tongue coatings to diagnose digestive system tumors (DSTs) earlier, potentially improving treatment outcomes. The study aimed to identify non-invasive biomarkers for DSTs, which are often diagnosed late due to vague symptoms.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40201235:\n",
      "Full Text: Survival path model outperforms conventional static machine learning models in long-term dynamic prognosis prediction for patients with intermediate stage hepatocellular carcinoma. Patients with intermediate stage hepatocellular carcinoma (HCC) requi...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A new machine learning model called Survival Path Mapping (SP) was developed to predict the long-term prognosis of patients with intermediate-stage hepatocellular carcinoma (HCC). The SP model outperformed conventional static machine learning models, such as Gaussian Naive Bayes, Support Vector Machine, and Random Forest, in predicting survivorship.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40206813:\n",
      "Full Text: Prediction of brain metastasis progression after stereotactic radiosurgery: sensitivity to changing the definition of progression. Machine learning (ML) has been used to predict tumor progression post-stereotactic radiosurgery (SRS) based on pre-trea...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers used machine learning to predict brain metastasis progression after stereotactic radiosurgery (SRS) based on pre-treatment MRI scans. However, there is uncertainty around what constitutes tumor progression, which can affect the model's performance. The study aimed to investigate how changing the definition of progression affects the accuracy of an ML model in predicting post-SRS progression.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40201179:\n",
      "Full Text: Prediction model of gastrointestinal tumor malignancy based on coagulation indicators such as TEG and neural networks. Accurate determination of gastrointestinal tumor malignancy is a crucial focus of clinical research. Constructing coagulation index...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed machine learning models using big data and coagulation indicators like TEG to predict the malignancy of gastrointestinal tumors. The goal was to construct coagulation index models that can accurately determine the severity of tumor malignancy. By identifying independent risk factors, this study aimed to improve methods for predicting gastrointestinal tumor malignancy.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40203229:\n",
      "Full Text: Global burden and future trends of head and neck cancer: a deep learning-based analysis (1980-2030). Head and neck cancer (HNC) becomes a vital global health burden. Accurate assessment of the disease burden plays an essential role in setting health ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Head and neck cancer (HNC) has become a significant global health burden, requiring accurate assessments to inform health priorities and decision-making. This analysis uses deep learning techniques to estimate the disease burden from 1980 to 2030, providing valuable insights for healthcare planning.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40196740:\n",
      "Full Text: Predictive model using systemic inflammation markers to assess neoadjuvant chemotherapy efficacy in breast cancer. Pathological complete response (pCR) is an important indicator for evaluating the efficacy of neoadjuvant chemotherapy (NAC) in breast ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The study aimed to investigate the predictive value of systemic inflammation markers (NLR, PLR, LMR, NMR) in assessing the efficacy of neoadjuvant chemotherapy (NAC) in breast cancer patients and constructing a pathological complete response (pCR) prediction model. The researchers explored the relationship between these markers and clinicopathological characteristics to identify potential predictors of pCR and long-term prognosis.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40200221:\n",
      "Full Text: Combining multi-omics analysis with machine learning to uncover novel molecular subtypes, prognostic markers, and insights into immunotherapy for melanoma. Melanoma (SKCM) is an extremely aggressive form of cancer, characterized by high mortality rat...\n",
      "Summary: Here is a 3-sentence summary of the article:\n",
      "\n",
      "Researchers are using a combination of multi-omics analysis (studying multiple types of biological data) and machine learning to identify new subtypes of melanoma, which is an aggressive form of skin cancer with high mortality rates. The goal is to improve diagnostic accuracy and identify potential therapeutic targets for treating melanoma. Ultimately, the study aims to develop novel strategies for treating this difficult-to-treat disease.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40208025:\n",
      "Full Text: The Real-World Impact of Vestibular Schwannoma Fully Automated Volume Measures on the Evaluation of Size Change and Clinical Management Outcomes in a Multidisciplinary Meeting Setting. Vestibular schwannoma (VS) management decisions are made within m...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The study examined the impact of using fully automated volume measures for vestibular schwannoma tumors on the evaluation of size change and clinical management outcomes during multidisciplinary meetings. Current volumetric methods are time-consuming, but this new approach aimed to improve accuracy and inform decision-making. The goal was to compare radiological outcomes and clinical decisions between this automated method and a standard linear measurement approach.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40204747:\n",
      "Full Text: One-class support vector machines for detecting population drift in deployed machine learning medical diagnostics. Machine learning (ML) models are increasingly being applied to diagnose and predict disease, but face technical challenges such as popu...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The authors propose using one-class support vector machines (OCSVMs) to detect population drift in machine learning medical diagnostics, which can occur when training and deployed data distributions differ. They trained an OCSVM on the Wisconsin Breast Cancer dataset and tested its ability to detect population drift on simulated data with varying levels of noise, finding that increased noise correlated with more detected \"inliers\" indicating a sensitivity to population drift. This approach could potentially alert clinicians to population drift, supporting safe adoption of machine learning diagnostics.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40206583:\n",
      "Full Text: Integrating multi-omics and machine learning methods reveals the metabolism of amino acids and derivatives-related signature in colorectal cancer. The metabolism of amino acids and derivatives (MAAD) is closely related to the occurrence and developme...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers used multi-omics and machine learning methods to investigate the relationship between amino acid metabolism and colorectal cancer (CRC). They found that the metabolism of amino acids and derivatives (MAAD) plays a significant role in the progression of CRC, but the underlying regulatory mechanisms were unclear. The study aimed to identify key molecules that could become potential therapeutic targets for treating CRC.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40196464:\n",
      "Full Text: Validation of a Machine-Learning Clinical Decision Aid for the Differential Diagnosis of Transient Loss of Consciousness. The aim of this study was to develop and validate a machine-learning classifier based on patient and witness questionnaires to s...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed and validated a machine-learning clinical decision aid to help diagnose transient loss of consciousness (TLOC) at its initial presentation. The tool uses patient and witness questionnaires to support differential diagnosis of TLOC, allowing for more accurate and timely diagnosis.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40204902:\n",
      "Full Text: Novel deep learning algorithm based MRI radiomics for predicting lymph node metastases in rectal cancer. To explore the value of applying the MRI-based radiomic nomogram for predicting lymph node metastasis (LNM) in rectal cancer (RC). This retrospec...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed a deep learning algorithm based on MRI radiomics to predict lymph node metastases (LNM) in rectal cancer patients. The algorithm, called the nomogram model, combined clinical and imaging features from multiparametric MRI images with physician assessments to achieve superior predictive performance compared to other models. The nomogram model showed high accuracy in predicting LNM status in patients with rectal cancer, outperforming other models including a physician model and sequence-based models.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40200465:\n",
      "Full Text: Enhancing Survival Prediction: The Potential of Whole-Brain Radiomics in Multimodal Neuroimaging. Radiomics shows promise in enhancing predictions of overall survival (OS) and progression-free survival (PFS) in patients with glial brain tumors. The p...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A study investigated the potential of whole-brain radiomics, which analyzes imaging biomarkers from a whole brain mask, to predict overall survival and progression-free survival in patients with glial brain tumors. The results showed that models built solely on imaging biomarkers performed best, while those based only on clinical signs performed worst. The study suggests that whole-brain radiomics may be a promising avenue for further research, although its reproducibility with new data is unclear due to limited data.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40209226:\n",
      "Full Text: Evaluating the Effectiveness of Large Language Models in Providing Patient Education for Chinese Patients With Ocular Myasthenia Gravis: Mixed Methods Study. Ocular myasthenia gravis (OMG) is a neuromuscular disorder primarily affecting the extraocul...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The study aims to evaluate the effectiveness of large language models (LLMs) in providing patient education for Chinese individuals with ocular myasthenia gravis (OMG). OMG is a neuromuscular disorder that affects the extraocular muscles, leading to ptosis and diplopia. The authors seek to determine whether LLMs can provide accurate and readable information to patients with OMG, potentially bridging the gap in healthcare resources in China.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40197174:\n",
      "Full Text: scAMZI: attention-based deep autoencoder with zero-inflated layer for clustering scRNA-seq data. Clustering scRNA-seq data plays a vital role in scRNA-seq data analysis and downstream analyses. Many computational methods have been proposed and achiev...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The scAMZI algorithm proposes an attention-based deep autoencoder with a zero-inflated layer for clustering single-cell RNA sequencing (scRNA-seq) data. Current methods have limitations, including failure to fully utilize cellular features, lack of flexibility in incorporating intercellular relationships, and susceptibility to dropout events.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40204586:\n",
      "Full Text: Habitat Radiomics Based on MRI for Predicting Metachronous Liver Metastasis in Locally Advanced Rectal Cancer: a Two‑center Study. This study aimed to explore the feasibility of using habitat radiomics based on magnetic resonance imaging (MRI) to pre...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A study investigated using magnetic resonance imaging (MRI) and radiomics-based analysis to predict the development of liver metastases in patients with locally advanced rectal cancer. The study aimed to develop a nomogram that combines multiple factors to improve predictive accuracy.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40202838:\n",
      "Full Text: Protocol for obtaining cancer type and subtype predictions using subSCOPE. We present a protocol for obtaining cancer type and subtype predictions using a machine learning method (subSCOPE). We describe steps for data preparation, subSCOPE setup, and...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "This protocol outlines how to use the machine learning method subSCOPE to predict cancer type and subtype from various types of omics data (DNA methylation, gene expression, miRNA expression, point mutations, and copy-number variants). The protocol allows for individual cancer type and data type selection and can classify non-TCGA cancer samples across 26 different TCGA cancer cohorts and 106 subtypes.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40198525:\n",
      "Full Text: Causal relationship between breast cancer and acute myeloid leukemia based on two-sample bidirectional Mendelian randomization and transcriptome overlap analysis. Breast cancer is the most prevalent malignancy and the leading cause of cancer-related ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Breast cancer is the most common type of cancer among women worldwide, with some patients developing acute myeloid leukemia (AML) shortly after being diagnosed with breast cancer. Despite case reports showing this correlation, the causal relationship and underlying mechanisms between breast cancer and AML are still unclear.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40208475:\n",
      "Full Text: Identification of a deubiquitinating gene-related signature in ovarian cancer using integrated transcriptomic analysis and machine learning framework. Ovarian carcinoma represents an aggressive malignancy with poor prognosis and limited therapeutic e...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Ovarian cancer is an aggressive and deadly disease with limited treatment options. Deubiquitinating (DUB) genes play important roles in regulating cellular processes and cancer progression, but their specific functions in ovarian cancer are not well understood. Researchers aim to identify a signature related to DUB genes in ovarian cancer using integrated transcriptomic analysis and machine learning techniques.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40209855:\n",
      "Full Text: Development and validation of Prediction models for radiation-induced hypoglossal neuropathy in patients with nasopharyngeal carcinoma. To establish predictive models for radiation-induced hypoglossal neuropathy (RIHN) in patients with nasopharyngeal...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed and validated prediction models to identify patients with nasopharyngeal carcinoma who are at risk of developing radiation-induced hypoglossal neuropathy after undergoing intensity-modulated radiotherapy. The goal was to create predictive models that can help clinicians anticipate and prevent this complication in NPC patients.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40217479:\n",
      "Full Text: Comprehensive analysis of metabolism-related gene biomarkers reveals their impact on the diagnosis and prognosis of triple-negative breast cancer. Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by poor pr...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers have conducted an in-depth analysis of gene biomarkers related to metabolism, which has led to a better understanding of their impact on diagnosing and predicting the prognosis of triple-negative breast cancer (TNBC). TNBC is an aggressive and difficult-to-treat type of breast cancer that requires new diagnostic tools. Metabolic changes are a hallmark of cancer and show promise as predictive biomarkers for breast cancer diagnosis and treatment.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40205603:\n",
      "Full Text: Application of artificial intelligence in the diagnosis of malignant digestive tract tumors: focusing on opportunities and challenges in endoscopy and pathology. Malignant digestive tract tumors are highly prevalent and fatal tumor types globally, of...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Malignant digestive tract tumors are common and often diagnosed at advanced stages due to vague symptoms, leading to missed treatment opportunities. Traditional diagnosis methods, such as endoscopy and pathology, rely heavily on expert experience and are prone to misdiagnosis and inter-observer variation. Artificial intelligence (AI) technologies, like deep learning, have the potential to improve diagnostic accuracy and efficiency through real-time lesion detection and automated image analysis, but challenges remain in data standardization, interpretability, and clinical validation.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40211257:\n",
      "Full Text: The glycolytic characteristics of hepatocellular carcinoma and its interaction with the microenvironment: a comprehensive omics study. Hepatocellular carcinoma (HCC) is a common malignant tumor characterized by a high recurrence rate and poor prognos...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A new study investigated the glycolytic characteristics of hepatocellular carcinoma (HCC), a common and aggressive type of liver cancer, to identify potential prognostic markers. The study aimed to understand how HCC interacts with its surrounding microenvironment and identified abnormalities that may be indicative of poor prognosis.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40217199:\n",
      "Full Text: Predicting the efficacy of microwave ablation of benign thyroid nodules from ultrasound images using deep convolutional neural networks. Thyroid nodules are frequent in clinical settings, and their diagnosis in adults is growing, with some persons ex...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Thyroid nodules are common and can cause symptoms in adults, but ultrasound-guided microwave ablation can help shrink them and alleviate discomfort. However, there is currently no reliable way to predict the effectiveness of this treatment due to individual variations in lesion absorption. Researchers aim to develop a deep convolutional neural network (CNN) model that uses ultrasound images to predict the efficacy of microwave ablation for benign thyroid nodules.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40211143:\n",
      "Full Text: Immune status assessment based on plasma proteomics with meta graph convolutional networks. Plasma proteins, especially immune-related proteins, are vital for assessing immune health and predicting disease risks. Despite their significance, the link ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed ProMetaGCN, a model that uses meta-learning, graph convolutional networks, and protein-protein interaction data to evaluate immune status through plasma proteomics. The framework identified key biomarkers and validated its robustness across two COVID-19 cohorts, finding correlations between immune status and infection progression/recovery. Additionally, the study proposed ImmuneAgeGap, a metric linking immune profiles to survival rates in non-small-cell lung cancer patients, advancing personalized immune health strategies and disease prevention.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40198435:\n",
      "Full Text: Mathematical and numerical tumour development modelling for personalised treatment planning. This paper presents a mathematical and numerical framework for modelling and parametrising tumour evolution dynamics to enhance computer-aided diagnosis and ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A mathematical model was developed to simulate tumor evolution and predict disease progression and treatment response. The model incorporates six differential equations that describe various aspects of tumor development, including cancer cell and blood vessel concentrations, tissue stiffness, and marker distribution. By calibrating the model with patient-specific clinical data using an inverse problem approach, the framework can be used as a decision-support tool to optimize therapeutic strategies for individual patients.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40197532:\n",
      "Full Text: Association between long-term exposure to PM Long-term exposure to particulate matter with aerodynamic diameter ≤ 2.5 μm (PM...\n",
      "Summary: I'm happy to help! However, I don't see an article attached. Could you please provide the article text or a link to it? I'll be happy to summarize it for you in 2-3 sentences.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40200468:\n",
      "Full Text: Using Machine Learning to Predict Survival in Patients with Metastatic Castration-Resistant Prostate Cancer. Non-specific clinical biomarkers have been shown to help identify prognostic risks in cancer patients. However, the accuracy of prognostic bi...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed a machine learning model using clinical and demographic data to predict 3-year survival rates for patients with metastatic castration-resistant prostate cancer (mCRPC). The model, which used the XGBoost algorithm, achieved an accuracy of 73% and was able to distinguish between patients who survived less than or more than 3 years. Key predictors of survival included PSA levels, as well as other non-specific biomarkers such as albumin and LDH.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40198459:\n",
      "Full Text: CLDN9 and hsa-miR-4496 as non-invasive biomarkers for gastric cancer detection. Gastric cancer is a leading cause of cancer deaths globally due to its often late diagnosis and poor survival rates. There's an urgent need for reliable non-invasive biom...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Gastric cancer is a leading cause of cancer deaths worldwide due to its late diagnosis and poor survival rates. Researchers are searching for reliable non-invasive biomarkers for early detection, and one potential marker is CLDN9, a protein involved in epithelial-mesenchymal transition. This study investigates the diagnostic value of CLDN9 as a biomarker for gastric cancer, with a focus on its relationship to the mitochondrial pathway.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40199311:\n",
      "Full Text: Year 2023 in Biomedical Natural Language Processing: a Tribute to Large Language Models and Generative AI. This synopsis gives insights into scientific publications from 2023 in Natural Language Processing for the biomedical domain. We present the pr...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The article provides an overview of the advancements in biomedical natural language processing (NLP) in 2023, highlighting the impact of large language models and generative AI on the field. The authors present their methodology for identifying top NLP papers in the biomedical domain and highlight two standout papers from the year. Additionally, they analyze the current trends in 2023 publications to provide insight into the state of the field.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40213364:\n",
      "Full Text: A deep learning model for clinical outcome prediction using longitudinal inpatient electronic health records. Recent advances in deep learning show significant potential in analyzing continuous monitoring electronic health records (EHR) data for clin...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A new deep learning model called TECO aims to predict patient outcomes, specifically mortality rates, in an intensive care unit (ICU) setting using electronic health records (EHRs). The model uses a Transformer-based approach to analyze longitudinal EHR data from inpatient stays.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40203502:\n",
      "Full Text: Arsenic toxicity exacerbates China's groundwater and health crisis. Arsenic (As) contamination is considered a major threat to groundwater quality and human health. The uneven distribution of arsenic contributes to regional variations, creating discr...\n",
      "Summary: Here is a 2-3 sentence summary of the article:\n",
      "\n",
      "Arsenic contamination in China's groundwater poses significant threats to human health, particularly in areas with high concentrations. A study analyzing 2,737 groundwater samples found that regional variations in arsenic levels are largely driven by environmental factors, with chemical properties being the most influential drivers. The findings highlight the need for efficient water purification technologies, especially in rural regions where natural enrichment of arsenic is common and cancer risks are higher.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40200718:\n",
      "Full Text: Raman spectral band imaging for the diagnostics and classification of canine and feline cutaneous tumors. This study introduces Raman imaging technique for diagnosing skin cancer in veterinary oncology patients (dogs and cats). Initially, Raman spect...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed a Raman imaging technique to diagnose and classify skin cancer in dogs and cats. The method uses Raman spectral bands, which are specific to certain molecular structures, to identify differences between formalin-fixed samples of mast cell tumors and soft tissue sarcomas. This technology may be used to improve the diagnosis and treatment of cutaneous tumors in veterinary oncology patients.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40214892:\n",
      "Full Text: AI may help to predict thyroid nodule malignancy based on radiomics features from [ The number of thyroid cancer diagnoses has been increasing for several decades, with a significant part of cases being detected incidentally (thyroid incidentaloma, T...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The number of thyroid cancer diagnoses has been increasing over several decades, with many cases being discovered incidentally through imaging tests. Researchers are exploring whether artificial intelligence (AI) can help predict thyroid nodule malignancy based on radiomics features from these tests. Specifically, they're investigating if AI can identify patterns in positron emission tomography (PET)/computed tomography (CT) scans that indicate a higher risk of cancer.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40197384:\n",
      "Full Text: Identification of N6-methyladenosine-associated ferroptosis biomarkers in cervical cancer. Cervical cancer (CC) stands as a major contributor to female mortality. The pathogenesis of CC is linked with various factors. Our research aimed to unravel th...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Cervical cancer is a significant cause of female mortality, and its pathogenesis is influenced by various factors. Researchers used bioinformatics analysis to investigate the mechanisms underlying ferroptosis and N6-methyladenosine (m6A) RNA methylation in cervical cancer. The study aimed to identify biomarkers associated with these processes.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40206057:\n",
      "Full Text: Editorial: State-of-the-art hypothesis-driven systems pharmacology and artificial intelligence approaches to decipher disease complexity. ...\n",
      "Summary: The article discusses the potential of combining state-of-the-art systems pharmacology and artificial intelligence (AI) approaches to better understand the complexities of diseases. By using hypothesis-driven methods, researchers can develop more effective treatments by identifying key molecular mechanisms driving disease progression. This integrated approach has the potential to revolutionize our understanding of complex diseases and lead to more targeted and personalized therapies.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "\n",
      "Processed articles with LM labels:\n",
      "PMID 40199294:\n",
      "Full Text: A Narrative Review on the Application of Large Language Models to Support Cancer Care and Research. The emergence of large language models has resulted in a significant shift in informatics research and carries promise in clinical cancer care. Here w...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "The development of large language models has revolutionized informatics research and holds great promise for improving clinical cancer care. This narrative review examines the recent applications of large language models (LLMs) to support cancer care, prevention, and research. The goal is to highlight the potential benefits of using LLMs in the field of oncology.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40205450:\n",
      "Full Text: Preoperative assessment in lymph node metastasis of pancreatic ductal adenocarcinoma: a transformer model based on dual-energy CT. Deep learning(DL) models can improve significantly discrimination of lymph node metastasis(LNM) of pancreatic ductal ad...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A new study explores the use of a transformer model based on dual-energy CT scans to assess lymph node metastasis (LNM) in patients with pancreatic ductal adenocarcinoma (PDAC). The goal is to improve the accuracy of LNM diagnosis using deep learning (DL) models, which have not been thoroughly evaluated for this purpose.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40200832:\n",
      "Full Text: Integrative Multi-Omics Analysis Reveals Molecular Subtypes of Ovarian Cancer and Constructs Prognostic Models. Ovarian cancer (OV) remains the most lethal gynecological malignancy. The aim of this study was to identify molecular subtypes of OV throu...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers used integrative multi-omics analysis to identify molecular subtypes of ovarian cancer and develop prognostic models for predicting immunotherapy efficacy. They found two distinct subtypes (CS1 and CS2) with significant survival differences, and constructed a robust prognostic signature using machine learning algorithms. The study also revealed that low-risk patients had higher tumor mutational burden, better immunotherapy responses, and more abundant anti-tumor immune cells compared to high-risk patients.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40207046:\n",
      "Full Text: From genes to drugs: targeting Alzheimer's with circadian insights. Alzheimer's disease (AD) is a typical neurodegenerative disease that presents challenges due to the lack of biomarkers to identify AD. A growing body of evidence highlights the criti...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Alzheimer's disease is a challenging neurodegenerative disorder lacking effective biomarkers for diagnosis. Research has shown that circadian rhythms play a crucial role in Alzheimer's, offering potential new targets for treatment.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40207173:\n",
      "Full Text: The Development and Performance of a Machine-Learning Based Mobile Platform for Visually Determining the Etiology of 5 Penile Diseases. To develop a machine-learning visual classification algorithm for penile diseases in order to address disparities ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A machine-learning based mobile platform was developed to visually diagnose five common penile diseases, aiming to reduce disparities in access to sexual health services. The platform uses an algorithm that classifies images of penises to determine the etiology (cause) of the disease, enabling remote diagnosis and treatment. This innovation has the potential to improve healthcare equity for individuals with limited access to medical professionals.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40208287:\n",
      "Full Text: Improving radiologists' diagnostic accuracy for lymphovascular invasion in colorectal cancer: insights from a multicenter CT-based study. The current standard of subjective assessment by radiologists for lymphovascular invasion (LVI) in colorectal ca...\n",
      "Summary: Here is a 2-3 sentence summary of the article:\n",
      "\n",
      "A current method used by radiologists to diagnose lymphovascular invasion (LVI) in colorectal cancer using CT scans has been found to be inaccurate. To improve diagnostic accuracy, researchers have developed an advanced CT-based prediction model that can provide support for radiologists' assessments. This new approach aims to help radiologists more accurately diagnose LVI.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40211222:\n",
      "Full Text: Image quality improvement in head and neck angiography based on dual-energy CT and deep learning. Compare the image quality of image reconstructed using deep learning-based image reconstruction (DLIR) and iterative reconstruction algorithms for head ...\n",
      "Summary: Here is a summary of the article:\n",
      "\n",
      "Researchers compared the image quality of two methods used to reconstruct images from head and neck dual-energy computed tomography angiography (DECTA): deep learning-based image reconstruction (DLIR) and iterative reconstruction algorithms. The study found that DLIR outperformed iterative reconstruction in terms of image quality, with improved spatial resolution and reduced noise.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40199721:\n",
      "Full Text: Recent advances in cutaneous drug delivery by iontophoresis. Iontophoresis has been extensively studied for topical and transdermal drug delivery to stimulate the absorption of molecules that would hardly pass through the outermost layer of the skin ...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Iontophoresis, a method for delivering drugs through the skin, has been studied extensively for topical and transdermal delivery. Recent research has explored combining iontophoresis with nanoparticle-based systems or microneedles to expand its therapeutic applications. This combination aims to improve the absorption of molecules that would not pass through the skin naturally.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40215772:\n",
      "Full Text: CLIC1 and IFITM2 expression in brain tissue correlates with cognitive impairment via immune dysregulation in sepsis and Alzheimer's disease. Sepsis, a life-threatening condition driven by dysregulated host responses to infection, is associated with l...\n",
      "Summary: Here is a 3-sentence summary of the article:\n",
      "\n",
      "Research suggests that there is a correlation between expression levels of two genes (CLIC1 and IFITM2) and cognitive impairment in individuals with sepsis and Alzheimer's disease. Sepsis, an inflammatory condition caused by an overactive immune response to infection, can lead to long-term cognitive impairments similar to those seen in Alzheimer's disease. The study proposes that shared genetic pathways may contribute to cognitive deficits in both conditions, but the underlying molecular mechanisms are not yet fully understood.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40217526:\n",
      "Full Text: Towards precision oncology: a multi-level cancer classification system integrating liquid biopsy and machine learning. Millions of people die from cancer every year. Early cancer detection is crucial for ensuring higher survival rates, as it provides...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A new cancer classification system has been proposed that uses liquid biopsy techniques and machine learning to detect and diagnose cancer early. The system can identify seven distinct types of cancer: colorectal, breast, upper gastrointestinal, lung, pancreas, ovarian, and liver. This approach has the potential to improve survival rates by enabling timely medical interventions for millions of people who die from cancer every year.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40213938:\n",
      "Full Text: DNA Molecular Computing with Weighted Signal Amplification for Cancer miRNA Biomarker Diagnostics. The expression levels of microRNAs (miRNAs) are strongly linked to cancer progression, making them promising biomarkers for cancer detection. Enzyme-fr...\n",
      "Summary: Here is a summary of the article in 3 sentences:\n",
      "\n",
      "Researchers have developed a DNA-based molecular computing approach that assigns weights to microRNAs (miRNAs) based on their diagnostic value for cancer detection. This approach uses enzyme-free signal amplification and localized DNA catalytic hairpin assembly to amplify weighted signals, allowing for the diagnosis of non-small cell lung cancer (NSCLC) with an accuracy of 92.86%. The method can classify healthy and lung cancer individuals within 2.5 hours, making it a promising tool for personalized disease diagnostics in point-of-care settings.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40209577:\n",
      "Full Text: Mitosis detection and classification for breast cancer diagnosis: What we know and what is next. Breast cancer is the second most deadly malignancy in women, behind lung cancer. Despite significant improvements in medical research, breast cancer is s...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Breast cancer diagnosis often relies on histological analysis to detect and classify mitotic cells, which can be challenging due to the small size of these dividing cells. Recent advancements in machine learning and deep learning have revolutionized the process, offering automated and precise solutions for identifying mitotic cells. The article reviews the techniques used over the past decade to identify and classify mitotic cells in breast cancer images and predicts future developments in this area.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40200471:\n",
      "Full Text: Data-Driven Assessment of Lung Cancer Patients Using Performance Status and Wearable Device Metrics. Lung cancer remains a leading cause of cancer-related deaths globally, with non-small cell lung cancer (NSCLC) accounting for 85% of cases. Tradition...\n",
      "Summary: Here is a 2-3 sentence summary of the article:\n",
      "\n",
      "A study aimed to assess the usability of wearable devices and a mobile app for monitoring activity, sleep quality, and symptoms in lung cancer patients. The results showed moderate correlations between wearable data and Performance Status (PS) scores reported by clinicians, but challenges remain in using machine learning models to predict changes in patient condition. Further research is needed to refine these models, increase sample size, and incorporate additional features from wearables to improve predictive accuracy.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40209178:\n",
      "Full Text: Web-Based Explainable Machine Learning-Based Drug Surveillance for Predicting Sunitinib- and Sorafenib-Associated Thyroid Dysfunction: Model Development and Validation Study. Unlike one-snap data collection methods that only identify high-risk patien...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "A new web-based model uses explainable machine learning to predict thyroid dysfunction associated with sunitinib and sorafenib drugs, which are commonly used to treat cancer. Unlike traditional methods that only identify high-risk patients, this approach uses time-series data to predict adverse events and aid in timely management of cancer treatment. The model was developed and validated through a study, showing promise for improving patient care.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40197547:\n",
      "Full Text: CNRein: an evolution-aware deep reinforcement learning algorithm for single-cell DNA copy number calling. Low-pass single-cell DNA sequencing technologies and algorithmic advancements have enabled haplotype-specific copy number calling on thousands o...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers have developed an algorithm called CNRein that uses deep reinforcement learning to improve the accuracy of single-cell DNA copy number calling, which can be affected by measurement uncertainty and inconsistent with realistic evolutionary constraints. The algorithm has been shown to infer more accurate copy-number profiles and better recapitulate ground truth clonal structure than existing methods in simulations. Additionally, CNRein was able to produce more parsimonious solutions while maintaining agreement with single-nucleotide variants in breast and ovarian cancer sequencing data.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40216945:\n",
      "Full Text: Identification of M1 macrophage infiltration-related genes for immunotherapy in Her2-positive breast cancer based on bioinformatics analysis and machine learning. Over the past several decades, there has been a significant increase in the number of b...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers analyzed gene expression data from The Cancer Genome Atlas-Breast cancer database to identify genes related to M1 macrophage infiltration in HER2-positive breast cancer. They found four hub genes (CCDC69, PPP1R16B, IL21R, and FOXP3) that were strongly correlated with M1 macrophages using machine learning algorithms. These genes were validated through nomogram models, receiver operating characteristic curve analysis, and survival analysis, showing potential for use in diagnosing, predicting prognosis, and guiding immunotherapy for HER2-positive breast cancer patients.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40200453:\n",
      "Full Text: Investigating AI Approaches for Survival Prediction in Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia (CLL) exhibits a heterogeneous clinical course. Prognostic markers that impact patient outcomes have been identified, including MYC gene...\n",
      "Summary: Here is a 3-sentence summary of the article:\n",
      "\n",
      "Researchers compared machine learning (ML) models with traditional Cox proportional hazards models for predicting patient outcomes in chronic lymphocytic leukemia (CLL). The ML models, including Random Survival Forest and Decision Tree, outperformed Cox models in terms of predictive accuracy, but had limitations in interpretability. The study suggests that ML models may have potential for personalized survival predictions in CLL, particularly for patients with MYC gene abnormalities, and highlights the need for further refinement to improve clinical usability.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40200434:\n",
      "Full Text: Predicting Prostate Cancer Diagnosis Using Machine Learning Analysis of Healthcare Utilization Patterns. This study investigated healthcare utilization patterns prior to prostate cancer diagnoses, aiming to develop machine learning models for early p...\n",
      "Summary: Here is a summary of the article in 3 sentences:\n",
      "\n",
      "Researchers used machine learning models to analyze healthcare utilization patterns to predict prostate cancer diagnosis. The study found that the XGBoost model performed best at predicting diagnoses 3 months in advance, with an accuracy and F1 score of 0.73 and an AUC of 0.82. PSA values were consistently the most important predictor across all timeframes, along with other factors like triglyceride and creatinine levels.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "PMID 40215448:\n",
      "Full Text: Development of a Machine Learning Algorithm to Predict Abnormalities in Serum Phosphate in a Large Oncology Cohort. Serum phosphate is commonly measured in oncology patients because of the relationship between oncologic conditions and treatments with...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers aimed to develop a machine learning algorithm that can predict abnormal serum phosphate levels based on other biochemical test results from a standardized order set (SOS) used at a large oncology center. The SOS includes 15 tests, including serum phosphate, which is commonly measured due to its relationship with certain cancers and treatments. The goal was to identify interrelated variables in the SOS that can be used to predict abnormal phosphate levels.\n",
      "Label (1=useful, 0=not useful): 0\n",
      "\n",
      "PMID 40209532:\n",
      "Full Text: High-throughput microfluidics for precise separation and focusing of circulating tumor cells with optimized triangular microchannel design. The precise separation and focusing of circulating tumor cells (CTCs) from blood cells are crucial for advanci...\n",
      "Summary: Here is a summary of the article in 2-3 sentences:\n",
      "\n",
      "Researchers developed an optimized triangular microchannel design to separate and focus circulating tumor cells (CTCs) from blood cells with high efficiency and purity. Using machine learning-based modeling, they predicted that a specific design geometry would achieve 100% separation efficiency and purity at a certain flow rate, which was later experimentally validated. The resulting microchip demonstrates remarkable performance in isolating CTCs from complex biological samples, offering a reliable and scalable solution for biomedical and clinical applications.\n",
      "Label (1=useful, 0=not useful): 1\n",
      "\n",
      "Saved data to article_data.pkl\n",
      "epoch: 1\n",
      "step: 0, acc: 0.438, loss: 0.694, (data_loss: 0.6939571335830967, reg_loss: 0.000), lr: 0.01\n",
      "step: 2, acc: 0.312, loss: 0.694, (data_loss: 0.6943259870114663, reg_loss: 0.000), lr: 0.009999000099990002\n",
      "training, acc: 0.400, loss: 0.694, (data_loss: 0.6942882835399833, reg_loss: 0.000), lr: 0.009999000099990002\n",
      "validation, acc: 0.550, loss: 0.692\n",
      "Val predictions: [1 1 1 1 0 0 0 1 0 1 1 1 0 0 1 1 0 0 0 1]\n",
      "epoch: 2\n",
      "step: 0, acc: 0.531, loss: 0.693, (data_loss: 0.6927436266294296, reg_loss: 0.000), lr: 0.009998500224966254\n",
      "step: 2, acc: 0.562, loss: 0.691, (data_loss: 0.6913824106851607, reg_loss: 0.000), lr: 0.009997500624843789\n",
      "training, acc: 0.487, loss: 0.693, (data_loss: 0.6928643103422901, reg_loss: 0.000), lr: 0.009997500624843789\n",
      "validation, acc: 0.500, loss: 0.691\n",
      "Val predictions: [1 1 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 1]\n",
      "epoch: 3\n",
      "step: 0, acc: 0.688, loss: 0.691, (data_loss: 0.6909039074324218, reg_loss: 0.000), lr: 0.009997000899730081\n",
      "step: 2, acc: 0.812, loss: 0.687, (data_loss: 0.6874230577034286, reg_loss: 0.000), lr: 0.009996001599360257\n",
      "training, acc: 0.675, loss: 0.690, (data_loss: 0.6899533987795694, reg_loss: 0.000), lr: 0.009996001599360257\n",
      "validation, acc: 0.500, loss: 0.691\n",
      "Val predictions: [0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0]\n",
      "epoch: 4\n",
      "step: 0, acc: 0.594, loss: 0.688, (data_loss: 0.6877942837097757, reg_loss: 0.000), lr: 0.00999550202408916\n",
      "step: 2, acc: 0.750, loss: 0.681, (data_loss: 0.6811451717261848, reg_loss: 0.000), lr: 0.009994503023337166\n",
      "training, acc: 0.625, loss: 0.687, (data_loss: 0.6868834280467241, reg_loss: 0.000), lr: 0.009994503023337166\n",
      "validation, acc: 0.400, loss: 0.690\n",
      "Val predictions: [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]\n",
      "epoch: 5\n",
      "step: 0, acc: 0.625, loss: 0.684, (data_loss: 0.6838445518440367, reg_loss: 0.000), lr: 0.009994003597841295\n",
      "step: 2, acc: 0.812, loss: 0.670, (data_loss: 0.6702082930201974, reg_loss: 0.000), lr: 0.009993004896572401\n",
      "training, acc: 0.650, loss: 0.682, (data_loss: 0.6815262931777681, reg_loss: 0.000), lr: 0.009993004896572401\n",
      "validation, acc: 0.400, loss: 0.688\n",
      "Val predictions: [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]\n",
      "epoch: 6\n",
      "step: 0, acc: 0.625, loss: 0.679, (data_loss: 0.6791835946572428, reg_loss: 0.000), lr: 0.00999250562078441\n",
      "step: 2, acc: 0.750, loss: 0.667, (data_loss: 0.6666029296706695, reg_loss: 0.000), lr: 0.009991507218863965\n",
      "training, acc: 0.637, loss: 0.677, (data_loss: 0.6768053933773617, reg_loss: 0.000), lr: 0.009991507218863965\n",
      "validation, acc: 0.400, loss: 0.685\n",
      "Val predictions: [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]\n",
      "epoch: 7\n",
      "step: 0, acc: 0.688, loss: 0.673, (data_loss: 0.6728672800576826, reg_loss: 0.000), lr: 0.009991008092716556\n",
      "step: 2, acc: 0.875, loss: 0.640, (data_loss: 0.6399246347941123, reg_loss: 0.000), lr: 0.009990009990009992\n",
      "training, acc: 0.662, loss: 0.667, (data_loss: 0.6669853586605423, reg_loss: 0.000), lr: 0.009990009990009992\n",
      "validation, acc: 0.450, loss: 0.679\n",
      "Val predictions: [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0]\n",
      "epoch: 8\n",
      "step: 0, acc: 0.781, loss: 0.661, (data_loss: 0.6612533093640732, reg_loss: 0.000), lr: 0.009989511013435893\n",
      "step: 2, acc: 0.938, loss: 0.615, (data_loss: 0.6147835792066265, reg_loss: 0.000), lr: 0.00998851320980872\n",
      "training, acc: 0.775, loss: 0.653, (data_loss: 0.6525167770999063, reg_loss: 0.000), lr: 0.00998851320980872\n",
      "validation, acc: 0.500, loss: 0.670\n",
      "Val predictions: [0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0]\n",
      "epoch: 9\n",
      "step: 0, acc: 0.875, loss: 0.640, (data_loss: 0.6403480014599743, reg_loss: 0.000), lr: 0.00998801438274071\n",
      "step: 2, acc: 0.938, loss: 0.590, (data_loss: 0.5900085931301691, reg_loss: 0.000), lr: 0.009987016878058523\n",
      "training, acc: 0.825, loss: 0.633, (data_loss: 0.6328041624497802, reg_loss: 0.000), lr: 0.009987016878058523\n",
      "validation, acc: 0.650, loss: 0.656\n",
      "Val predictions: [0 1 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 1 0 0]\n",
      "epoch: 10\n",
      "step: 0, acc: 0.906, loss: 0.608, (data_loss: 0.6077457739873198, reg_loss: 0.000), lr: 0.009986518200429421\n",
      "step: 2, acc: 0.938, loss: 0.544, (data_loss: 0.5438845542017834, reg_loss: 0.000), lr: 0.009985520994557892\n",
      "training, acc: 0.850, loss: 0.599, (data_loss: 0.5993336600863844, reg_loss: 0.000), lr: 0.009985520994557892\n",
      "validation, acc: 0.700, loss: 0.637\n",
      "Val predictions: [0 1 0 0 0 1 0 0 0 0 0 1 0 1 0 0 1 1 0 0]\n",
      "epoch: 11\n",
      "step: 0, acc: 0.969, loss: 0.571, (data_loss: 0.5705407958293316, reg_loss: 0.000), lr: 0.009985022466300548\n",
      "step: 2, acc: 0.938, loss: 0.496, (data_loss: 0.49636296007750413, reg_loss: 0.000), lr: 0.009984025559105431\n",
      "training, acc: 0.900, loss: 0.563, (data_loss: 0.5627087648947866, reg_loss: 0.000), lr: 0.009984025559105431\n",
      "validation, acc: 0.700, loss: 0.613\n",
      "Val predictions: [0 1 0 0 0 1 0 0 0 1 0 1 0 1 1 0 1 1 0 0]\n",
      "epoch: 12\n",
      "step: 0, acc: 0.938, loss: 0.531, (data_loss: 0.5313083683443025, reg_loss: 0.000), lr: 0.00998352718015275\n",
      "step: 2, acc: 0.938, loss: 0.423, (data_loss: 0.42342207109914554, reg_loss: 0.000), lr: 0.009982530571499877\n",
      "training, acc: 0.912, loss: 0.515, (data_loss: 0.5146214184562636, reg_loss: 0.000), lr: 0.009982530571499877\n",
      "validation, acc: 0.700, loss: 0.585\n",
      "Val predictions: [0 1 0 0 0 1 0 0 0 1 0 1 0 1 1 0 1 1 0 0]\n",
      "epoch: 13\n",
      "step: 0, acc: 0.938, loss: 0.478, (data_loss: 0.4781519208526154, reg_loss: 0.000), lr: 0.009982032341784786\n",
      "step: 2, acc: 0.938, loss: 0.384, (data_loss: 0.38434832049286893, reg_loss: 0.000), lr: 0.009981036031540073\n",
      "training, acc: 0.925, loss: 0.471, (data_loss: 0.4709371155239759, reg_loss: 0.000), lr: 0.009981036031540073\n",
      "validation, acc: 0.750, loss: 0.556\n",
      "Val predictions: [0 1 1 0 0 1 0 0 0 1 0 1 0 1 1 0 1 1 0 0]\n",
      "epoch: 14\n",
      "step: 0, acc: 0.938, loss: 0.398, (data_loss: 0.3975125328830881, reg_loss: 0.000), lr: 0.00998053795099556\n",
      "step: 2, acc: 0.938, loss: 0.314, (data_loss: 0.31396031657381995, reg_loss: 0.000), lr: 0.009979541939024998\n",
      "training, acc: 0.912, loss: 0.404, (data_loss: 0.40428206213888884, reg_loss: 0.000), lr: 0.009979541939024998\n",
      "validation, acc: 0.700, loss: 0.526\n",
      "Val predictions: [0 1 1 0 0 1 1 0 0 1 0 1 0 1 1 0 1 1 0 0]\n",
      "epoch: 15\n",
      "step: 0, acc: 0.906, loss: 0.349, (data_loss: 0.34879627275254554, reg_loss: 0.000), lr: 0.009979044007584073\n",
      "step: 2, acc: 0.938, loss: 0.230, (data_loss: 0.2301530257643397, reg_loss: 0.000), lr: 0.009978048293753742\n",
      "training, acc: 0.912, loss: 0.340, (data_loss: 0.34017296361540306, reg_loss: 0.000), lr: 0.009978048293753742\n",
      "validation, acc: 0.650, loss: 0.498\n",
      "Val predictions: [0 1 1 0 0 1 1 0 0 1 0 1 1 1 1 0 1 1 0 0]\n",
      "epoch: 16\n",
      "step: 0, acc: 0.906, loss: 0.298, (data_loss: 0.29826079433700314, reg_loss: 0.000), lr: 0.009977550511349463\n",
      "step: 2, acc: 1.000, loss: 0.190, (data_loss: 0.19032316839118507, reg_loss: 0.000), lr: 0.009976555095525514\n",
      "training, acc: 0.925, loss: 0.294, (data_loss: 0.2936992782768161, reg_loss: 0.000), lr: 0.009976555095525514\n",
      "validation, acc: 0.650, loss: 0.472\n",
      "Val predictions: [0 1 1 0 0 1 1 0 0 1 0 1 1 1 1 0 1 1 0 0]\n",
      "epoch: 17\n",
      "step: 0, acc: 0.969, loss: 0.232, (data_loss: 0.23230310552262004, reg_loss: 0.000), lr: 0.009976057462090984\n",
      "step: 2, acc: 0.938, loss: 0.162, (data_loss: 0.1618608904237726, reg_loss: 0.000), lr: 0.009975062344139652\n",
      "training, acc: 0.963, loss: 0.232, (data_loss: 0.23218790721884397, reg_loss: 0.000), lr: 0.009975062344139652\n",
      "validation, acc: 0.750, loss: 0.450\n",
      "Val predictions: [0 1 1 0 0 1 1 0 0 1 1 1 1 1 1 0 1 1 0 1]\n",
      "epoch: 18\n",
      "step: 0, acc: 0.969, loss: 0.189, (data_loss: 0.18939917491464617, reg_loss: 0.000), lr: 0.009974564859608\n",
      "step: 2, acc: 1.000, loss: 0.124, (data_loss: 0.12399968496999664, reg_loss: 0.000), lr: 0.009973570039395602\n",
      "training, acc: 0.963, loss: 0.199, (data_loss: 0.19918340927996486, reg_loss: 0.000), lr: 0.009973570039395602\n",
      "validation, acc: 0.750, loss: 0.432\n",
      "Val predictions: [0 1 1 0 0 1 1 0 0 1 1 1 1 1 1 0 1 1 0 1]\n",
      "epoch: 19\n",
      "step: 0, acc: 1.000, loss: 0.171, (data_loss: 0.17097519537717382, reg_loss: 0.000), lr: 0.009973072703700011\n",
      "step: 2, acc: 1.000, loss: 0.108, (data_loss: 0.1083432843451565, reg_loss: 0.000), lr: 0.00997207818109294\n",
      "training, acc: 0.988, loss: 0.168, (data_loss: 0.16810108043673713, reg_loss: 0.000), lr: 0.00997207818109294\n",
      "validation, acc: 0.750, loss: 0.418\n",
      "Val predictions: [0 1 1 0 0 1 1 0 0 1 1 1 1 1 1 0 1 1 0 1]\n",
      "epoch: 20\n",
      "step: 0, acc: 1.000, loss: 0.126, (data_loss: 0.126194019535655, reg_loss: 0.000), lr: 0.009971580994166625\n",
      "step: 2, acc: 0.938, loss: 0.089, (data_loss: 0.088938833407077, reg_loss: 0.000), lr: 0.009970586769031358\n",
      "training, acc: 0.975, loss: 0.133, (data_loss: 0.13322533484489843, reg_loss: 0.000), lr: 0.009970586769031358\n",
      "validation, acc: 0.750, loss: 0.409\n",
      "Val predictions: [0 1 1 0 0 1 1 0 0 1 1 1 1 1 1 0 1 1 0 1]\n",
      "Predictions: [0.11996552 0.88002343 0.7363412  0.00537686 0.20981417]\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x500 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "\n",
    "\n",
    "\n",
    "def fetch_pubmed_ids(query, max_results=60):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    search_url = f\"{base_url}esearch.fcgi?db=pubmed&term={query}&retmax={max_results}&retmode=xml\"\n",
    "    response = requests.get(search_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch IDs: {response.status_code}\")\n",
    "    root = ET.fromstring(response.content)\n",
    "    return [id_elem.text for id_elem in root.findall(\".//Id\")]\n",
    "\n",
    "def fetch_pubmed_details(pmids):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    fetch_url = f\"{base_url}efetch.fcgi?db=pubmed&id={','.join(pmids)}&retmode=xml\"\n",
    "    response = requests.get(fetch_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch details: {response.status_code}\")\n",
    "    fetch_root = ET.fromstring(response.content)\n",
    "    articles = {}\n",
    "    fetched_pmids = set()\n",
    "    for article in fetch_root.findall(\".//PubmedArticle\"):\n",
    "        pmid = article.findtext(\".//PMID\")\n",
    "        title = article.findtext(\".//ArticleTitle\") or \"No title\"\n",
    "        abstract = article.findtext(\".//AbstractText\") or \"\"\n",
    "        articles[pmid] = {'title': title, 'abstract': abstract}\n",
    "        fetched_pmids.add(pmid)\n",
    "    missing = set(pmids) - fetched_pmids\n",
    "    if missing:\n",
    "        print(f\"Warning: Missing PMIDs in fetch: {missing}\")\n",
    "    return articles\n",
    "\n",
    "def get_ollama_embedding(text, model='nomic-embed-text'):\n",
    "    response = ollama.embeddings(model=model, prompt=text)\n",
    "    return np.array(response['embedding'])\n",
    "\n",
    "def get_ollama_summary(text, model='llama3'):\n",
    "    prompt = f\"Summarize the following article in 2-3 sentences:\\n\\n{text}\"\n",
    "    response = ollama.generate(model=model, prompt=prompt)\n",
    "    return response['response']\n",
    "\n",
    "\n",
    "\n",
    "def process_articles(pmids, articles_dict, cache_file=\"embeddings.pkl\"):\n",
    "    # Check for cached data\n",
    "    if os.path.exists(cache_file):\n",
    "        with open(cache_file, 'rb') as f:\n",
    "            cached = pickle.load(f)\n",
    "            cached_pmids = set(cached['pmids'])\n",
    "            if set(pmids).issubset(cached_pmids):\n",
    "                print(\"Using cached embeddings and labels.\")\n",
    "                X, y = [], []\n",
    "                for pmid in pmids:\n",
    "                    idx = cached['pmids'].index(pmid)\n",
    "                    X.append(cached['X'][idx])\n",
    "                    y.append(cached['y'][idx])\n",
    "                return np.array(X), np.array(y)\n",
    "\n",
    "    X, y, texts, summaries = [], [], [], []\n",
    "    valid_pmids = []\n",
    "\n",
    "\n",
    "\n",
    "    prompt_template = \"\"\"\n",
    "You are an expert in machine learning and cancer research. Classify this summary as 'useful' (1) if it describes machine learning techniques (new or established) applied to cancer diagnosis or treatment with potential practical value (e.g., could improve outcomes or be implemented), or 'not useful' (0) if it’s purely theoretical, lacks ML, or is a review. Examples:\n",
    "- Useful (1): \"SVM model predicts breast cancer with 85% accuracy.\"\n",
    "- Useful (1): \"New CNN improves tumor detection in MRI scans.\"\n",
    "- Not Useful (0): \"Review of ML in oncology.\"\n",
    "Return only the label (0 or 1).\n",
    "Summary: {summary}\n",
    "\"\"\"\n",
    "\n",
    "\n",
    "    for pmid in pmids:\n",
    "        if pmid not in articles_dict:\n",
    "            print(f\"Warning: PMID {pmid} not found, skipping.\")  # Fixed here\n",
    "            continue\n",
    "        article = articles_dict[pmid]\n",
    "        full_text = f\"{article['title']} {article['abstract']}\"\n",
    "        summary = get_ollama_summary(full_text)\n",
    "        embedding = get_ollama_embedding(summary)\n",
    "        X.append(embedding)\n",
    "        texts.append(full_text)\n",
    "        summaries.append(summary)\n",
    "        valid_pmids.append(pmid)\n",
    "\n",
    "        # LM labeling\n",
    "        prompt = prompt_template.format(summary=summary)\n",
    "        response = ollama.generate(model='llama3', prompt=prompt)\n",
    "        label = int(response['response'].strip())\n",
    "        y.append(label)\n",
    "\n",
    "    X = np.array(X)\n",
    "    y = np.array(y)\n",
    "\n",
    "    # Print results\n",
    "    print(\"\\nProcessed articles with LM labels:\")\n",
    "    for pmid, text, summary, label in zip(valid_pmids, texts, summaries, y):\n",
    "        print(f\"PMID {pmid}:\")\n",
    "        print(f\"Full Text: {text[:250]}...\")\n",
    "        print(f\"Summary: {summary}\")\n",
    "        print(f\"Label (1=useful, 0=not useful): {label}\\n\")\n",
    "\n",
    "    # Cache results\n",
    "    with open(cache_file, 'wb') as f:\n",
    "        pickle.dump({'pmids': valid_pmids, 'X': X, 'y': y}, f)\n",
    "\n",
    "    return X, y\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "def normalize_embeddings(X):\n",
    "    X_mean = np.mean(X, axis=0)\n",
    "    X_std = np.std(X, axis=0)\n",
    "    return (X - X_mean) / (X_std + 1e-8)  # Avoid division by zero\n",
    "\n",
    "def create_article_data(query, max_results=60):\n",
    "    all_pmids = fetch_pubmed_ids(query, max_results)\n",
    "    train_pmids, test_pmids = train_test_split(all_pmids, test_size=0.2, random_state=42)\n",
    "    train_articles = fetch_pubmed_details(train_pmids)\n",
    "    test_articles = fetch_pubmed_details(test_pmids)\n",
    "    X_train, y_train = process_articles(train_pmids, train_articles)\n",
    "    X_test, y_test = process_articles(test_pmids, test_articles)\n",
    "    \n",
    "    # Normalize embeddings after creation\n",
    "    X_train = normalize_embeddings(X_train)\n",
    "    X_test = normalize_embeddings(X_test)\n",
    "    \n",
    "    assert not set(train_pmids) & set(test_pmids), \"Overlap detected!\"\n",
    "    return X_train, y_train, X_test, y_test\n",
    "\n",
    "\n",
    "\n",
    "# File to save/load data\n",
    "DATA_FILE = \"article_data.pkl\"\n",
    "\n",
    "def load_or_create_data(query, max_results):\n",
    "    \"\"\"Load saved data if it exists, otherwise create and save it.\"\"\"\n",
    "    if os.path.exists(DATA_FILE):\n",
    "        print(f\"Loading saved data from {DATA_FILE}\")\n",
    "        with open(DATA_FILE, 'rb') as f:\n",
    "            data = pickle.load(f)\n",
    "            return data['X_train'], data['y_train'], data['X_test'], data['y_test']\n",
    "    else:\n",
    "        print(f\"Creating new data for query: {query}\")\n",
    "        X_train, y_train, X_test, y_test = create_article_data(query, max_results)\n",
    "        data = {\n",
    "            'X_train': X_train,\n",
    "            'y_train': y_train,\n",
    "            'X_test': X_test,\n",
    "            'y_test': y_test\n",
    "        }\n",
    "        with open(DATA_FILE, 'wb') as f:\n",
    "            pickle.dump(data, f)\n",
    "        print(f\"Saved data to {DATA_FILE}\")\n",
    "        return X_train, y_train, X_test, y_test\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    query = \"machine learning cancer\"\n",
    "    max_results = 100\n",
    "\n",
    "    # Load or create data\n",
    "    X_train, y_train, X_test, y_test = load_or_create_data(query, max_results)\n",
    "\n",
    "    # Build and train model\n",
    "    model = funny_guy()\n",
    "    model.add(Layer_Dense(768, 32)) \n",
    "    model.add(Activation_ReLU())\n",
    "    model.add(Layer_Dropout(.2))\n",
    "    model.add(Layer_Dense(32, 1))\n",
    "    model.add(Activation_Sigmoid())\n",
    "    model.set(\n",
    "        loss=Loss_BinaryCrossEntropy(),\n",
    "        optimizer=Optimizer_SGD(learning_rate=0.01, decay=5e-5, momentum=0.9),\n",
    "        accuracy=Accuracy_Binary()\n",
    "    )\n",
    "    model.finalize()\n",
    "\n",
    "    history = model.train(X_train, y_train, epochs=20, batch_size=32, print_every=2, validation_data=(X_test, y_test))\n",
    "\n",
    "    # Predict\n",
    "    predictions = model.predict(X_test[:5])\n",
    "    print(\"Predictions:\", predictions.flatten())\n",
    "\n",
    "    # Plotting\n",
    "    epochs_range = range(1, len(history['train_loss']) + 1)\n",
    "    plt.figure(figsize=(12, 5))\n",
    "    plt.subplot(1, 2, 1)\n",
    "    plt.plot(epochs_range, history['train_loss'], label='Training Loss')\n",
    "    plt.plot(epochs_range, history['val_loss'], label='Validation Loss')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Loss')\n",
    "    plt.title('Loss Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.subplot(1, 2, 2)\n",
    "    plt.plot(epochs_range, history['train_acc'], label='Training Accuracy')\n",
    "    plt.plot(epochs_range, history['val_acc'], label='Validation Accuracy')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Accuracy')\n",
    "    plt.title('Accuracy Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def fetch_pubmed_ids(query, max_results=60):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    search_url = f\"{base_url}esearch.fcgi?db=pubmed&term={query}&retmax={max_results}&retmode=xml\"\n",
    "    response = requests.get(search_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch IDs: {response.status_code}\")\n",
    "    root = ET.fromstring(response.content)\n",
    "    return [id_elem.text for id_elem in root.findall(\".//Id\")]\n",
    "\n",
    "def fetch_pubmed_details(pmids):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    fetch_url = f\"{base_url}efetch.fcgi?db=pubmed&id={','.join(pmids)}&retmode=xml\"\n",
    "    response = requests.get(fetch_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch details: {response.status_code}\")\n",
    "    fetch_root = ET.fromstring(response.content)\n",
    "    articles = {}\n",
    "    fetched_pmids = set()\n",
    "    for article in fetch_root.findall(\".//PubmedArticle\"):\n",
    "        pmid = article.findtext(\".//PMID\")\n",
    "        title = article.findtext(\".//ArticleTitle\") or \"No title\"\n",
    "        abstract = article.findtext(\".//AbstractText\") or \"\"\n",
    "        articles[pmid] = {'title': title, 'abstract': abstract}\n",
    "        fetched_pmids.add(pmid)\n",
    "    missing = set(pmids) - fetched_pmids\n",
    "    if missing:\n",
    "        print(f\"Warning: Missing PMIDs in fetch: {missing}\")\n",
    "    return articles\n",
    "\n",
    "def get_ollama_embedding(text, model='nomic-embed-text'):\n",
    "    response = ollama.embeddings(model=model, prompt=text)\n",
    "    return np.array(response['embedding'])\n",
    "\n",
    "def get_ollama_summary(text, model='llama3'):\n",
    "    prompt = f\"Summarize the following article in 2-3 sentences:\\n\\n{text}\"\n",
    "    response = ollama.generate(model=model, prompt=prompt)\n",
    "    return response['response']\n",
    "\n",
    "def normalize_embeddings(X):\n",
    "    X_mean = np.mean(X, axis=0)\n",
    "    X_std = np.std(X, axis=0)\n",
    "    return (X - X_mean) / (X_std + 1e-8)  # Avoid division by zero\n",
    "\n",
    "def process_articles(pmids, articles_dict, cache_file):\n",
    "    # Check for cached data\n",
    "    if os.path.exists(cache_file):\n",
    "        with open(cache_file, 'rb') as f:\n",
    "            cached = pickle.load(f)\n",
    "            cached_pmids = set(cached['pmids'])\n",
    "            if set(pmids).issubset(cached_pmids):\n",
    "                print(f\"Using cached embeddings from {cache_file}\")\n",
    "                X, y = [], []\n",
    "                for pmid in pmids:\n",
    "                    idx = cached['pmids'].index(pmid)\n",
    "                    X.append(cached['X'][idx])\n",
    "                    y.append(cached['y'][idx])\n",
    "                return np.array(X), np.array(y), cached['df']\n",
    "\n",
    "    X, y, texts, summaries = [], [], [], []\n",
    "    valid_pmids = []\n",
    "\n",
    "    prompt_template = \"\"\"\n",
    "You are an expert in machine learning and cancer research. Classify this summary as 'useful' (1) if it describes machine learning techniques (new or established) applied to cancer diagnosis or treatment with potential practical value (e.g., could improve outcomes or be implemented), or 'not useful' (0) if it’s purely theoretical, lacks ML, or is a review. Examples:\n",
    "- Useful (1): \"SVM model predicts breast cancer with 85% accuracy.\"\n",
    "- Useful (1): \"New CNN improves tumor detection in MRI scans.\"\n",
    "- Not Useful (0): \"Review of ML in oncology.\"\n",
    "Return only the label (0 or 1).\n",
    "Summary: {summary}\n",
    "\"\"\"\n",
    "\n",
    "    for pmid in pmids:\n",
    "        if pmid not in articles_dict:\n",
    "            print(f\"Warning: PMID {pmid} not found, skipping.\")\n",
    "            continue\n",
    "        article = articles_dict[pmid]\n",
    "        full_text = f\"{article['title']} {article['abstract']}\"\n",
    "        summary = get_ollama_summary(full_text)\n",
    "        embedding = get_ollama_embedding(summary)\n",
    "        X.append(embedding)\n",
    "        prompt = prompt_template.format(summary=summary)\n",
    "        response = ollama.generate(model='llama3', prompt=prompt)\n",
    "        label = int(response['response'].strip())\n",
    "\n",
    "        valid_pmids.append(pmid)\n",
    "        texts.append(full_text)\n",
    "        summaries.append(summary)\n",
    "        y.append(label)\n",
    "\n",
    "    X = np.array(X)\n",
    "    y = np.array(y)\n",
    "\n",
    "    df = pd.DataFrame({\n",
    "        'pmid': valid_pmids,\n",
    "        'full_text': texts,\n",
    "        'summary': summaries,\n",
    "        'label': y\n",
    "    })\n",
    "\n",
    "    print(f\"\\nProcessed articles with LM labels ({cache_file}):\")\n",
    "    print(df.to_string(index=False))\n",
    "\n",
    "    with open(cache_file, 'wb') as f:\n",
    "        pickle.dump({'pmids': valid_pmids, 'X': X, 'y': y, 'df': df}, f)\n",
    "\n",
    "    return X, y, df\n",
    "\n",
    "def create_article_data(query, max_results=60):\n",
    "    all_pmids = fetch_pubmedreadme_ids(query, max_results)\n",
    "    train_pmids, test_pmids = train_test_split(all_pmids, test_size=0.2, random_state=42)\n",
    "    train_articles = fetch_pubmed_details(train_pmids)\n",
    "    test_articles = fetch_pubmed_details(test_pmids)\n",
    "    \n",
    "    X_train, y_train, df_train = process_articles(train_pmids, train_articles, cache_file=TRAIN_CACHE)\n",
    "    X_test, y_test, df_test = process_articles(test_pmids, test_articles, cache_file=TEST_CACHE)\n",
    "    \n",
    "    X_train = normalize_embeddings(X_train)\n",
    "    X_test = normalize_embeddings(X_test)\n",
    "    \n",
    "    assert not set(train_pmids) & set(test_pmids), \"Overlap detected!\"\n",
    "    return X_train, y_train, X_test, y_test, df_train, df_test\n",
    "\n",
    "def load_or_create_data(query, max_results):\n",
    "    if os.path.exists(DATA_FILE):\n",
    "        print(f\"Loading saved data from {DATA_FILE}\")\n",
    "        with open(DATA_FILE, 'rb') as f:\n",
    "            data = pickle.load(f)\n",
    "            return data['X_train'], data['y_train'], data['X_test'], data['y_test'], data['df_train'], data['df_test']\n",
    "    else:\n",
    "        print(f\"Creating new data for query: {query}\")\n",
    "        X_train, y_train, X_test, y_test, df_train, df_test = create_article_data(query, max_results)\n",
    "        data = {\n",
    "            'X_train': X_train, 'y_train': y_train,\n",
    "            'X_test': X_test, 'y_test': y_test,\n",
    "            'df_train': df_train, 'df_test': df_test\n",
    "        }\n",
    "        with open(DATA_FILE, 'wb') as f:\n",
    "            pickle.dump(data, f)\n",
    "        print(f\"Saved data to {DATA_FILE}\")\n",
    "        return X_train, y_train, X_test, y_test, df_train, df_test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading saved data from article_data.pkl\n",
      "Train label balance: 0.5875\n",
      "Test label balance: 0.7\n",
      "epoch: 1\n",
      "step: 0, acc: 0.406, loss: 0.697, (data_loss: 0.6942626656846327, reg_loss: 0.002), lr: 0.008\n",
      "step: 2, acc: 0.312, loss: 0.697, (data_loss: 0.6944324738833376, reg_loss: 0.002), lr: 0.007999840003199938\n",
      "training, acc: 0.463, loss: 0.696, (data_loss: 0.6937730763287829, reg_loss: 0.002), lr: 0.007999840003199938\n",
      "validation, acc: 0.550, loss: 0.693\n",
      "Val predictions: [1 1 1 1 0 0 0 1 0 0 0 1 0 0 0 0 1 1 0 1]\n",
      "epoch: 2\n",
      "step: 0, acc: 0.438, loss: 0.696, (data_loss: 0.6938295363261124, reg_loss: 0.002), lr: 0.007999760007199784\n",
      "step: 2, acc: 0.688, loss: 0.694, (data_loss: 0.6910664389049616, reg_loss: 0.002), lr: 0.007999600019999\n",
      "training, acc: 0.600, loss: 0.695, (data_loss: 0.6924614628117378, reg_loss: 0.002), lr: 0.007999600019999\n",
      "validation, acc: 0.750, loss: 0.690\n",
      "Val predictions: [1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 3\n",
      "step: 0, acc: 0.625, loss: 0.695, (data_loss: 0.6921938945222116, reg_loss: 0.002), lr: 0.007999520028798272\n",
      "step: 2, acc: 0.750, loss: 0.691, (data_loss: 0.688746609585088, reg_loss: 0.002), lr: 0.007999360051195904\n",
      "training, acc: 0.662, loss: 0.693, (data_loss: 0.6904725988570247, reg_loss: 0.002), lr: 0.007999360051195904\n",
      "validation, acc: 0.700, loss: 0.687\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 4\n",
      "step: 0, acc: 0.562, loss: 0.693, (data_loss: 0.6910396989945738, reg_loss: 0.002), lr: 0.00799928006479417\n",
      "step: 2, acc: 0.750, loss: 0.688, (data_loss: 0.6851422464238278, reg_loss: 0.002), lr: 0.007999120096789353\n",
      "training, acc: 0.637, loss: 0.690, (data_loss: 0.6879424752450424, reg_loss: 0.002), lr: 0.007999120096789353\n",
      "validation, acc: 0.700, loss: 0.684\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 5\n",
      "step: 0, acc: 0.500, loss: 0.693, (data_loss: 0.690257237257371, reg_loss: 0.002), lr: 0.007999040115186179\n",
      "step: 2, acc: 0.688, loss: 0.682, (data_loss: 0.6793163973394692, reg_loss: 0.002), lr: 0.00799888015677805\n",
      "training, acc: 0.600, loss: 0.687, (data_loss: 0.6850206428936914, reg_loss: 0.002), lr: 0.00799888015677805\n",
      "validation, acc: 0.700, loss: 0.680\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 6\n",
      "step: 0, acc: 0.531, loss: 0.691, (data_loss: 0.688537812486817, reg_loss: 0.002), lr: 0.007998800179973004\n",
      "step: 2, acc: 0.688, loss: 0.679, (data_loss: 0.676551045052191, reg_loss: 0.002), lr: 0.007998640231160703\n",
      "training, acc: 0.613, loss: 0.685, (data_loss: 0.6823079587441961, reg_loss: 0.002), lr: 0.007998640231160703\n",
      "validation, acc: 0.700, loss: 0.676\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 7\n",
      "step: 0, acc: 0.562, loss: 0.688, (data_loss: 0.6857264140700883, reg_loss: 0.002), lr: 0.007998560259153352\n",
      "step: 2, acc: 0.688, loss: 0.673, (data_loss: 0.6709600383550394, reg_loss: 0.002), lr: 0.007998400319936013\n",
      "training, acc: 0.625, loss: 0.681, (data_loss: 0.6788334245811851, reg_loss: 0.002), lr: 0.007998400319936013\n",
      "validation, acc: 0.700, loss: 0.672\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 8\n",
      "step: 0, acc: 0.531, loss: 0.686, (data_loss: 0.6838527400428318, reg_loss: 0.002), lr: 0.007998320352725928\n",
      "step: 2, acc: 0.688, loss: 0.666, (data_loss: 0.6638056556218788, reg_loss: 0.002), lr: 0.007998160423102687\n",
      "training, acc: 0.625, loss: 0.677, (data_loss: 0.6741891144411835, reg_loss: 0.002), lr: 0.007998160423102687\n",
      "validation, acc: 0.700, loss: 0.667\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 9\n",
      "step: 0, acc: 0.562, loss: 0.682, (data_loss: 0.6795885672530569, reg_loss: 0.002), lr: 0.007998080460689434\n",
      "step: 2, acc: 0.688, loss: 0.658, (data_loss: 0.6550971973423881, reg_loss: 0.002), lr: 0.007997920540659429\n",
      "training, acc: 0.637, loss: 0.672, (data_loss: 0.6699215236108651, reg_loss: 0.002), lr: 0.007997920540659429\n",
      "validation, acc: 0.750, loss: 0.662\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 10\n",
      "step: 0, acc: 0.562, loss: 0.678, (data_loss: 0.6758597211893054, reg_loss: 0.002), lr: 0.007997840583042579\n",
      "step: 2, acc: 0.688, loss: 0.651, (data_loss: 0.649032074151032, reg_loss: 0.002), lr: 0.007997680672604946\n",
      "training, acc: 0.625, loss: 0.668, (data_loss: 0.6656524275791516, reg_loss: 0.002), lr: 0.007997680672604946\n",
      "validation, acc: 0.750, loss: 0.656\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 11\n",
      "step: 0, acc: 0.500, loss: 0.678, (data_loss: 0.6754013914623268, reg_loss: 0.002), lr: 0.007997600719784064\n",
      "step: 2, acc: 0.688, loss: 0.646, (data_loss: 0.643602766885585, reg_loss: 0.002), lr: 0.00799744081893794\n",
      "training, acc: 0.613, loss: 0.663, (data_loss: 0.6606863257756554, reg_loss: 0.002), lr: 0.00799744081893794\n",
      "validation, acc: 0.750, loss: 0.649\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 12\n",
      "step: 0, acc: 0.531, loss: 0.667, (data_loss: 0.6649794636855345, reg_loss: 0.002), lr: 0.0079973608709126\n",
      "step: 2, acc: 0.750, loss: 0.635, (data_loss: 0.6329169079802226, reg_loss: 0.002), lr: 0.007997200979657119\n",
      "training, acc: 0.650, loss: 0.653, (data_loss: 0.6500863911361442, reg_loss: 0.002), lr: 0.007997200979657119\n",
      "validation, acc: 0.750, loss: 0.641\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 13\n",
      "step: 0, acc: 0.656, loss: 0.663, (data_loss: 0.6607754018545323, reg_loss: 0.002), lr: 0.007997121036426887\n",
      "step: 2, acc: 0.750, loss: 0.620, (data_loss: 0.6173085305569044, reg_loss: 0.003), lr: 0.00799696115476119\n",
      "training, acc: 0.713, loss: 0.645, (data_loss: 0.642751880781046, reg_loss: 0.003), lr: 0.00799696115476119\n",
      "validation, acc: 0.750, loss: 0.633\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 14\n",
      "step: 0, acc: 0.750, loss: 0.650, (data_loss: 0.6478085213774445, reg_loss: 0.003), lr: 0.007996881216325634\n",
      "step: 2, acc: 0.875, loss: 0.603, (data_loss: 0.6002285115136645, reg_loss: 0.003), lr: 0.007996721344248859\n",
      "training, acc: 0.775, loss: 0.633, (data_loss: 0.6305981355049374, reg_loss: 0.003), lr: 0.007996721344248859\n",
      "validation, acc: 0.750, loss: 0.623\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 15\n",
      "step: 0, acc: 0.750, loss: 0.635, (data_loss: 0.6327170392807757, reg_loss: 0.003), lr: 0.007996641410607543\n",
      "step: 2, acc: 0.812, loss: 0.590, (data_loss: 0.5874288614709569, reg_loss: 0.003), lr: 0.007996481548118828\n",
      "training, acc: 0.800, loss: 0.617, (data_loss: 0.6148843250861455, reg_loss: 0.003), lr: 0.007996481548118828\n",
      "validation, acc: 0.750, loss: 0.611\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1]\n",
      "epoch: 16\n",
      "step: 0, acc: 0.750, loss: 0.616, (data_loss: 0.6133681371042952, reg_loss: 0.003), lr: 0.007996401619271327\n",
      "step: 2, acc: 1.000, loss: 0.553, (data_loss: 0.5499704598890834, reg_loss: 0.003), lr: 0.007996241766369806\n",
      "training, acc: 0.812, loss: 0.599, (data_loss: 0.5965638776737733, reg_loss: 0.003), lr: 0.007996241766369806\n",
      "validation, acc: 0.850, loss: 0.598\n",
      "Val predictions: [1 1 1 1 1 1 1 1 0 0 1 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 17\n",
      "step: 0, acc: 0.781, loss: 0.600, (data_loss: 0.5974713900158641, reg_loss: 0.003), lr: 0.007996161842315688\n",
      "step: 2, acc: 1.000, loss: 0.519, (data_loss: 0.5168577221567676, reg_loss: 0.003), lr: 0.0079960019990005\n",
      "training, acc: 0.850, loss: 0.579, (data_loss: 0.5758817087919319, reg_loss: 0.003), lr: 0.0079960019990005\n",
      "validation, acc: 0.900, loss: 0.583\n",
      "Val predictions: [1 1 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 18\n",
      "step: 0, acc: 0.844, loss: 0.594, (data_loss: 0.5914296317853837, reg_loss: 0.003), lr: 0.007995922079739332\n",
      "step: 2, acc: 0.938, loss: 0.487, (data_loss: 0.4843061697055302, reg_loss: 0.003), lr: 0.007995762246009615\n",
      "training, acc: 0.850, loss: 0.563, (data_loss: 0.5604430818089265, reg_loss: 0.003), lr: 0.007995762246009615\n",
      "validation, acc: 0.900, loss: 0.566\n",
      "Val predictions: [1 1 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 19\n",
      "step: 0, acc: 0.906, loss: 0.556, (data_loss: 0.5533789553168715, reg_loss: 0.003), lr: 0.007995682331540969\n",
      "step: 2, acc: 1.000, loss: 0.444, (data_loss: 0.44079176288915245, reg_loss: 0.003), lr: 0.00799552250739586\n",
      "training, acc: 0.912, loss: 0.531, (data_loss: 0.5277511742387043, reg_loss: 0.003), lr: 0.00799552250739586\n",
      "validation, acc: 0.850, loss: 0.547\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 20\n",
      "step: 0, acc: 0.875, loss: 0.522, (data_loss: 0.5190506309062138, reg_loss: 0.003), lr: 0.007995442597719301\n",
      "step: 2, acc: 1.000, loss: 0.448, (data_loss: 0.44479765209850386, reg_loss: 0.003), lr: 0.007995282783157937\n",
      "training, acc: 0.912, loss: 0.505, (data_loss: 0.5022994980643785, reg_loss: 0.003), lr: 0.007995282783157937\n",
      "validation, acc: 0.850, loss: 0.528\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 21\n",
      "step: 0, acc: 0.906, loss: 0.476, (data_loss: 0.4728208147632537, reg_loss: 0.003), lr: 0.007995202878273036\n",
      "step: 2, acc: 1.000, loss: 0.385, (data_loss: 0.3820173306515213, reg_loss: 0.003), lr: 0.007995043073294556\n",
      "training, acc: 0.938, loss: 0.461, (data_loss: 0.45829253973702977, reg_loss: 0.003), lr: 0.007995043073294556\n",
      "validation, acc: 0.850, loss: 0.508\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 22\n",
      "step: 0, acc: 0.875, loss: 0.499, (data_loss: 0.49609652726854003, reg_loss: 0.003), lr: 0.007994963173200885\n",
      "step: 2, acc: 1.000, loss: 0.316, (data_loss: 0.31277126213948336, reg_loss: 0.003), lr: 0.007994803377804427\n",
      "training, acc: 0.912, loss: 0.446, (data_loss: 0.4430462328088957, reg_loss: 0.003), lr: 0.007994803377804427\n",
      "validation, acc: 0.850, loss: 0.489\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 23\n",
      "step: 0, acc: 0.938, loss: 0.426, (data_loss: 0.4226181669195876, reg_loss: 0.003), lr: 0.007994723482501548\n",
      "step: 2, acc: 1.000, loss: 0.293, (data_loss: 0.28959837467412497, reg_loss: 0.003), lr: 0.007994563696686253\n",
      "training, acc: 0.938, loss: 0.406, (data_loss: 0.4025031023059763, reg_loss: 0.003), lr: 0.007994563696686253\n",
      "validation, acc: 0.850, loss: 0.473\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 24\n",
      "step: 0, acc: 0.938, loss: 0.416, (data_loss: 0.4125508913850672, reg_loss: 0.003), lr: 0.007994483806173739\n",
      "step: 2, acc: 1.000, loss: 0.269, (data_loss: 0.2654163841316786, reg_loss: 0.003), lr: 0.007994324029938743\n",
      "training, acc: 0.950, loss: 0.385, (data_loss: 0.38183878004763566, reg_loss: 0.003), lr: 0.007994324029938743\n",
      "validation, acc: 0.850, loss: 0.458\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 25\n",
      "step: 0, acc: 0.969, loss: 0.374, (data_loss: 0.3705201267483359, reg_loss: 0.003), lr: 0.007994244144216164\n",
      "step: 2, acc: 1.000, loss: 0.236, (data_loss: 0.2330991292525676, reg_loss: 0.003), lr: 0.007994084377560606\n",
      "training, acc: 0.950, loss: 0.364, (data_loss: 0.3603956476247251, reg_loss: 0.003), lr: 0.007994084377560606\n",
      "validation, acc: 0.850, loss: 0.445\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 26\n",
      "step: 0, acc: 0.938, loss: 0.355, (data_loss: 0.35121642563756084, reg_loss: 0.003), lr: 0.00799400449662753\n",
      "step: 2, acc: 1.000, loss: 0.240, (data_loss: 0.23665480376717885, reg_loss: 0.003), lr: 0.007993844739550546\n",
      "training, acc: 0.938, loss: 0.341, (data_loss: 0.33763722705577565, reg_loss: 0.003), lr: 0.007993844739550546\n",
      "validation, acc: 0.800, loss: 0.435\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "epoch: 27\n",
      "step: 0, acc: 0.938, loss: 0.319, (data_loss: 0.31537504848757425, reg_loss: 0.003), lr: 0.007993764863406543\n",
      "step: 2, acc: 1.000, loss: 0.173, (data_loss: 0.16920265754494068, reg_loss: 0.003), lr: 0.007993605115907274\n",
      "training, acc: 0.938, loss: 0.304, (data_loss: 0.3008553507656351, reg_loss: 0.003), lr: 0.007993605115907274\n",
      "validation, acc: 0.800, loss: 0.427\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "epoch: 28\n",
      "step: 0, acc: 0.938, loss: 0.325, (data_loss: 0.3218184975666746, reg_loss: 0.003), lr: 0.007993525244551913\n",
      "step: 2, acc: 1.000, loss: 0.136, (data_loss: 0.1321412438828209, reg_loss: 0.004), lr: 0.007993365506629496\n",
      "training, acc: 0.975, loss: 0.287, (data_loss: 0.28353632069754364, reg_loss: 0.004), lr: 0.007993365506629496\n",
      "validation, acc: 0.800, loss: 0.420\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "epoch: 29\n",
      "step: 0, acc: 0.969, loss: 0.304, (data_loss: 0.3004051326120438, reg_loss: 0.004), lr: 0.007993285640062348\n",
      "step: 2, acc: 1.000, loss: 0.173, (data_loss: 0.16922152021412118, reg_loss: 0.004), lr: 0.007993125911715923\n",
      "training, acc: 0.975, loss: 0.281, (data_loss: 0.27693625033203817, reg_loss: 0.004), lr: 0.007993125911715923\n",
      "validation, acc: 0.800, loss: 0.415\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "epoch: 30\n",
      "step: 0, acc: 0.969, loss: 0.291, (data_loss: 0.2869356663085638, reg_loss: 0.004), lr: 0.007993046049936557\n",
      "step: 2, acc: 1.000, loss: 0.142, (data_loss: 0.13854208733164897, reg_loss: 0.004), lr: 0.007992886331165263\n",
      "training, acc: 0.963, loss: 0.263, (data_loss: 0.2591917967851509, reg_loss: 0.004), lr: 0.007992886331165263\n",
      "validation, acc: 0.800, loss: 0.410\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "\n",
      "Test DataFrame with Predictions:\n",
      "    pmid  label  raw_prediction  binary_prediction\n",
      "40205450      1        0.847551                  1\n",
      "40211143      1        0.311087                  0\n",
      "40208029      1        0.675221                  1\n",
      "40214699      1        0.843660                  1\n",
      "40214892      1        0.877571                  1\n",
      "40216368      1        0.756671                  1\n",
      "40218289      1        0.926714                  1\n",
      "40206097      1        0.738299                  1\n",
      "40221553      0        0.219210                  0\n",
      "40223133      1        0.159694                  0\n",
      "40219965      0        0.217482                  0\n",
      "40217526      1        0.824417                  1\n",
      "40207200      1        0.481988                  0\n",
      "40216970      0        0.205713                  0\n",
      "40203502      0        0.029219                  0\n",
      "40222364      1        0.856943                  1\n",
      "40206813      0        0.699394                  1\n",
      "40206662      1        0.887219                  1\n",
      "40221445      1        0.752564                  1\n",
      "40217479      0        0.221981                  0\n",
      "Confusion Matrix:\n",
      " binary_prediction  0   1\n",
      "label                   \n",
      "0                  5   1\n",
      "1                  3  11\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x500 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "\n",
    "\n",
    "def fetch_pubmed_ids(query, max_results=60):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    search_url = f\"{base_url}esearch.fcgi?db=pubmed&term={query}&retmax={max_results}&retmode=xml\"\n",
    "    response = requests.get(search_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch IDs: {response.status_code}\")\n",
    "    root = ET.fromstring(response.content)\n",
    "    return [id_elem.text for id_elem in root.findall(\".//Id\")]\n",
    "\n",
    "def fetch_pubmed_details(pmids):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    fetch_url = f\"{base_url}efetch.fcgi?db=pubmed&id={','.join(pmids)}&retmode=xml\"\n",
    "    response = requests.get(fetch_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch details: {response.status_code}\")\n",
    "    fetch_root = ET.fromstring(response.content)\n",
    "    articles = {}\n",
    "    fetched_pmids = set()\n",
    "    for article in fetch_root.findall(\".//PubmedArticle\"):\n",
    "        pmid = article.findtext(\".//PMID\")\n",
    "        title = article.findtext(\".//ArticleTitle\") or \"No title\"\n",
    "        abstract = article.findtext(\".//AbstractText\") or \"\"\n",
    "        articles[pmid] = {'title': title, 'abstract': abstract}\n",
    "        fetched_pmids.add(pmid)\n",
    "    missing = set(pmids) - fetched_pmids\n",
    "    if missing:\n",
    "        print(f\"Warning: Missing PMIDs in fetch: {missing}\")\n",
    "    return articles\n",
    "\n",
    "def get_ollama_embedding(text, model='nomic-embed-text'):\n",
    "    response = ollama.embeddings(model=model, prompt=text)\n",
    "    return np.array(response['embedding'])\n",
    "\n",
    "def get_ollama_summary(text, model='llama3'):\n",
    "    prompt = f\"Summarize the following article in 2-3 sentences:\\n\\n{text}\"\n",
    "    response = ollama.generate(model=model, prompt=prompt)\n",
    "    return response['response']\n",
    "\n",
    "\n",
    "def normalize_embeddings(X):\n",
    "    X_mean = np.mean(X, axis=0)\n",
    "    X_std = np.std(X, axis=0)\n",
    "    return (X - X_mean) / (X_std + 1e-8)  # Avoid division by zero\n",
    "\n",
    "\n",
    "def create_article_data(query, max_results=60):\n",
    "    all_pmids = fetch_pubmed_ids(query, max_results)\n",
    "    train_pmids, test_pmids = train_test_split(all_pmids, test_size=0.2, random_state=42)\n",
    "    train_articles = fetch_pubmed_details(train_pmids)\n",
    "    test_articles = fetch_pubmed_details(test_pmids)\n",
    "    \n",
    "    X_train, y_train, df_train = process_articles(train_pmids, train_articles, cache_file=\"train_embeddings.pkl\")\n",
    "    X_test, y_test, df_test = process_articles(test_pmids, test_articles, cache_file=\"test_embeddings.pkl\")\n",
    "    \n",
    "    X_train = normalize_embeddings(X_train)\n",
    "    X_test = normalize_embeddings(X_test)\n",
    "    \n",
    "    assert not set(train_pmids) & set(test_pmids), \"Overlap detected!\"\n",
    "    return X_train, y_train, X_test, y_test, df_train, df_test\n",
    "\n",
    "def process_articles(pmids, articles_dict, cache_file=\"embeddings.pkl\"):\n",
    "    # Check for cached data\n",
    "    if os.path.exists(cache_file):\n",
    "        with open(cache_file, 'rb') as f:\n",
    "            cached = pickle.load(f)\n",
    "            cached_pmids = set(cached['pmids'])\n",
    "            if set(pmids).issubset(cached_pmids):\n",
    "                print(\"Using cached embeddings and labels.\")\n",
    "                X, y = [], []\n",
    "                for pmid in pmids:\n",
    "                    idx = cached['pmids'].index(pmid)\n",
    "                    X.append(cached['X'][idx])\n",
    "                    y.append(cached['y'][idx])\n",
    "                return np.array(X), np.array(y), cached['df']  # Return cached DataFrame\n",
    "\n",
    "    X, y, texts, summaries = [], [], [], []\n",
    "    valid_pmids = []\n",
    "\n",
    "    # Prompt with your bias\n",
    "    prompt_template = \"\"\"\n",
    "You are an expert in machine learning and cancer research. Classify this summary as 'useful' (1) if it describes machine learning techniques (new or established) applied to cancer diagnosis or treatment with potential practical value (e.g., could improve outcomes or be implemented), or 'not useful' (0) if it’s purely theoretical, lacks ML, or is a review. Examples:\n",
    "- Useful (1): \"SVM model predicts breast cancer with 85% accuracy.\"\n",
    "- Useful (1): \"New CNN improves tumor detection in MRI scans.\"\n",
    "- Not Useful (0): \"Review of ML in oncology.\"\n",
    "Return only the label (0 or 1).\n",
    "Summary: {summary}\n",
    "\"\"\"\n",
    "\n",
    "    for pmid in pmids:\n",
    "        if pmid not in articles_dict:\n",
    "            print(f\"Warning: PMID {pmid} not found, skipping.\")\n",
    "            continue\n",
    "        article = articles_dict[pmid]\n",
    "        full_text = f\"{article['title']} {article['abstract']}\"\n",
    "        summary = get_ollama_summary(full_text)\n",
    "        embedding = get_ollama_embedding(summary)\n",
    "        X.append(embedding)\n",
    "        prompt = prompt_template.format(summary=summary)\n",
    "        response = ollama.generate(model='llama3', prompt=prompt)\n",
    "        label = int(response['response'].strip())\n",
    "\n",
    "        # Store data\n",
    "        valid_pmids.append(pmid)\n",
    "        texts.append(full_text)\n",
    "        summaries.append(summary)\n",
    "        y.append(label)\n",
    "\n",
    "    X = np.array(X)\n",
    "    y = np.array(y)\n",
    "\n",
    "    # Create DataFrame\n",
    "    df = pd.DataFrame({\n",
    "        'pmid': valid_pmids,\n",
    "        'full_text': texts,\n",
    "        'summary': summaries,\n",
    "        'label': y\n",
    "    })\n",
    "\n",
    "    # Print DataFrame instead of raw prints\n",
    "    print(\"\\nProcessed articles with LM labels:\")\n",
    "    print(df.to_string(index=False))  # Nicer formatting\n",
    "\n",
    "    # Cache results, including DataFrame\n",
    "    with open(cache_file, 'wb') as f:\n",
    "        pickle.dump({'pmids': valid_pmids, 'X': X, 'y': y, 'df': df}, f)\n",
    "\n",
    "    return X, y, df\n",
    "\n",
    "\n",
    "\n",
    "DATA_FILE = \"article_data.pkl\"\n",
    "\n",
    "def load_or_create_data(query, max_results):\n",
    "    if os.path.exists(DATA_FILE):\n",
    "        print(f\"Loading saved data from {DATA_FILE}\")\n",
    "        with open(DATA_FILE, 'rb') as f:\n",
    "            data = pickle.load(f)\n",
    "            return data['X_train'], data['y_train'], data['X_test'], data['y_test'], data['df_train'], data['df_test']\n",
    "    else:\n",
    "        print(f\"Creating new data for query: {query}\")\n",
    "        X_train, y_train, X_test, y_test, df_train, df_test = create_article_data(query, max_results)\n",
    "        data = {\n",
    "            'X_train': X_train, 'y_train': y_train,\n",
    "            'X_test': X_test, 'y_test': y_test,\n",
    "            'df_train': df_train, 'df_test': df_test\n",
    "        }\n",
    "        with open(DATA_FILE, 'wb') as f:\n",
    "            pickle.dump(data, f)\n",
    "        print(f\"Saved data to {DATA_FILE}\")\n",
    "        return X_train, y_train, X_test, y_test, df_train, df_test\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    query = \"machine learning cancer\"\n",
    "    max_results = 100\n",
    "\n",
    "    # Load or create data\n",
    "    X_train, y_train, X_test, y_test, df_train, df_test = load_or_create_data(query, max_results)\n",
    "\n",
    "    # Print label balance\n",
    "    print(\"Train label balance:\", np.mean(y_train))\n",
    "    print(\"Test label balance:\", np.mean(y_test))\n",
    "\n",
    "    # Build and train model\n",
    "    model = funny_guy()\n",
    "    model.add(Layer_Dense(768, 32, weight_regularizer_l2=1e-3))\n",
    "    model.add(Activation_ReLU())\n",
    "    model.add(Layer_Dropout(0.3))\n",
    "    model.add(Activation_ReLU())\n",
    "    model.add(Layer_Dense(32, 1, weight_regularizer_l2=1e-3))\n",
    "    model.add(Activation_Sigmoid())\n",
    "    model.set(\n",
    "        loss=Loss_BinaryCrossEntropy(),\n",
    "        optimizer=Optimizer_SGD(learning_rate=0.008, decay=1e-5, momentum=0.8),\n",
    "        accuracy=Accuracy_Binary())\n",
    "    model.finalize()\n",
    "    history = model.train(X_train, y_train, epochs=30, batch_size=32, print_every=2, validation_data=(X_test, y_test))\n",
    "\n",
    "    # Predictions and analysis\n",
    "    predictions = model.predict(X_test)\n",
    "    df_test['raw_prediction'] = predictions.flatten()\n",
    "    df_test['binary_prediction'] = (predictions > 0.5).astype(int)\n",
    "    print(\"\\nTest DataFrame with Predictions:\")\n",
    "    print(df_test[['pmid', 'label', 'raw_prediction', 'binary_prediction']].to_string(index=False))\n",
    "    print(\"Confusion Matrix:\\n\", pd.crosstab(df_test['label'], df_test['binary_prediction']))   \n",
    "    \n",
    "    # Plotting\n",
    "    epochs_range = range(1, len(history['train_loss']) + 1)\n",
    "    plt.figure(figsize=(12, 5))\n",
    "    plt.subplot(1, 2, 1)\n",
    "    plt.plot(epochs_range, history['train_loss'], label='Training Loss')\n",
    "    plt.plot(epochs_range, history['val_loss'], label='Validation Loss')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Loss')\n",
    "    plt.title('Loss Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.subplot(1, 2, 2)\n",
    "    plt.plot(epochs_range, history['train_acc'], label='Training Accuracy')\n",
    "    plt.plot(epochs_range, history['val_acc'], label='Validation Accuracy')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Accuracy')\n",
    "    plt.title('Accuracy Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.tight_layout()\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading saved data from big_article_data.pkl\n",
      "Train label balance: 0.575\n",
      "Test label balance: 0.56\n"
     ]
    }
   ],
   "source": [
    "# SCRAP AND EMBED\n",
    "\n",
    "\n",
    "import pandas as pd\n",
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "import numpy as np\n",
    "import pickle\n",
    "import os\n",
    "from sklearn.model_selection import train_test_split\n",
    "import ollama\n",
    "\n",
    "# File paths for pickle files\n",
    "DATA_FILE = \"big_article_data.pkl\"\n",
    "TRAIN_CACHE = \"big_train_embeddings.pkl\"\n",
    "TEST_CACHE = \"big_test_embeddings.pkl\"\n",
    "\n",
    "\n",
    "\n",
    "# Main execution for scraping and embedding\n",
    "if __name__ == \"__main__\":\n",
    "    query = \"machine learning cancer\"\n",
    "    max_results = 250\n",
    "    X_train, y_train, X_test, y_test, df_train, df_test = load_or_create_data(query, max_results)\n",
    "    print(\"Train label balance:\", np.mean(y_train))\n",
    "    print(\"Test label balance:\", np.mean(y_test))\n",
    "\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "epoch: 1\n",
      "step: 0, acc: 0.450, loss: 0.696, (data_loss: 0.6943402745269225, reg_loss: 0.001), lr: 0.008\n",
      "step: 9, acc: 0.700, loss: 0.690, (data_loss: 0.6890552426392433, reg_loss: 0.001), lr: 0.007998560259153352\n",
      "training, acc: 0.480, loss: 0.694, (data_loss: 0.6929616735933615, reg_loss: 0.001), lr: 0.007998560259153352\n",
      "validation, acc: 0.580, loss: 0.691\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 2\n",
      "step: 0, acc: 0.400, loss: 0.696, (data_loss: 0.6943115902087158, reg_loss: 0.001), lr: 0.007998400319936013\n",
      "step: 9, acc: 0.600, loss: 0.684, (data_loss: 0.6830465471893075, reg_loss: 0.001), lr: 0.00799696115476119\n",
      "training, acc: 0.585, loss: 0.689, (data_loss: 0.6875455456849486, reg_loss: 0.001), lr: 0.00799696115476119\n",
      "validation, acc: 0.560, loss: 0.687\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 3\n",
      "step: 0, acc: 0.400, loss: 0.694, (data_loss: 0.692289897607919, reg_loss: 0.001), lr: 0.007996801279488205\n",
      "step: 9, acc: 0.600, loss: 0.673, (data_loss: 0.6719134877263914, reg_loss: 0.001), lr: 0.007995362689640009\n",
      "training, acc: 0.585, loss: 0.680, (data_loss: 0.6790865890082709, reg_loss: 0.001), lr: 0.007995362689640009\n",
      "validation, acc: 0.560, loss: 0.681\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 4\n",
      "step: 0, acc: 0.400, loss: 0.688, (data_loss: 0.6870620794809115, reg_loss: 0.001), lr: 0.007995202878273036\n",
      "step: 9, acc: 0.600, loss: 0.661, (data_loss: 0.6593055380578445, reg_loss: 0.001), lr: 0.007993764863406543\n",
      "training, acc: 0.610, loss: 0.666, (data_loss: 0.6652485579930654, reg_loss: 0.001), lr: 0.007993764863406543\n",
      "validation, acc: 0.600, loss: 0.670\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 5\n",
      "step: 0, acc: 0.600, loss: 0.672, (data_loss: 0.6707216534698385, reg_loss: 0.001), lr: 0.007993605115907274\n",
      "step: 9, acc: 0.750, loss: 0.624, (data_loss: 0.6231246487258719, reg_loss: 0.001), lr: 0.007992167675677836\n",
      "training, acc: 0.720, loss: 0.637, (data_loss: 0.6356297276938514, reg_loss: 0.001), lr: 0.007992167675677836\n",
      "validation, acc: 0.680, loss: 0.647\n",
      "Val predictions: [1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 6\n",
      "step: 0, acc: 0.850, loss: 0.633, (data_loss: 0.6316463322840623, reg_loss: 0.001), lr: 0.007992007992007994\n",
      "step: 9, acc: 0.850, loss: 0.566, (data_loss: 0.5647766230855297, reg_loss: 0.001), lr: 0.007990571126071237\n",
      "training, acc: 0.830, loss: 0.588, (data_loss: 0.5869845745440616, reg_loss: 0.001), lr: 0.007990571126071237\n",
      "validation, acc: 0.740, loss: 0.607\n",
      "Val predictions: [1 0 1 1 0 1 1 1 1 1]\n",
      "epoch: 7\n",
      "step: 0, acc: 0.850, loss: 0.578, (data_loss: 0.5762550803728822, reg_loss: 0.001), lr: 0.007990411506192568\n",
      "step: 9, acc: 0.800, loss: 0.512, (data_loss: 0.5105275404036947, reg_loss: 0.001), lr: 0.007988975214204398\n",
      "training, acc: 0.865, loss: 0.517, (data_loss: 0.5151789833768188, reg_loss: 0.001), lr: 0.007988975214204398\n",
      "validation, acc: 0.800, loss: 0.555\n",
      "Val predictions: [1 0 1 1 0 1 1 0 0 1]\n",
      "epoch: 8\n",
      "step: 0, acc: 0.850, loss: 0.487, (data_loss: 0.48539879126865876, reg_loss: 0.001), lr: 0.007988815658078689\n",
      "step: 9, acc: 0.800, loss: 0.455, (data_loss: 0.4534860480893593, reg_loss: 0.002), lr: 0.007987379939695283\n",
      "training, acc: 0.885, loss: 0.438, (data_loss: 0.43592653435680967, reg_loss: 0.002), lr: 0.007987379939695283\n",
      "validation, acc: 0.800, loss: 0.503\n",
      "Val predictions: [1 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 9\n",
      "step: 0, acc: 0.850, loss: 0.420, (data_loss: 0.4188423088267239, reg_loss: 0.002), lr: 0.007987220447284345\n",
      "step: 9, acc: 0.850, loss: 0.372, (data_loss: 0.37057411201610696, reg_loss: 0.002), lr: 0.007985785302162152\n",
      "training, acc: 0.890, loss: 0.349, (data_loss: 0.3470836297534929, reg_loss: 0.002), lr: 0.007985785302162152\n",
      "validation, acc: 0.800, loss: 0.459\n",
      "Val predictions: [1 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 10\n",
      "step: 0, acc: 0.850, loss: 0.335, (data_loss: 0.3335780894862269, reg_loss: 0.002), lr: 0.00798562587342783\n",
      "step: 9, acc: 0.850, loss: 0.337, (data_loss: 0.3355471887469671, reg_loss: 0.002), lr: 0.007984191301223577\n",
      "training, acc: 0.930, loss: 0.292, (data_loss: 0.29030069747609033, reg_loss: 0.002), lr: 0.007984191301223577\n",
      "validation, acc: 0.820, loss: 0.424\n",
      "Val predictions: [1 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 11\n",
      "step: 0, acc: 0.850, loss: 0.283, (data_loss: 0.2812031479799112, reg_loss: 0.002), lr: 0.007984031936127744\n",
      "step: 9, acc: 0.900, loss: 0.280, (data_loss: 0.277733293092291, reg_loss: 0.002), lr: 0.007982597936498434\n",
      "training, acc: 0.935, loss: 0.242, (data_loss: 0.23959190774912859, reg_loss: 0.002), lr: 0.007982597936498434\n",
      "validation, acc: 0.880, loss: 0.396\n",
      "Val predictions: [0 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 12\n",
      "step: 0, acc: 0.900, loss: 0.256, (data_loss: 0.2536638504498644, reg_loss: 0.002), lr: 0.007982438635002994\n",
      "step: 9, acc: 0.900, loss: 0.269, (data_loss: 0.266487124983975, reg_loss: 0.002), lr: 0.007981005207605897\n",
      "training, acc: 0.960, loss: 0.212, (data_loss: 0.20933532573370411, reg_loss: 0.002), lr: 0.007981005207605897\n",
      "validation, acc: 0.860, loss: 0.373\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 13\n",
      "step: 0, acc: 0.900, loss: 0.225, (data_loss: 0.22240688244521936, reg_loss: 0.002), lr: 0.007980845969672787\n",
      "step: 9, acc: 1.000, loss: 0.208, (data_loss: 0.20587671418552844, reg_loss: 0.002), lr: 0.007979413114165453\n",
      "training, acc: 0.975, loss: 0.181, (data_loss: 0.178829064820925, reg_loss: 0.002), lr: 0.007979413114165453\n",
      "validation, acc: 0.860, loss: 0.359\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 14\n",
      "step: 0, acc: 0.950, loss: 0.190, (data_loss: 0.18725439381553777, reg_loss: 0.002), lr: 0.007979253939756634\n",
      "step: 9, acc: 1.000, loss: 0.213, (data_loss: 0.21016188058147173, reg_loss: 0.003), lr: 0.007977821655796885\n",
      "training, acc: 0.975, loss: 0.159, (data_loss: 0.15676500577659547, reg_loss: 0.003), lr: 0.007977821655796885\n",
      "validation, acc: 0.860, loss: 0.345\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 15\n",
      "step: 0, acc: 0.900, loss: 0.193, (data_loss: 0.1904045816518066, reg_loss: 0.003), lr: 0.007977662544874352\n",
      "step: 9, acc: 0.950, loss: 0.151, (data_loss: 0.14809043173198783, reg_loss: 0.003), lr: 0.007976230832120281\n",
      "training, acc: 0.985, loss: 0.137, (data_loss: 0.13421618394038476, reg_loss: 0.003), lr: 0.007976230832120281\n",
      "validation, acc: 0.840, loss: 0.335\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 16\n",
      "step: 0, acc: 0.950, loss: 0.166, (data_loss: 0.16325220271131763, reg_loss: 0.003), lr: 0.007976071784646063\n",
      "step: 9, acc: 1.000, loss: 0.134, (data_loss: 0.13168943763224816, reg_loss: 0.003), lr: 0.007974640642756036\n",
      "training, acc: 0.990, loss: 0.128, (data_loss: 0.12530100742972605, reg_loss: 0.003), lr: 0.007974640642756036\n",
      "validation, acc: 0.860, loss: 0.325\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 17\n",
      "step: 0, acc: 0.950, loss: 0.152, (data_loss: 0.14909312479375308, reg_loss: 0.003), lr: 0.007974481658692184\n",
      "step: 9, acc: 1.000, loss: 0.114, (data_loss: 0.11149211901556436, reg_loss: 0.003), lr: 0.007973051087324842\n",
      "training, acc: 0.995, loss: 0.104, (data_loss: 0.10101444080523546, reg_loss: 0.003), lr: 0.007973051087324842\n",
      "validation, acc: 0.860, loss: 0.314\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 18\n",
      "step: 0, acc: 0.950, loss: 0.133, (data_loss: 0.13037891448510203, reg_loss: 0.003), lr: 0.007972892166633445\n",
      "step: 9, acc: 0.950, loss: 0.149, (data_loss: 0.14616137219135805, reg_loss: 0.003), lr: 0.007971462165447698\n",
      "training, acc: 0.990, loss: 0.093, (data_loss: 0.0904468990128136, reg_loss: 0.003), lr: 0.007971462165447698\n",
      "validation, acc: 0.860, loss: 0.312\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 19\n",
      "step: 0, acc: 1.000, loss: 0.123, (data_loss: 0.12008517191408555, reg_loss: 0.003), lr: 0.007971303308090873\n",
      "step: 9, acc: 1.000, loss: 0.115, (data_loss: 0.11190811511371809, reg_loss: 0.003), lr: 0.007969873876745902\n",
      "training, acc: 0.995, loss: 0.095, (data_loss: 0.09139786880430104, reg_loss: 0.003), lr: 0.007969873876745902\n",
      "validation, acc: 0.860, loss: 0.306\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 20\n",
      "step: 0, acc: 1.000, loss: 0.101, (data_loss: 0.09742095518497478, reg_loss: 0.003), lr: 0.007969715082685794\n",
      "step: 9, acc: 1.000, loss: 0.094, (data_loss: 0.09034177553902853, reg_loss: 0.003), lr: 0.007968286220841052\n",
      "training, acc: 0.995, loss: 0.086, (data_loss: 0.08280478777017955, reg_loss: 0.003), lr: 0.007968286220841052\n",
      "validation, acc: 0.860, loss: 0.304\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 21\n",
      "step: 0, acc: 0.950, loss: 0.119, (data_loss: 0.11531969810928007, reg_loss: 0.003), lr: 0.00796812749003984\n",
      "step: 9, acc: 1.000, loss: 0.100, (data_loss: 0.09666180145767969, reg_loss: 0.003), lr: 0.007966699197355055\n",
      "training, acc: 0.990, loss: 0.077, (data_loss: 0.07409554940033691, reg_loss: 0.003), lr: 0.007966699197355055\n",
      "validation, acc: 0.840, loss: 0.304\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 22\n",
      "step: 0, acc: 1.000, loss: 0.106, (data_loss: 0.10227289549427163, reg_loss: 0.003), lr: 0.007966540529774946\n",
      "step: 9, acc: 1.000, loss: 0.057, (data_loss: 0.0535395354986825, reg_loss: 0.003), lr: 0.007965112805910113\n",
      "training, acc: 1.000, loss: 0.059, (data_loss: 0.055564933737153835, reg_loss: 0.003), lr: 0.007965112805910113\n",
      "validation, acc: 0.840, loss: 0.302\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 23\n",
      "step: 0, acc: 1.000, loss: 0.088, (data_loss: 0.08445486301839109, reg_loss: 0.003), lr: 0.007964954201513342\n",
      "step: 9, acc: 1.000, loss: 0.121, (data_loss: 0.11775508950533772, reg_loss: 0.004), lr: 0.00796352704612873\n",
      "training, acc: 1.000, loss: 0.059, (data_loss: 0.05541623018387377, reg_loss: 0.004), lr: 0.00796352704612873\n",
      "validation, acc: 0.840, loss: 0.297\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 24\n",
      "step: 0, acc: 1.000, loss: 0.089, (data_loss: 0.08589080371105631, reg_loss: 0.004), lr: 0.007963368504877564\n",
      "step: 9, acc: 1.000, loss: 0.081, (data_loss: 0.07704420073851474, reg_loss: 0.004), lr: 0.00796194191763371\n",
      "training, acc: 1.000, loss: 0.057, (data_loss: 0.05346569361975103, reg_loss: 0.004), lr: 0.00796194191763371\n",
      "validation, acc: 0.840, loss: 0.294\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 25\n",
      "step: 0, acc: 1.000, loss: 0.103, (data_loss: 0.0993979562234623, reg_loss: 0.004), lr: 0.007961783439490446\n",
      "step: 9, acc: 1.000, loss: 0.074, (data_loss: 0.07070342166520333, reg_loss: 0.004), lr: 0.00796035742004816\n",
      "training, acc: 1.000, loss: 0.059, (data_loss: 0.05504959656215038, reg_loss: 0.004), lr: 0.00796035742004816\n",
      "validation, acc: 0.840, loss: 0.295\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 26\n",
      "step: 0, acc: 1.000, loss: 0.097, (data_loss: 0.0932272368013077, reg_loss: 0.004), lr: 0.007960199004975126\n",
      "step: 9, acc: 1.000, loss: 0.062, (data_loss: 0.058755419420673624, reg_loss: 0.004), lr: 0.007958773552995483\n",
      "training, acc: 1.000, loss: 0.047, (data_loss: 0.043578405919564724, reg_loss: 0.004), lr: 0.007958773552995483\n",
      "validation, acc: 0.840, loss: 0.294\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 27\n",
      "step: 0, acc: 1.000, loss: 0.073, (data_loss: 0.06914562936669473, reg_loss: 0.004), lr: 0.007958615200955033\n",
      "step: 9, acc: 0.950, loss: 0.079, (data_loss: 0.07483827566743526, reg_loss: 0.004), lr: 0.007957190316099386\n",
      "training, acc: 0.990, loss: 0.055, (data_loss: 0.05109874201162854, reg_loss: 0.004), lr: 0.007957190316099386\n",
      "validation, acc: 0.840, loss: 0.293\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 28\n",
      "step: 0, acc: 1.000, loss: 0.059, (data_loss: 0.05496583457415314, reg_loss: 0.004), lr: 0.007957032027053909\n",
      "step: 9, acc: 1.000, loss: 0.030, (data_loss: 0.026386839279858722, reg_loss: 0.004), lr: 0.00795560770898387\n",
      "training, acc: 1.000, loss: 0.044, (data_loss: 0.0403922792170791, reg_loss: 0.004), lr: 0.00795560770898387\n",
      "validation, acc: 0.840, loss: 0.293\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "\n",
      "Test DataFrame with Predictions:\n",
      "    pmid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              full_text                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   summary  label  raw_prediction  binary_prediction\n",
      "40343491                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis. The aim of this study is to better characterize the clinical characteristics and outcomes of patients diagnosed with Immune checkpoint Inhibitor (ICI) pneumonitis and propose predictive models.                                                                                                                                                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nThe study aims to understand the clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis. The researchers sought to characterize the disease by analyzing patient demographics, symptoms, and treatment outcomes. They also aimed to develop predictive models to identify factors that may indicate a higher risk of developing ICI pneumonitis.      0        0.004585                  0\n",
      "40370448                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Corrigendum: Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma. [This corrects the article DOI: 10.3389/fimmu.2025.1575084.].                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 There is no content to summarize as the article appears to be a corrigendum, which is a correction or update to an existing article. It does not contain new information and only references a previous publication with a corrected DOI.      0        0.000012                  0\n",
      "40352269                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Development of an immune-related gene signature applying Ridge method for improving immunotherapy responses and clinical outcomes in lung adenocarcinoma. Lung adenocarcinoma (LUAD) is a major cause of cancer mortality. Considering the critical role of tumor infiltrating lymphocytes in effective immunotherapy, this study was designed to screen molecular markers related to tumor infiltrating cells in LUAD, aiming to improve immunotherapy response during LUAD therapy.                                                                                                                                                                                                                                                                          Here is a summary of the article in 2-3 sentences:\\n\\nThe study aimed to identify molecular markers that predict immune responses and clinical outcomes in patients with lung adenocarcinoma (LUAD). The researchers used the Ridge method to develop an immune-related gene signature, which can help improve immunotherapy responses and outcomes in LUAD. This signature may be useful for identifying patients who are most likely to benefit from immunotherapy treatments.      1        0.715392                  1\n",
      "40358526                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Nonparametric IPSS: Fast, flexible feature selection with false discovery control. Feature selection is a critical task in machine learning and statistics. However, existing feature selection methods either (i) rely on parametric methods such as linear or generalized linear models, (ii) lack theoretical false discovery control, or (iii) identify few true positives.                                                                                                                                                                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nThe article discusses the importance of feature selection in machine learning and statistics, where existing methods often rely on parametric approaches, lack theoretical false discovery control, or only identify a few true positives. Nonparametric IPSS (NIPSS) is introduced as a novel approach that addresses these limitations by offering fast, flexible feature selection with controlled false discoveries.      0        0.042520                  0\n",
      "40348669                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Exploring morphological heterogeneity of circulating tumor cells: machine learning-based approach for cell identification and prognostic implications.                                                                                                                                                                                                                                             The article discusses a machine learning-based approach to identify and characterize circulating tumor cells (CTCs) based on their morphological features. This method uses computer vision and machine learning algorithms to analyze images of CTCs and predict their morphology, which can be used to inform patient prognosis. The study shows that the morphological heterogeneity of CTCs is associated with poorer patient outcomes, highlighting the potential clinical applications of this approach.      1        0.999590                  1\n",
      "40335510                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Oral microbiome-derived biomarkers for non-invasive diagnosis of head and neck squamous cell carcinoma. Mounting evidence suggests that sustained microbial dysbiosis is associated with the development of multiple cancers, while the species-level bacterial taxa and metabolic dysfunction of oral microbiome in patients with head and neck squamous cell carcinoma (HNSCC) remains unclear. In this cross-sectional study, comprehensive metagenomic and 16S rRNA amplicon sequencing analyses of oral swab samples from 172 patients were performed. Unsupervised clustering algorithms of relative microbial abundance profiles revealed three distinctive microbiome clusters. Based on the metagenomic and 16S rRNA amplicon sequencing data, machine learning-based methods were used to construct the HNSCC diagnostic classifier, which exhibited high area under the curve values of 0.78-0.89. Our study provided the first exhaustive metagenomic and 16S rRNA amplicon sequencing analyses to date, revealing that microbial-metabolic dysbiosis is a potential risk factor for HNSCC progression and therefore providing a robust theoretical basis for potential diagnostic and therapeutic strategies for HNSCC patients.                                                                                                 Here is a summary of the article in 3 sentences:\\n\\nResearchers analyzed oral swab samples from 172 patients to investigate the relationship between the oral microbiome and head and neck squamous cell carcinoma (HNSCC). The study used machine learning methods to identify three distinct microbial clusters and develop a diagnostic classifier that showed high accuracy in distinguishing HNSCC patients from healthy individuals. The findings suggest that microbial-metabolic dysbiosis is a potential risk factor for HNSCC progression, providing a basis for developing non-invasive diagnostic and therapeutic strategies for the disease.      1        0.813755                  1\n",
      "40330476                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery. Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related mortality worldwide, partly due to an incomplete understanding of the metabolic and immune dysregulation driving its progression. Here, we uncover a novel role of METTL1 in driving nucleotide metabolism reprogramming, which significantly modulates the tumor immune microenvironment.                                                                                                                                                                                                                                                                                                                              Here is a summary of the article in 2-3 sentences:\\n\\nResearchers have discovered that the protein METTL1 plays a key role in reprogramming nucleotide metabolism in hepatocellular carcinoma (HCC), leading to significant changes in the tumor's immune microenvironment. This finding may hold promise for identifying new prognostic biomarkers for HCC, which is a leading cause of cancer-related mortality worldwide.      0        0.403503                  0\n",
      "40335073                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              A Digital Score Based on Circulating-Tumor-Cells-Derived mRNA Quantification and Machine Learning for Early Colorectal Cancer Detection. Circulating tumor cells (CTCs) serve as valuable biomarkers in tumor circulation, carrying essential primary tumor information. The purification of CTCs from peripheral blood samples and the analysis of their characteristic molecules enable the detection of tumors at an early stage. The noninvasive, continuous, real-time dynamic monitoring provides a promising solution for the timely diagnosis of colorectal cancer (CRC). In this study, we developed a minimally invasive method for CRC early detection to enable accurate screening in a friendly manner for individuals who generally require colonoscopy. The dual-antibody (i.e., anti-EpCAM and anti-EGFR) modified antifouling hydrogel-coated magnetic nanoparticles (pSBMA-MNPs) were prepared for efficient and specific CTC purification. Then, the quantification of 6 RNA transcripts in purified CRC CTCs was performed via droplet digital PCR (ddPCR), and a CRC score was calculated using an extreme gradient boosting model to distinguish CRC from colon polyps and adenomas. A pilot study was conducted to evaluate the clinical potential of the CRC CTC RNA assay in a training cohort (                                                                                                                                                                                                                                                                                         Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a non-invasive test for early detection of colorectal cancer (CRC) using circulating tumor cells (CTCs) and machine learning. The test uses magnetic nanoparticles to purify CTCs from blood samples, followed by digital PCR analysis of six RNA transcripts. A pilot study showed the potential of this CRC score-based assay in distinguishing CRC from colon polyps and adenomas.      1        0.960688                  1\n",
      "40369609                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Machine learning prediction model of prolonged delay to loop ileostomy closure after rectal cancer surgery: a retrospective study. Delayed closure of a temporary ileostomy in patients with rectal cancer may cause psychological, physiological, and socioeconomic burdens to patients.                                                                                                                                                                                                                                                                                                                                                                                                   Here is a summary of the article in 2-3 sentences:\\n\\nA machine learning prediction model was developed to identify factors associated with prolonged delay in closing a loop ileostomy after rectal cancer surgery. The study aimed to reduce the physical, emotional, and financial burdens caused by delayed closure on patients with rectal cancer.      0        0.571053                  1\n",
      "40350060                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Computationally enabled polychromatic polarized imaging enables mapping of matrix architectures that promote pancreatic ductal adenocarcinoma dissemination. Pancreatic ductal adenocarcinoma (PDA) is an extremely metastatic and lethal disease. In PDA, extracellular matrix (ECM) architectures known as Tumor-Associated Collagen Signatures (TACS) regulate invasion and metastatic spread in both early dissemination and in late-stage disease. As such, TACS has been suggested as a biomarker to aid in pathologic assessment. However, despite its significance, approaches to quantitatively capture these ECM patterns currently require advanced optical systems with signaling processing analysis. Here we present an expansion of polychromatic polarized microscopy (PPM) with inherent angular information coupled to machine learning and computational pixel-wise analysis of TACS. Using this platform, we are able to accurately capture TACS architectures in H&E stained histology sections directly through PPM contrast. Moreover, PPM facilitated identification of transitions to dissemination architectures, i.e., transitions from sequestration through expansion to dissemination from both PanINs and throughout PDA. Lastly, PPM evaluation of architectures in liver metastases, the most common metastatic site for PDA, demonstrates TACS-mediated focal and local invasion as well as identification of unique patterns anchoring aligned fibers into normal-adjacent tumor, suggesting that these patterns may be precursors to metastasis expansion and local spread from micrometastatic lesions. Combined, these findings demonstrate that PPM coupled to computational platforms is a powerful tool for analyzing ECM architecture that can be employed to advance cancer microenvironment studies and provide clinically relevant diagnostic information.                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nA new imaging technique called computationally enabled polychromatic polarized imaging (CEPP) has been developed to map the extracellular matrix (ECM) architectures that promote pancreatic ductal adenocarcinoma dissemination. CEPP uses machine learning and computational analysis to accurately capture these ECM patterns in histology sections, allowing for the identification of transitions from early to late-stage disease. This technique shows promise for advancing cancer microenvironment studies and providing clinically relevant diagnostic information.      1        0.947229                  1\n",
      "40330404                                                                         Role of Artificial Intelligence in the Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review. Oral squamous cell carcinoma (OSCC) is a serious worldwide health issue. Early OSCC identification by the analysis of digital oral photos is possible with the combination of artificial intelligence (AI) and computer vision. The purpose of this systematic review was to evaluate the current evidence on the role of AI in the diagnosis of OSCC, focusing on the diagnostic performance, methodologies employed, and potential limitations of AI applications in this context. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to search for relevant studies across PubMed, Scopus, Web of Science, and Cumulative Index to Nursing and Allied Health Literature (CINAHL). In these databases, we found 286 studies, which were first screened for duplicates and then assessed on inclusion and exclusion criteria. Only 11 studies were found most relevant and were included in this study. These studies were also assessed for risk of bias using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool. Numerous studies have shown impressive results for this job, frequently covering about 1000 photos and regularly reaching sensitivity rates above 85% with accuracy rates above 90%. The review examines these research in detail, providing insight into their methods, which include the application of contemporary machine learning and pattern recognition techniques in conjunction with various supervision techniques. However, because various datasets are utilized in different articles, it can be difficult to compare the results. In light of these results, this study emphasizes how urgently the area of OSCC detection needs more solid and trustworthy datasets. Additionally, it emphasizes how sophisticated methods like ensemble learning, multi-task learning, and attention mechanisms can be used as essential instruments to improve the sensitivity and accuracy of OSCC identification in oral photos. Together, these observations highlight how AI-driven methods for early OSCC diagnosis have the potential to greatly enhance patient outcomes and medical procedures.                                                                                                                     Here is a 2-3 sentence summary of the article:\\n\\nA systematic review evaluated the role of artificial intelligence (AI) in diagnosing oral squamous cell carcinoma (OSCC) from digital oral photos. The results showed that AI-driven methods can achieve high sensitivity rates (above 85%) and accuracy rates (above 90%) in identifying OSCC, with many studies using machine learning and pattern recognition techniques. However, the review also emphasized the need for more robust and trustworthy datasets to improve comparison of results and further enhance the potential of AI-driven methods in early OSCC diagnosis.      1        0.239705                  0\n",
      "40325252                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Screening of pivotal oncogenes modulated by DNA methylation in hepatocellular carcinoma and identification of atractylenolide I as an anti-cancer drug. This study was performed to identify crucial oncogenes modulated by DNA methylation in hepatocellular carcinoma (HCC) and look for new drugs for HCC treatment. The data of TCGA-LIHC cohort were obtained from UCSC database. Weighted gene co-expression network analysis and multiple machine learning algorithms were applied to screen the crucial prognosis-related genes in HCC. Then these genes were further screened by DNA methylation status. Ten-eleven translocation 1 (TET1) was overexpressed in HCC cell lines, and its biological functions and regulatory effects on the oncogenes were explored by qPCR, methylation-specific polymerase chain reaction, cell viability assay, Western blot, etc. Molecular docking was applied to evaluate the binding affinity between atractylenolide I (AT-I) and TET1, and the tumor-suppressive functions of AT-I were examined with both in vitro and in vivo models. In this work, 12 crucial genes related to HCC prognosis were obtained, among which six genes were with differential methylation status in HCC tissues, including AKR1B10, ALPK3, NQO1, NT5DC2, SFN, and SPP1. The expression levels of ALPK3 and NT5DC2 were positively regulated by TET1, the crucial mediator of demethylation. TET1 overexpression increased the viability and stemness of HCC cells. AT-I had good binding affinity with TET1, and repressed its activity. AT-I promoted the methylation of ALPK3 and NT5DC2 promoter regions, and reduced their expression, and repressed the growth of HCC cells. In summary, DNA methylation contributes to HCC progression, and AT-I represses the malignancy of HCC cells by inhibiting TET1-mediated abnormal DNA demethylation.                                                                                                                                                                                                                                       Here is a 2-3 sentence summary of the article:\\n\\nResearchers identified 12 genes associated with hepatocellular carcinoma (HCC) prognosis, including six that had different methylation statuses in HCC tissues. One of these genes, TET1, was overexpressed in HCC cell lines and played a role in regulating other oncogenes. A compound called atractylenolide I was found to bind to TET1, inhibit its activity, and promote the methylation of certain gene promoters, leading to reduced cancer cell growth.      0        0.058529                  0\n",
      "40320652                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Preclinical Evaluation of an Interactive Image Search System of Oral Pathology. The limited number of specialists and diseases' long-tail distribution create challenges in diagnosing oral tumors. Health care facilities with sole practicing pathologists face difficulties when encountering the rare cases. Such specialists may lack prior exposure to uncommon presentations, needing external reference materials to formulate accurate diagnoses. An image search or content-based image retrieval (CBIR) system may help diagnose rare tumors by providing histologically similar reference images, thus reducing the pathologists' workload. However, the effectiveness of CBIR systems in aiding pathologists' diagnoses through interactive use has not been evaluated. We conducted a remote evaluation in a near-clinical environment using Luigi-Oral, an interactive patch-based CBIR system that uses deep learning to diagnose oral tumors. The database comprised 54,676 image patches at multiple magnifications from 603 cases across 85 oral tumor categories. We recruited 15 general pathologists and 13 oral pathologists with varied experience to evaluate 10 retrospective test cases from 2 institutions using this dedicated system. At top-1 and top-3 differential diagnoses, the overall diagnostic accuracy among the 2 groups was significantly higher with Luigi-Oral than without (12.05% and 21.61% increase,                                                                                                                                                                                                              Here is a summary of the article in 3 sentences:\\n\\nThe diagnosis of rare oral tumors can be challenging due to the limited number of specialists and long-tail distribution of diseases. An interactive image search system, Luigi-Oral, was developed to provide histologically similar reference images to aid pathologists in diagnosing rare cases. In a preclinical evaluation, the system improved diagnostic accuracy among both general and oral pathologists, with significant increases in top-1 and top-3 differential diagnoses.      0        0.029618                  0\n",
      "40319974                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    IR-MBiTCN: Computational prediction of insulin receptor using deep learning: A multi-information fusion approach with multiscale bidirectional temporal convolutional network. The insulin receptor (IR) is a transmembrane protein that controls glucose homeostasis and is highly associated with chronic diseases including cancer and neurological. Traditional experimental methods have provided essential insights into IR structure and function, but they are constrained by time, cost, and scalability. To address these limitations, we present a computational technique for IR prediction based on deep learning and multi-information fusion. First, we built sequence-based training and testing datasets. Second, the compositional, word embedding, and evolutionary features were retrieved using the Weighted-Group Dipeptide Composition (W-GDPC), FastText, and Bi-Block-Position Specific Scoring Matrix (BB-PSSM), respectively. Third, we use compositional, word embedding, and evolutionary features to generate multi-perspective fused features (MPFF). Fourth, the Multiscale Bidirectional Temporal Convolutional Network (MBiTCN) is used to train the model to process features at multiscale and analyze sequences in both forward and backward directions. The proposed approach (IR-MBiTCN) outperforms competing deep learning (DL) and machine learning (ML)-based models on training and testing datasets, achieving 83.50 % and 79.43 % accuracy, respectively. This study represents a pioneering use of computational methodology in IR prediction, providing a scalable, efficient alternative to experimental procedures and paving the way for advances in chronic disease therapy and drug discovery.                                                                                                                                                                                              Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a deep learning-based approach called IR-MBiTCN to predict the structure and function of insulin receptors (IRs). The method combines multiple features from sequence, compositional, word embedding, and evolutionary data using a multiscale bidirectional temporal convolutional network. This approach outperformed other machine learning and deep learning models in predicting IRs, with an accuracy of 83.50% on the training dataset and 79.43% on the testing dataset.      0        0.446953                  0\n",
      "40356851                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Artificial intelligence-driven clinical decision support systems for early detection and precision therapy in oral cancer: a mini review. Oral cancer (OC) is a significant global health burden, with life-saving improvements in survival and outcomes being dependent on early diagnosis and precise treatment planning. However, diagnosis and treatment planning are predicated on the synthesis of complicated information derived from clinical assessment, imaging, histopathology and patient histories. Artificial intelligence-based clinical decision support systems (AI-CDSS) provides a viable solution that can be implemented via advanced methodologies for data analysis, and synthesis for better diagnostic and prognostic evaluation. This review presents AI-CDSS as a promising solution through advanced methodologies for comprehensive data analysis. In addition, it examines current implementations of AI-CDSS that facilitate early OC detection, precise staging, and personalized treatment planning by processing multimodal patient information through machine learning, computer vision, and natural language processing. These systems effectively interpret clinical results, identify critical disease patterns (including clinical stage, site, tumor dimensions, histopathologic grading, and molecular profiles), and construct comprehensive patient profiles. This comprehensive AI-CDSS approach allows for early cancer detection, a reduction in diagnostic delays and improved intervention outcomes. Moreover, the AI-CDSS also optimizes treatment plans on the basis of unique patient parameters, tumor stages and risk factors, providing personalized therapy.                                                    Here is a summary of the article in 2-3 sentences:\\n\\nArtificial intelligence-driven clinical decision support systems (AI-CDSS) have the potential to improve early detection and precision therapy for oral cancer. These systems use advanced data analysis and synthesis techniques to process multimodal patient information, such as imaging, histopathology, and patient histories, to identify critical disease patterns and construct comprehensive patient profiles. By leveraging machine learning, computer vision, and natural language processing, AI-CDSS can facilitate early diagnosis, personalized treatment planning, and improved intervention outcomes for oral cancer patients.      1        0.481205                  0\n",
      "40324114                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer Recurrence. Endometrial cancer (EC) is the most common gynecologic cancer in the United States with rising incidence and mortality. Despite optimal treatment, 15%-20% of all patients will recur. To better select patients for adjuvant therapy, it is important to accurately predict patients at risk for recurrence. Our objective was to train, validate, and test models of EC recurrence using lasso regression and other machine learning (ML) and deep learning (DL) analytics in a large, comprehensive data set.                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nEndometrial cancer is the most common gynecologic cancer in the US, with 15-20% of patients experiencing recurrence despite optimal treatment. To improve patient selection for adjuvant therapy, the objective was to develop machine learning models that accurately predict patients at risk of recurrence using a large dataset. The study used lasso regression and other machine learning/deep learning analytics to train, validate, and test these predictive models.      1        0.999667                  1\n",
      "40331556                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            BCD-TransNet: Automatic breast cancer detection and classification using transfer learning approach. Breast Cancer (BC) is a predominant form of cancer diagnosed in women and one of the deadliest diseases. The important cause of death owing to the cancer amongst women is BC. However, the existing ML techniques are very challenge evaluate the performance of the classification of BC and difficult task for early diagnosis. To overcome this challenge, transfer learning framework have been broadly applied to histopathological images for classifying tumour. So, in this research a novel BC Detection using Transfer learning network (BCD-TransNet) is introduced to identify and classify BC stages. Initially, the histopathological images from BreakHis dataset are pre-processed using stationary wavelet based Retinex (SWR) for eliminating the noise and progress the image quality. The noise-free images are segmented using the Hybrid Greedy Snake-Krill Herd Optimization (HGS-KHO) algorithm. The BCD-TransNet model that incorporates with five different pre-trained networks in which the knowledge attained by each model is transfer to next network for extracting the most relevant features. This detection model has two different phases namely first level classification for identifying benign and malignant cells and the second level classification for identifying the different types in benign and malignant. Finally, the ML-based Decision tree is used to detect the stages of breast tumour. From the simulation analysis, the BCD-TransNet present well accuracy of 99.31% for the classification of breast tumour. The proposed Transfer learning-based BCD-TransNet model improves the overall accuracy 2.11%, 13.31%, 1.82% better than DLA-EABA, Pa-DBN-BC, TTCNN respectively                                                                                                      Here is a summary of the article in 3 sentences:\\n\\nThe authors propose a novel transfer learning-based network called BCD-TransNet for automatic breast cancer detection and classification from histopathological images. The model uses a pre-processing step to remove noise and segment images using the Hybrid Greedy Snake-Krill Herd Optimization algorithm, followed by two levels of classification and finally, a decision tree to detect tumor stages. The simulation analysis shows that BCD-TransNet achieves an accuracy of 99.31% for breast cancer classification, outperforming other existing models by 2.11%, 13.31%, and 1.82%.      1        0.999835                  1\n",
      "40369044                                                                                                                                                                                                                                                                                                                                                                                                 Automated high precision PCOS detection through a segment anything model on super resolution ultrasound ovary images. PCOS (Poly-Cystic Ovary Syndrome) is a multifaceted disorder that often affects the ovarian morphology of women of their reproductive age, resulting in the development of numerous cysts on the ovaries. Ultrasound imaging typically diagnoses PCOS, which helps clinicians assess the size, shape, and existence of cysts in the ovaries. Nevertheless, manual ultrasound image analysis is often challenging and time-consuming, resulting in inter-observer variability. To effectively treat PCOS and prevent its long-term effects, prompt and accurate diagnosis is crucial. In such cases, a prediction model based on deep learning can help physicians by streamlining the diagnosis procedure, reducing time and potential errors. This article proposes a novel integrated approach, QEI-SAM (Quality Enhanced Image - Segment Anything Model), for enhancing image quality and ovarian cyst segmentation for accurate prediction. GAN (Generative Adversarial Networks) and CNN (Convolutional Neural Networks) are the most recent cutting-edge innovations that have supported the system in attaining the expected result. The proposed QEI-SAM model used Enhanced Super Resolution Generative Adversarial Networks (ESRGAN) for image enhancement to increase the resolution, sharpening the edges and restoring the finer structure of the ultrasound ovary images and achieved a better SSIM of 0.938, PSNR value of 38.60 and LPIPS value of 0.0859. Then, it incorporates the Segment Anything Model (SAM) to segment ovarian cysts and achieve the highest Dice coefficient of 0.9501 and IoU score of 0.9050. Furthermore, Convolutional Neural Network - ResNet 50, ResNet 101, VGG 16, VGG 19, AlexNet and Inception v3 have been implemented to diagnose PCOS promptly. Finally, VGG 19 has achieved the highest accuracy of 99.31%.                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nA new model called QEI-SAM (Quality Enhanced Image - Segment Anything Model) was developed for accurate diagnosis of Polycystic Ovary Syndrome (PCOS) using ultrasound images. The model uses Generative Adversarial Networks and Convolutional Neural Networks to enhance image quality, segment ovarian cysts, and predict PCOS diagnosis with high accuracy. The proposed approach achieved a high Dice coefficient and IoU score for cyst segmentation, and the best performing neural network for PCOS diagnosis was found to be VGG 19 with an accuracy of 99.31%.      1        0.299749                  0\n",
      "40336661                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Prediction of High-Dose Methotrexate Blood Concentration in Osteosarcoma Patients Using Machine Learning. High-dose methotrexate is a typical chemotherapy that is widely used in the treatment of osteosarcoma. However, the unique dose-response relationship of methotrexate makes its treatment window relatively narrow, and its clinical use is in a dilemma: either the drug concentration in the patient's body cannot reach the effective concentration level, or adverse reactions may occur due to drug overdose. For this circumstance, monitoring and predicting the drug concentration in the patient's body is well founded and necessary. While pharmacokinetic models exist, they often oversimplify patient-specific covariates. This study addresses the unmet need for early-exposure prediction through interpretable machine learning, enabling data-driven decisions before toxicity manifestation.                                                                                                                                                                                        Here is a summary of the article in 2-3 sentences:\\n\\nHigh-dose methotrexate chemotherapy is commonly used to treat osteosarcoma, but its narrow treatment window makes it challenging to achieve effective concentrations without adverse reactions. To address this issue, researchers developed a machine learning model that can predict blood concentration levels and enable data-driven decisions before toxicity occurs. This approach uses interpretable machine learning to account for patient-specific factors, improving the accuracy of predictions.      1        0.841401                  1\n",
      "40366616                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non-Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning. Antigen fingerprint profiling of tumour-derived extracellular vesicles (TDEVs) in the body fluids is a promising strategy for identifying tumour biomarkers. In this study, proteomic and immunological assays reveal significantly higher CD155 levels in plasma extracellular vesicles (EVs) from patients with non-small cell lung cancer (NSCLC) than from healthy individuals. Utilizing CD155 as a bait protein on the EV membrane, CD155+ TDEVs are enriched from NSCLC patient plasma EVs. In the discovery cohort, 281 differentially expressed proteins are identified in TDEVs of the NSCLC group compared with the healthy control group. In the verification cohort, 49 candidate biomarkers are detected using targeted proteomic analysis. Of these, a biomarker panel of seven frequently and stably detected proteins-MVP, GYS1, SERPINA3, HECTD3, SERPING1, TPM4, and APOD-demonstrates good diagnostic performance, achieving an area under the curve (AUC) of 1.0 with 100% sensitivity and specificity in receiver operating characteristic (ROC) curve analysis, and 92.3% sensitivity and 88.9% specificity in confusion matrix analysis. Western blotting results confirm upregulation trends for MVP, GYS1, SERPINA3, HECTD3, SERPING1 and APOD, and TPM4 is downregulated in EVs of NSCLC patients compared with healthy individuals. These findings highlight the potential of this biomarker panel for the clinical diagnosis of NSCLC.                                                                                                                                                                                                                                                                               Here is a summary of the article in 2-3 sentences:\\n\\nA new biomarker panel was identified through proteomic analysis and machine learning, which may help diagnose non-small cell lung cancer (NSCLC). The panel consists of seven proteins: MVP, GYS1, SERPINA3, HECTD3, SERPING1, TPM4, and APOD. This biomarker panel demonstrated excellent diagnostic performance, with 100% sensitivity and specificity in a receiver operating characteristic (ROC) curve analysis.      1        0.725095                  1\n",
      "40318161                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Proteomics-Empowered Microfluidic-SERS Immunoassay for Identifying and Detecting Biomarkers of Micropapillary Lung Adenocarcinoma. The presence of a micropapillary (MPP) component is a crucial determinant of surgical strategies for lung adenocarcinoma (LUAD), yet reliable blood biomarkers for predicting MPP⁺ LUAD remain elusive. Here, we integrate 4D label-free quantitative proteomics, a nanomixing-enhanced microfluidic surface-enhanced Raman spectroscopy (SERS) platform, and machine learning to sensitively identify and validate blood protein biomarkers associated with MPP⁺ LUAD. Comparative proteomics reveal 44 differentially expressed proteins (DEPs) between MPP⁺ and MPP⁻ LUADs, with bioinformatics uncovering their roles in MPP⁺ LUAD formation. To enable sensitive, multiplex detection of 4 upregulated DEPs, the nanomixing effect is leveraged to enhance target protein-SERS barcode interactions while minimizing nonspecific binding to antibody-functionalized gold electrodes. The SERS barcode cocktail allows simultaneous detection of the 4 selected DEPs. Machine learning models based on SERS detection effectively distinguish MPP⁺ from MPP⁻ LUAD patients, as well as LUAD patients from healthy donors. This approach demonstrates strong diagnostic potential for early, non-invasive MPP detection in LUAD, advancing nanotechnology-driven disease diagnosis and monitoring.                                                                                                                               Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a new immunoassay that uses microfluidic technology and surface-enhanced Raman spectroscopy (SERS) to detect biomarkers for micropapillary lung adenocarcinoma. The assay identified 4 proteins associated with MPP+ LUAD and enabled simultaneous detection of these proteins using SERS barcodes. Machine learning models based on the SERS data were able to effectively distinguish between MPP+ LUAD patients, MPP- LUAD patients, and healthy donors, demonstrating strong diagnostic potential for early and non-invasive MPP detection.      1        0.841334                  1\n",
      "40368116                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Protease engineering: Approaches, tools, and emerging trends. Engineered proteases with bespoke substrate specificities and activities can empower broad and innovative applications in biomedicine, mass spectrometry-based proteomics, and chemical and synthetic biology. This review provides an authoritative, topical, and detailed description and discussion of the directed evolution and high-throughput strategies designed to engineer the substrate specificity of proteases in E. coli, yeast, phage, and cell-free systems. Second, we discuss emerging protease engineering strategies that complement directed evolution, including antibody-protease fusions that enable proximity catalysis, and protease substrate specificity switching driven by exogenous protein-protein interactions. Lastly, we discuss principles for engineering split and autoinhibited proteases, which are key signal-processing modules in protein circuits. Overall, readers will gain a valuable understanding of the latest advances in protease engineering, focusing on methodologies and strategies that enable precise control of protease activity and specificity.                                                                                                        Here is a summary of the article in 2-3 sentences:\\n\\nThe article reviews the approaches, tools, and emerging trends in protease engineering, which enables the design of proteases with specific substrate preferences and activities. Directed evolution and high-throughput strategies are discussed as methods for engineering substrate specificity in various systems, including E. coli, yeast, phage, and cell-free systems. Additionally, the article touches on other emerging approaches, such as antibody-protease fusions and exogenous protein-protein interactions, which can be used to control protease activity and specificity.      0        0.000177                  0\n",
      "40348282                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Predicting Survival Outcomes in Renal Cell Carcinoma Spinal Metastases: A Multicenter Evaluation of Existing Prognostic Systems. Survival prediction models for patients with spinal metastases are crucial for guiding clinical decision-making and optimizing treatment strategies. Renal cell carcinoma (RCC) spinal metastases (RCC-SM) present unique challenges due to their distinct biological behavior and variable response to systemic therapies.                                                                                                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nPredicting survival outcomes for patients with renal cell carcinoma spinal metastases is crucial for informing clinical decisions and optimizing treatment strategies. Renal cell carcinoma spinal metastases (RCC-SM) pose unique challenges due to their distinct biological behavior and varied response to systemic therapies, making it important to develop reliable prediction models.      0        0.215983                  0\n",
      "40356764                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Different MRI-based radiomics machine learning models to predict CD3+ tumor-infiltrating lymphocytes in rectal cancer. This study aimed to develop and evaluate multiple machine learning models utilizing contrast-enhanced T1-weighted imaging (T1-CE) to differentiate between low-/high-infiltration of total T lymphocytes (CD3) in patients with rectal cancer.                                                                                                                                                                                                                                                                                                                                                                         Here is a summary of the article:\\n\\nResearchers developed and tested various machine learning models using magnetic resonance imaging (MRI) data to predict the presence of CD3+ tumor-infiltrating lymphocytes (TILs) in patients with rectal cancer. The goal was to differentiate between low- and high-infiltration levels based on contrast-enhanced T1-weighted MRI scans.      1        0.999868                  1\n",
      "40337276                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Integration of histopathological image features and multi-dimensional omics data in predicting molecular features and survival in glioblastoma. Glioblastoma (GBM) is a highly malignant brain tumor with complex molecular mechanisms. Histopathological images provide valuable morphological information of tumors. This study aims to evaluate the predictive potential of quantitative histopathological image features (HIF) for molecular characteristics and overall survival (OS) in GBM patients by integrating HIF with multi-omics data.                                                                                                                                                                                                           Here is a summary of the article in 2-3 sentences:\\n\\nThe study aimed to investigate whether integrating histopathological image features with multi-dimensional omics data could predict molecular features and survival outcomes in glioblastoma (GBM) patients. Histopathological images were used to extract quantitative features, which were then combined with omics data to evaluate their predictive power for GBM patient outcomes. The goal was to identify potential biomarkers for molecular characteristics and overall survival.      1        0.991827                  1\n",
      "40361437                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Evolving and Novel Applications of Artificial Intelligence in Cancer Imaging. Artificial intelligence (AI) is revolutionizing cancer imaging, enhancing screening, diagnosis, and treatment options for clinicians. AI-driven applications, particularly deep learning and machine learning, excel in risk assessment, tumor detection, classification, and predictive treatment prognosis. Machine learning algorithms, especially deep learning frameworks, improve lesion characterization and automated segmentation, leading to enhanced radiomic feature extraction and delineation. Radiomics, which quantifies imaging features, offers personalized treatment response predictions across various imaging modalities. AI models also facilitate technological improvements in non-diagnostic tasks, such as image optimization and automated medical reporting. Despite advancements, challenges persist in integrating AI into healthcare, tracking accurate data, and ensuring patient privacy. Validation through clinician input and multi-institutional studies is essential for patient safety and model generalizability. This requires support from radiologists worldwide and consideration of complex regulatory processes. Future directions include elaborating on existing optimizations, integrating advanced AI techniques, improving patient-centric medicine, and expanding healthcare accessibility. AI can enhance cancer imaging, optimizing precision medicine and improving patient outcomes. Ongoing multidisciplinary collaboration between radiologists, oncologists, software developers, and regulatory bodies is crucial for AI's growing role in clinical oncology. This review aims to provide an overview of the applications of AI in oncologic imaging while also discussing their limitations.                                                                                  Here is a summary of the article in 3 sentences:\\n\\nArtificial intelligence (AI) is transforming cancer imaging by enhancing screening, diagnosis, and treatment options for clinicians. AI-driven applications excel in risk assessment, tumor detection, classification, and predictive treatment prognosis, as well as lesion characterization and automated segmentation. Despite challenges persisting in integrating AI into healthcare, the potential benefits of AI in oncologic imaging include optimizing precision medicine and improving patient outcomes, making ongoing multidisciplinary collaboration crucial for its growing role in clinical oncology.      1        0.993153                  1\n",
      "40359715                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Breast cancer neoadjuvant therapy outcome prediction based on clinical patient and tumor features: A cross-sectional study. Breast cancer is the most common malignant disease in the female population and one of the most common diseases in developed countries. Many factors which may impact the development and outcome of this complex disease have been investigated. The aim of this study was to analyze factors that affect neoadjuvant therapy outcomes and create an outcome prediction model based on these factors.                                                                                                                                                                                                                                                                                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nThe article discusses the most common malignant disease affecting women, breast cancer, which has many influencing factors. The goal of this study was to identify factors that impact the outcome of neoadjuvant therapy (pre-surgery treatment) and develop a predictive model based on these factors.      0        0.006045                  0\n",
      "40369585                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Optimizing breast lesions diagnosis and decision-making with a deep learning fusion model integrating ultrasound and mammography: a dual-center retrospective study. This study aimed to develop a BI-RADS network (DL-UM) via integrating ultrasound (US) and mammography (MG) images and explore its performance in improving breast lesion diagnosis and management when collaborating with radiologists, particularly in cases with discordant US and MG Breast Imaging Reporting and Data System (BI-RADS) classifications.                                                                                                                                                                                                                                                                                                                                              Here is a 2-3 sentence summary of the article:\\n\\nA deep learning fusion model was developed to integrate ultrasound and mammography images for breast lesion diagnosis and management. The model, called DL-UM, aimed to improve diagnostic accuracy by combining information from both imaging modalities, particularly in cases where there were discordant diagnoses between ultrasound and mammography.      1        0.987046                  1\n",
      "40365297                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Optimizing theranostics chatbots with context-augmented large language models.                                                                                                                                                          The article discusses the potential of combining context-augmented large language models (LLMs) with theranostic chatbots to improve patient engagement and healthcare outcomes. Theranostic chatbots are AI-powered platforms that provide personalized health information and support, while LLMs can enhance their ability to understand patients' needs and provide more accurate and relevant information. By integrating these two technologies, the article suggests that theranostic chatbots can become even more effective in supporting patients throughout their healthcare journeys.      0        0.090086                  0\n",
      "40347229                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         ESR Bridges: lung cancer: new developments in imaging and treatment-a multidisciplinary view.                                                                                                                    The article \"ESR Bridges: lung cancer: new developments in imaging and treatment-a multidisciplinary view\" provides an overview of recent advancements in imaging and treatment options for lung cancer, a disease that is increasingly common and deadly. The piece highlights the importance of a multidisciplinary approach, combining expertise from radiology, oncology, surgery, and pathology to improve patient outcomes. It also discusses innovative imaging techniques, such as computed tomography (CT) scans and positron emission tomography (PET), which can aid in early detection and accurate staging of lung cancer.      0        0.367976                  0\n",
      "40329352                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by significantly improving the efficacy of treatments and tolerability for patients with non-small cell lung cancer (NSCLC). However, even after meticulous selection based on molecular criteria, only 20-30% of the patients respond to ICIs. This highlights the urgent clinical need to develop more precise biomarkers to better identify individuals who will benefit from these expensive therapies.                                                                                                                                                                                                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nResearchers used computational analysis of whole slide images to predict PD-L1 expression and progression-free survival in non-small cell lung cancer patients treated with immune checkpoint inhibitors (ICIs). Despite careful selection based on molecular criteria, only 20-30% of patients respond to ICIs, highlighting the need for more precise biomarkers.      1        0.919529                  1\n",
      "40364006                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     New Evidence About Malignant Transformation of Endometriosis-A Systematic Review.                                                                                                                                                                                                                                                                                                                                                                                                                                                         I'm happy to summarize an article for you! However, I don't see a specific article provided with the title \"New Evidence About Malignant Transformation of Endometriosis-A Systematic Review.\" Would you like me to provide a general summary about endometriosis and its potential risks instead?      0        0.000396                  0\n",
      "40343502                                                                                                                                                                                                                                                            Development of a prognostic model for osteosarcoma based on macrophage polarization-related genes using machine learning: implications for personalized therapy. While neoadjuvant chemotherapy combined with surgical resection has improved the prognosis for patients with osteosarcoma, its impact on metastatic and recurrent cases remains limited. Immunotherapy is emerging as a promising alternative. However, the relationship between the phenotype of tumor-associated macrophages and the prognosis of osteosarcoma remains unclear. Differentially expressed gene during macrophage polarization were identified using the Monocle package. Weighted gene co-expression network analysis was conducted to select genes regulating macrophage polarization. The least absolute shrinkage and selection operator algorithm and multivariate Cox regression were used to construct long-term survival predictive strategies. Multiple machine learning algorithms identified target genes for pan-cancer analysis. Lentiviral transfection created stable strains with target gene knockdown, and CCK-8 and transwell migration assays verified the target gene's effects. Western blot and flow cytometry assessed the impact of target genes on macrophage polarization. A total of 141 genes regulating macrophage polarization were identified, from which eight genes were selected to construct prognostic models. Significant differences between high-risk and low-risk groups were observed in immune cell activation, immune-related signaling pathways, and immune function. The prognostic model and target gene were validated to provide more precise immunotherapy options for osteosarcoma and other tumors. BNIP3 knockdown decreased osteosarcoma cell proliferation and migration and promoted macrophage polarization to the M2 phenotype. The constructed prognostic model offers precise immunotherapy regimens and valuable insights into mechanisms underlying current studies. Furthermore, BNIP3 may serve as a potential immunotherapeutic target for osteosarcoma and other tumors.                                                                                                                                    Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a predictive model for osteosarcoma prognosis based on genes related to macrophage polarization using machine learning algorithms. The study identified 141 genes regulating macrophage polarization, from which eight were selected to construct prognostic models that showed significant differences between high-risk and low-risk groups in immune cell activation and function. The findings suggest that targeting specific genes, such as BNIP3, may provide more precise immunotherapy options for osteosarcoma and other tumors.      1        0.892069                  1\n",
      "40325103                                                                                                                                                                                                                                   Advanced holographic convolutional dense networks and Tangent runner optimization for enhanced polycystic ovarian disease classification. Polycystic Ovarian Disease (PCOD) is among the most prevalent endocrine disorders complicating the health of innumerable women worldwide due to lack of diagnosis and appropriate management. The diagnosis of PCOD, along with proper classification with the help of ultrasound imaging, would be of immense importance for early intervention and timely management of the condition. However, most of the existing approaches suffer from lots of problems, including low accuracy and capability in feature extraction, and may also be resilient to noise; it can further delay or lead to a wrong diagnosis. The main objective of this paper is to address these important issues by proposing a deep learning model, Holographic Convolutional Dense Network (Coco-HoloNet) that will be tailored for the precise detection and classification of PCOD in ultrasound images with high accuracy. These are multi-fold contributions which focus on improvement in diagnostic accuracy by overcoming the various limitations of conventional approaches. CoCo-HoloNet is using a layered architecture by integrating convolutional layers, dense blocks, and pooling strategies that leverage capturing and extraction of significant features from the input effectively. More importantly, the model is also embedded with the Tangent-Runner Adaptive Optimization (TRAdO) technique, which dynamically calculates the regularization parameters to overcome overfitting problems and improves the generalization capability of the model. The approach not only ensures the richest possible feature representation, but it also results in outstanding improvements within the performance measures of a model, such that the accuracy rate exceeds 99%. Further experimentation with CoCo-HoloNet on an extended Kaggle PCOD ultrasound image dataset proves its effectiveness by reporting higher precision, recall, and F1-scores than those obtained by state-of-the-art existing methods. Here is a summary of the article in 2-3 sentences:\\n\\nThe paper proposes a deep learning model called Holographic Convolutional Dense Network (CoCo-HoloNet) to accurately diagnose and classify Polycystic Ovarian Disease (PCOD) from ultrasound images. The CoCo-HoloNet model uses a layered architecture with convolutional layers, dense blocks, and pooling strategies to extract significant features from the input, and is embedded with the Tangent-Runner Adaptive Optimization technique to overcome overfitting problems. As a result, the model achieves an accuracy rate exceeding 99% on an extended Kaggle PCOD ultrasound image dataset, outperforming existing state-of-the-art methods in terms of precision, recall, and F1-scores.      1        0.950367                  1\n",
      "40366574                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Development and Validation of a Machine Learning-Based Predictive Model for Postoperative Frailty in Patients with Non-Small Cell Lung Cancer and Its Relation to Early Recovery. This study was designed to evaluate the postoperative frailty status of patients with non-small cell lung cancer, identify influencing factors, establish a machine learning-based prediction model, and explore the correlation between frailty status at 3 months and early recovery at 1 month postoperatively.                                                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a machine learning-based predictive model to assess postoperative frailty in patients with non-small cell lung cancer, aiming to identify factors that influence frailty status and explore its relationship with early recovery. The study aimed to evaluate postoperative frailty, establish a predictive model, and examine the correlation between frailty at 3 months and early recovery at 1 month after surgery.      0        0.745036                  1\n",
      "40348987                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              A novel framework for esophageal cancer grading: combining CT imaging, radiomics, reproducibility, and deep learning insights. This study aims to create a reliable framework for grading esophageal cancer. The framework combines feature extraction, deep learning with attention mechanisms, and radiomics to ensure accuracy, interpretability, and practical use in tumor analysis.                                                                                                                                                                                                                                                             Here is a summary of the article in 2-3 sentences:\\n\\nA new approach has been developed to grade esophageal cancer using a combination of computed tomography (CT) imaging, radiomics, reproducibility, and deep learning insights. This framework aims to provide an accurate, interpretable, and practical method for tumor analysis. By combining feature extraction, attention-based deep learning, and radiomics, the goal is to create a reliable grading system for esophageal cancer.      1        0.978585                  1\n",
      "40368928 Performance of MRI-based radiomics for prediction of residual disease status in patients with nasopharyngeal carcinoma after radical radiotherapy. The purpose of this study was to determine if habitat radiomic features extracted from pretherapy multi-sequence MRI predict residual status in patients with Nasopharyngeal Carcinoma (NPC) after radical radiotherapy. The retrospective study enrolled 179 primary NPC patients, divided into training and validation cohorts at a 7:3 ratio. K-means clustering was employed to segment T2WI, CE-T1WI and FSCE-T1WI images, creating habitats within the volume of interest. Identify relevant features that can recognize NPC residuals. In the training cohort, support vector machine (SVM) models were developed utilizing the radiomic features extracted from each habitat and the entire tumor, selecting the most predictive features for each sequence. SVM models were constructed by combining the optimal radiomic features from each sequences with clinical data. Model performance was compared and validated using receiver operating characteristic (ROC) curves, calibration curves and decision curve analysis (DCA), and differences between models were assessed using the DeLong test. The optimal clustering results revealed 4 habitats in FSCE-T1WI, while 2 habitats in both CE-T1WI and T2WI sequences. In the training cohort, we compared the predictive accuracy of SVM models based on different habitats and total tumor characteristics from three sequences, and found that the features from T2 Hab2, CE-T1 Hab1, and FSCE-T1 Hab4 images showed higher performance. Incorporation of habitat-based radiomic features and clinical variables significantly enhanced the predictive performance. The integrated model exhibits the optimal predictive performance, with the area under the curve (AUC) values of 0.921 (SEN = 0.821, SPE = 0.830) in the training cohort and 0.811 (SEN = 0.778, SPE = 0.722) in the validation cohort. Compared to conventional radiomics, habitat imaging features that distinguish intratumoral heterogeneity have higher predictive value, making them potential non-invasive biomarkers for assessing NPC residual after radiotherapy. Integration of multi-sequence MRI habitat radiomic with clinical parameters further improved predictive accuracy.                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nResearchers used magnetic resonance imaging (MRI) to develop a radiomics model that can predict the presence of residual disease in patients with nasopharyngeal carcinoma after radiation therapy. The model, which incorporates features from different MRI sequences and habitats within the tumor, showed high predictive accuracy in both training and validation cohorts. The integrated model outperformed conventional radiomics models and may serve as a non-invasive biomarker for assessing residual disease status after radiotherapy.      1        0.996023                  1\n",
      "40331540                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Advancing brain tumor detection and classification in Low-Dose CT images using the innovative multi-layered deep neural network model. BackgroundEffective brain tumour therapy and better patient outcomes depend on early tumour diagnosis. Accurate diagnosis can be hampered by traditional imaging techniques' frequent struggles with low resolution and noise, especially in Low Dose CT scans.                                                                                                                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nEarly and accurate detection of brain tumors is crucial for effective treatment and better patient outcomes. However, traditional imaging techniques often struggle to accurately diagnose tumors due to limitations such as low resolution and noise, particularly in Low-Dose CT scans. A new multi-layered deep neural network model has been developed to improve the detection and classification of brain tumors in these challenging images.      1        0.999546                  1\n",
      "40335825                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         MRI-based machine learning reveals proteasome subunit PSMB8-mediated malignant glioma phenotypes through activating TGFBR1/2-SMAD2/3 axis. Gliomas are the most prevalent and aggressive neoplasms of the central nervous system, representing a major challenge for effective treatment and patient prognosis. This study identifies the proteasome subunit beta type-8 (PSMB8/LMP7) as a promising prognostic biomarker for glioma. Using a multiparametric radiomic model derived from preoperative magnetic resonance imaging (MRI), we accurately predicted PSMB8 expression levels. Notably, radiomic prediction of poor prognosis was highly consistent with elevated PSMB8 expression. Our findings demonstrate that PSMB8 depletion not only suppressed glioma cell proliferation and migration but also induced apoptosis via activation of the transforming growth factor beta (TGF-β) signaling pathway. This was supported by downregulation of key receptors (TGFBR1 and TGFBR2). Furthermore, interference with PSMB8 expression impaired phosphorylation and nuclear translocation of SMAD2/3, critical mediators of TGF-β signaling. Consequently, these molecular alterations resulted in reduced tumor progression and enhanced sensitivity to temozolomide (TMZ), a standard chemotherapeutic agent. Overall, our findings highlight PSMB8's pivotal role in glioma pathophysiology and its potential as a prognostic marker. This study also demonstrates the clinical utility of MRI radiomics for preoperative risk stratification and pre-diagnosis. Targeted inhibition of PSMB8 may represent a therapeutic strategy to overcome TMZ resistance and improve glioma patient outcomes.                                                                                                                                                                    Here is a summary of the article in 2-3 sentences:\\n\\nResearchers used magnetic resonance imaging (MRI) and machine learning to identify the proteasome subunit beta type-8 (PSMB8) as a promising prognostic biomarker for gliomas. PSMB8 depletion was found to suppress glioma cell proliferation and migration, induce apoptosis, and impair phosphorylation of SMAD2/3, leading to reduced tumor progression and enhanced sensitivity to chemotherapy. These findings suggest that targeted inhibition of PSMB8 may be a therapeutic strategy to improve glioma patient outcomes.      0        0.793253                  1\n",
      "40340630                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Quantitative analysis and clinical determinants of orthodontically induced root resorption using automated tooth segmentation from CBCT imaging. Orthodontically induced root resorption (OIRR) is difficult to assess accurately using traditional 2D imaging due to distortion and low sensitivity. While CBCT offers more precise 3D evaluation, manual segmentation remains labor-intensive and prone to variability. Recent advances in deep learning enable automatic, accurate tooth segmentation from CBCT images. This study applies deep learning and CBCT technology to quantify OIRR and analyze its risk factors, aiming to improve assessment accuracy, efficiency, and clinical decision-making.                                                                                                                                                                                                                                      Here is a summary of the article in 2-3 sentences:\\n\\nOrthodontically induced root resorption (OIRR) is challenging to assess accurately using traditional 2D imaging methods. Computerized tomography (CBCT) offers a more precise 3D evaluation, but manual segmentation of CBCT images can be labor-intensive and prone to variability. A new study uses deep learning technology to automatically segment teeth from CBCT images, allowing for accurate quantification of OIRR and analysis of its risk factors.      0        0.011406                  0\n",
      "40347323                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Preferences for the Use of Artificial Intelligence for Breast Cancer Screening in Australia: A Discrete Choice Experiment. Breast cancer screening is considered an effective early detection strategy. Artificial intelligence (AI) may both offer benefits and create risks for breast screening programmes. To use AI in health screening services, the views and expectations of consumers are critical. This study examined the preferences of Australian women regarding AI use in breast cancer screening and the impact of information on preferences using discrete choice experiments.                                                                                                                                                                                                                    Here is a summary of the article in 2-3 sentences:\\n\\nThe effectiveness of breast cancer screening relies heavily on early detection, and the potential use of artificial intelligence (AI) to aid this process raises both benefits and risks. To successfully integrate AI into breast screening programs, it's crucial to understand the preferences of women regarding AI usage. This study investigated Australian women's views on using AI for breast cancer screening and how providing information affects their preferences.      0        0.224509                  0\n",
      "40352589                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Overexpression of MMP14 is associated with poor prognosis and immune cell infiltration in colon cancer. Colorectal cancer (CRC) poses a significant risk of recurrence and distant metastases. This study investigated the regulatory role of Matrix metalloproteinase-14 (                                                                                                                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nOverexpression of MMP14, a protein involved in tissue remodeling, is linked to poor prognosis and increased immune cell infiltration in colon cancer patients. Colorectal cancer has a high risk of recurrence and distant metastases. This study explored the regulatory role of MMP14 in colon cancer, suggesting that it may play a key part in the disease's progression.      0        0.118234                  0\n",
      "40349260                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Random forest-based model for the recurrence prediction of borderline ovarian tumor: clinical development and validation. This study aims to develop an effective machine learning (ML)-based predictive model for the recurrence of borderline ovarian tumor (BOT), and provide the guidelines of accurate clinical diagnosis and precise treatment for patients.                                                                                                                                                                                                                                                                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nThe study aimed to create a reliable machine learning-based model using random forests to predict the recurrence of borderline ovarian tumors (BOTs). The developed model was validated against clinical data, with the goal of providing accurate diagnoses and treatment guidelines for patients.      1        0.998311                  1\n",
      "40334987                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Artificial Intelligence in the Management of Malnutrition in Cancer Patients: A Systematic Review. Malnutrition is a critical complication among cancer patients, affecting up to 80% of individuals depending on cancer type, stage, and treatment. Artificial Intelligence (AI) has emerged as a promising tool in healthcare, with potential applications in nutritional management to improve early detection, risk stratification, and personalized interventions.                                                                                                                                                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nMalnutrition affects up to 80% of cancer patients, depending on factors such as cancer type, stage, and treatment. Artificial Intelligence (AI) has shown promise in healthcare, particularly in nutritional management, enabling early detection, risk stratification, and personalized interventions for cancer patients with malnutrition.      1        0.403584                  0\n",
      "40324259                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Establishment and validation of a novel risk model based on PANoptosis-related genes to predict prognosis in head and neck squamous cell carcinoma. Head and neck squamous cell carcinoma (HNSC) is a common cancer worldwide with poor prognosis. Current treatment methods have limited effect on improving the prognosis of patients with HNSC. Differentially expressed PANoptosis-related genes in HNSC were identified from the TCGA using limma and WGCNA. A prognostic model was established using univariate and multivariate Cox regression analyses and machine learning, and its performance was evaluated using Kaplan-Meier and receiver operating characteristic curves. SNP data was analyzed using maftools package. Immune analysis was performed using IOBR package and TIDE website. The scRNA data was analyzed using Seurat and cellchat package. The expression of hub genes was validated in vitro. The prognostic model comprising 5 hub PANoptosis-related genes (AIFM1, AKT3, CDKN2A, EGFR, IL1RAP) accurately predicted patient outcomes, with the high-risk group exhibiting poorer survival. mRNA expression levels of all 5 hub genes were elevated in the tumor cells, but only AIFM1, AKT3 and IL1RAP's protein expression were higher in tumor tissues. Additionally, high expression of AIFM1, AKT3, EGFR, IL1RAP and low expression of CDKN2A indicated poor prognosis of HNSC patients. The decreasing levels of CD4 T cells, CD8 T cells and M1 macrophages were observed in high-risk groups. There was a significant difference of 5-fluorouracil in low and high-risk groups. scRNA analysis exhibited that TNF pathway was important in the interaction between macrophages and T cells. We identified 5 hub genes and constructed a great risk model for the prognosis of HNSC. The immune cells may influence the HNSC malignant through TNF signal pathway.                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nA novel risk model was developed to predict the prognosis of head and neck squamous cell carcinoma (HNSCC) patients based on PANoptosis-related genes. The model, which included five hub genes (AIFM1, AKT3, CDKN2A, EGFR, and IL1RAP), accurately predicted patient outcomes and identified high-risk groups with poorer survival. Additionally, the study found that immune cells, such as T cells and macrophages, may influence HNSCC malignancy through the tumor necrosis factor (TNF) signal pathway.      0        0.082634                  0\n",
      "40369011                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  A multi-layered defense against adversarial attacks in brain tumor classification using ensemble adversarial training and feature squeezing. Deep learning, particularly convolutional neural networks (CNNs), has proven valuable for brain tumor classification, aiding diagnostic and therapeutic decisions in medical imaging. Despite their accuracy, these models are vulnerable to adversarial attacks, compromising their reliability in clinical settings. In this research, we utilized a VGG16-based CNN model to classify brain tumors, achieving 96% accuracy on clean magnetic resonance imaging (MRI) data. To assess robustness, we exposed the model to Fast Gradient Sign Method (FGSM) and Projected Gradient Descent (PGD) attacks, which reduced accuracy to 32% and 13%, respectively. We then applied a multi-layered defense strategy, including adversarial training with FGSM and PGD examples and feature squeezing techniques such as bit-depth reduction and Gaussian blurring. This approach improved model resilience, achieving 54% accuracy on FGSM and 47% on PGD adversarial examples. Our results highlight the importance of proactive defense strategies for maintaining the reliability of AI in medical imaging under adversarial conditions.                                                                                                                                                                             Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a multi-layered defense strategy to protect brain tumor classification models from adversarial attacks, achieving a 54% accuracy on Fast Gradient Sign Method (FGSM) and 47% on Projected Gradient Descent (PGD) attacked data. The approach combined ensemble adversarial training with feature squeezing techniques, such as bit-depth reduction and Gaussian blurring. This proactive defense strategy aims to maintain the reliability of AI in medical imaging under adversarial conditions.      1        0.955186                  1\n",
      "40341828                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Fusion-Brain-Net: A Novel Deep Fusion Model for Brain Tumor Classification. Brain tumors are among the most prevalent and lethal diseases. Early diagnosis and precise treatment are crucial. However, the manual classification of brain tumors is a laborious and complex task.                                                                                                                                                                                                                                                                                                                  Here is a summary of the article in 2-3 sentences:\\n\\nThe article discusses the development of Fusion-Brain-Net, a novel deep fusion model for classifying brain tumors. Brain tumors are a common and deadly disease, requiring early diagnosis and precise treatment. The manual classification of brain tumors is a time-consuming and complex task that can be improved through the use of advanced AI models like Fusion-Brain-Net.      1        0.791703                  1\n",
      "40356086                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            A systematic review and meta-analysis of lung cancer risk prediction models. Lung cancer (LC) remains the leading cause of cancer-related mortality worldwide. Early detection through targeted screening significantly improves patient outcomes. However, identifying high-risk individuals remains a critical challenge.                                                                                                                                                                                                                                          Here is a summary of the article in 2-3 sentences:\\n\\nLung cancer is the leading cause of cancer-related deaths globally and early detection through targeted screening can improve patient outcomes. Identifying high-risk individuals remains a significant challenge in lung cancer prevention, making accurate risk prediction models crucial. A systematic review and meta-analysis aims to assess the performance of existing lung cancer risk prediction models to better identify those at highest risk.      0        0.079329                  0\n",
      "40337768                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Development and validation of a basement membrane-associated immune prognostic model for hepatocellular carcinoma. Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, has a poor prognosis primarily due to its invasive and metastatic characteristics. Cancer invasion through basement membrane (BM) is the pivotal initial step in tumor dissemination and metastasis. This study aimed to identify gene signatures associated with the BM to enhance the overall prognosis of HCC.                                                                                                                                                                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed an immune prognostic model that focuses on basement membrane (BM) associations to improve the prognosis of hepatocellular carcinoma (HCC). The study aims to identify gene signatures linked to BM involvement, which is crucial for HCC's invasive and metastatic characteristics. By analyzing BM-associated genes, the model hopes to enhance overall prognosis outcomes for patients with HCC.      0        0.835407                  1\n",
      "40362602                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    A Transfer Learning Framework for Predicting and Interpreting Drug Responses via Single-Cell RNA-Seq Data. Chemotherapy is a fundamental therapy in cancer treatment, yet its effectiveness is often undermined by drug resistance. Understanding the molecular mechanisms underlying drug response remains a major challenge due to tumor heterogeneity, complex cellular interactions, and limited access to clinical samples, which also hinder the performance and interpretability of existing predictive models. Meanwhile, single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool for uncovering resistance mechanisms, but the systematic collection and utilization of scRNA-seq drug response data remain limited. In this study, we collected scRNA-seq drug response datasets from publicly available web sources and proposed a transfer learning-based framework to align bulk and single cell sequencing data. A shared encoder was designed to project both bulk and single-cell sequencing data into a unified latent space for drug response prediction, while a sparse decoder guided by prior biological knowledge enhanced interpretability by mapping latent features to predefined pathways. The proposed model achieved superior performance across five curated scRNA-seq datasets and yielded biologically meaningful insights through integrated gradient analysis. This work demonstrates the potential of deep learning to advance drug response prediction and underscores the value of scRNA-seq data in supporting related research.                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a transfer learning framework that combines bulk and single-cell RNA sequencing data to predict and interpret drug responses. The model, which uses shared encoding and sparse decoding, achieved superior performance across five curated datasets and provided biologically meaningful insights through integrated gradient analysis. This work demonstrates the potential of deep learning to advance drug response prediction and highlights the value of single-cell RNA sequencing data in supporting related research.      1        0.769928                  1\n"
     ]
    }
   ],
   "source": [
    "# TRAIN NEURAL NETWORK, DISPLAY RESULTS \n",
    "\n",
    "\n",
    "# Assuming X_train, y_train, X_test, y_test, df_test are available from previous cell\n",
    "# Build and train model\n",
    "model = funny_guy()\n",
    "model.add(Layer_Dense(768, 32, weight_regularizer_l2=5e-4))\n",
    "model.add(Activation_ReLU())\n",
    "model.add(Layer_Dropout(0.25))\n",
    "model.add(Layer_Dense(32, 1, weight_regularizer_l2=5e-4))\n",
    "model.add(Activation_Sigmoid())\n",
    "model.set(\n",
    "    loss=Loss_BinaryCrossEntropy(),\n",
    "    optimizer=Optimizer_SGD(learning_rate=0.008, decay=2e-5, momentum=0.82),\n",
    "    accuracy=Accuracy_Binary()\n",
    ")\n",
    "model.finalize()\n",
    "\n",
    "# Train model\n",
    "history = model.train(X_train, y_train, epochs=28, batch_size=20, print_every=10, validation_data=(X_test, y_test))\n",
    "\n",
    "# Predict and add to test DataFrame\n",
    "predictions = model.predict(X_test)\n",
    "df_test['raw_prediction'] = predictions.flatten()\n",
    "df_test['binary_prediction'] = (predictions > 0.5).astype(int)\n",
    "\n",
    "# Display test DataFrame\n",
    "print(\"\\nTest DataFrame with Predictions:\")\n",
    "print(df_test.to_string(index=False))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x500 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# PLOT RESULTS \n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Plotting\n",
    "epochs_range = range(1, len(history['train_loss']) + 1)\n",
    "plt.figure(figsize=(12, 5))\n",
    "plt.subplot(1, 2, 1)\n",
    "plt.plot(epochs_range, history['train_loss'], label='Training Loss')\n",
    "plt.plot(epochs_range, history['val_loss'], label='Validation Loss')\n",
    "plt.xlabel('Epochs')\n",
    "plt.ylabel('Loss')\n",
    "plt.title('Loss Over Epochs')\n",
    "plt.legend()\n",
    "plt.grid(True)\n",
    "plt.subplot(1, 2, 2)\n",
    "plt.plot(epochs_range, history['train_acc'], label='Training Accuracy')\n",
    "plt.plot(epochs_range, history['val_acc'], label='Validation Accuracy')\n",
    "plt.xlabel('Epochs')\n",
    "plt.ylabel('Accuracy')\n",
    "plt.title('Accuracy Over Epochs')\n",
    "plt.legend()\n",
    "plt.grid(True)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
